Micron Technology (MU) 10-Q 7 Jan 14 2014 Q1 Quarterly report Financial data

Document_and_Entity_Informatio

Document and Entity Information Document Document and Entity Information	3 Months Ended
	Nov. 28, 2013	Jan. 02, 2014
Entity Information [Line Items]	'	'
Entity Registrant Name	'MICRON TECHNOLOGY INC	'
Entity Central Index Key	'0000723125	'
Current Fiscal Year End Date	'--08-28	'
Entity Filer Category	'Large Accelerated Filer	'
Document Type	'10-Q	'
Document Period End Date	28-Nov-13	'
Document Fiscal Year Focus	'2014	'
Document Fiscal Period Focus	'Q1	'
Amendment Flag	'false	'
Entity Common Stock, Shares Outstanding	'	1,060,879,576

CONSOLIDATED_STATEMENTS_OF_OPE

CONSOLIDATED STATEMENTS OF OPERATIONS (USD $)	3 Months Ended
In Millions, except Per Share data, unless otherwise specified	Nov. 28, 2013	Nov. 29, 2012
Income Statement [Abstract]	'	'
Net sales	$4,042	$1,834
Cost of goods sold	2,761	1,617
Gross margin	1,281	217
Selling, general and administrative	176	119
Research and development	320	224
Restructure and asset impairments	-3	-21
Other operating (income) expense, net	237	-8
Operating income (loss)	551	-97
Interest income	5	3
Interest expense	-101	-57
Other non-operating income (expense), net	-80	-59
Income (loss) from continuing operations before equity method investments, income taxes, and noncontrolling interest	375	-210
Income tax provision	-80	-13
Equity in net income (loss) of equity method investees	86	-52
Net income (loss)	381	-275
Net income attributable to noncontrolling interests	-23	0
Net income (loss) attributable to Micron	$358	($275)
Earnings (loss) per share:	'	'
Basic (in dollars per share)	$0.34	($0.27)
Diluted (in dollars per share)	$0.30	($0.27)
Number of shares used in per share calculations:	'	'
Basic (in shares)	1,046	1,014
Diluted (in shares)	1,196	1,014

CONSOLIDATED_STATEMENTS_OF_COM

CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (USD $)	3 Months Ended
In Millions, unless otherwise specified	Nov. 28, 2013	Nov. 29, 2012
Net income (loss)	$381	($275)
Other comprehensive income (loss), net of tax	'	'
Foreign currency translation adjustments	6	7
Gain (loss) on investments, net	1	2
Gain (loss) on derivative instruments, net	-2	-5
Pension liability adjustments	0	-1
Other comprehensive income (loss)	5	3
Total comprehensive income (loss)	386	-272
Comprehensive (income) loss attributable to noncontrolling interests	-23	0
Comprehensive income (loss) attributable to Micron	$363	($272)

CONSOLIDATED_BALANCE_SHEETS

CONSOLIDATED BALANCE SHEETS (USD $)	Nov. 28, 2013	Aug. 29, 2013
In Millions, unless otherwise specified
Assets	'	'
Cash and equivalents	$3,654	$2,880
Short-term investments	216	221
Receivables	2,833	2,329
Inventories	2,459	2,649
Restricted cash	0	556
Other current assets	207	276
Total current assets	9,369	8,911
Long-term marketable investments	538	499
Property, plant and equipment, net	7,733	7,626
Equity method investments	490	396
Intangible assets, net	368	386
Deferred tax assets	802	861
Other noncurrent assets	494	439
Total assets	19,794	19,118
Liabilities and equity	'	'
Accounts payable and accrued expenses	2,630	2,115
Deferred income	236	243
Equipment purchase contracts	104	182
Current portion of long-term debt	1,543	1,585
Total current liabilities	4,513	4,125
Long-term debt	4,260	4,452
Other noncurrent liabilities	875	535
Total liabilities	9,648	9,112
Commitments and contingencies	'	'
Micron shareholders' equity:	'	'
Common stock, $0.10 par value, 3,000 shares authorized, 1,058 shares issued and outstanding (1,044 as of August 29, 2013)	106	104
Additional capital	8,919	9,187
Retained earnings (accumulated deficit)	126	-212
Accumulated other comprehensive income	68	63
Total Micron shareholders' equity	9,219	9,142
Noncontrolling interests in subsidiaries	927	864
Total equity	10,146	10,006
Total liabilities and equity	$19,794	$19,118

CONSOLIDATED_BALANCE_SHEETS_Pa

CONSOLIDATED BALANCE SHEETS (Parenthetical) (USD $)	Nov. 28, 2013	Aug. 29, 2013
In Millions, except Per Share data, unless otherwise specified
Liabilities and equity	'	'
Common stock, par value (in dollars per share)	$0.10	$0.10
Common Stock, authorized shares (in shares)	3,000	3,000
Common Stock, issued (in shares)	1,058	1,044
Common Stock, outstanding (in shares)	1,058	1,044

CONSOLIDATED_STATEMENTS_OF_CAS

CONSOLIDATED STATEMENTS OF CASH FLOWS (USD $)	3 Months Ended
In Millions, unless otherwise specified	Nov. 28, 2013	Nov. 29, 2012
Cash flows from operating activities	'	'
Net income (loss)	$381	($275)
Adjustments to reconcile net income (loss) to net cash provided by operating activities:	'	'
Depreciation expense and amortization of intangible assets	491	457
Amortization of debt discount and other costs	50	28
Noncash loss on restructure of debt	86	0
Stock-based compensation	22	19
(Gains) losses from currency hedges, net	14	51
Equity in net (income) loss of equity method investees	-86	52
Restructure and asset impairments	-8	-22
Change in operating assets and liabilities:	'	'
Receivables	-494	98
Inventories	190	-26
Accounts payable and accrued expenses	408	-108
Customer prepayments	212	-36
Deferred income taxes, net	59	4
Other	182	-6
Net cash provided by operating activities	1,507	236
Cash flows from investing activities	'	'
Expenditures for property, plant and equipment	-526	-434
Purchases of available-for-sale securities	-196	-317
Decrease in restricted cash	556	0
Proceeds from sales and maturities of available-for-sale securities	162	109
Other	25	3
Net cash provided by (used for) investing activities	21	-639
Cash flows from financing activities	'	'
Repayments of debt	-737	-52
Payments on equipment purchase contracts	-143	-104
Cash paid to purchase common stock	-42	-2
Proceeds from sales issuance of common stock	144	0
Cash received from noncontrolling interests	49	0
Proceeds from equipment sale-leaseback transactions	14	26
Proceeds from issuance of debt	0	173
Cash received for capped call transactions	0	24
Other	-20	-19
Net cash provided by (used for) financing activities	-735	46
Effect on changes in foreign currency exchange rates on cash and cash equivalents	-19	0
Net increase (decrease) in cash and equivalents	774	-357
Cash and equivalents at beginning of period	2,880	2,459
Cash and equivalents at end of period	3,654	2,102
Noncash investing and financing activities:	'	'
Exchange of convertible notes	756	0
Equipment acquisitions on contracts payable and capital leases	$80	$59

Business_and_Basis_of_Presenta

Business and Basis of Presentation	3 Months Ended
	Nov. 28, 2013
Disclosure Text Block [Abstract]	'
Business and Basis of Presentation	'
	Business and Basis of Presentation
	Micron Technology, Inc. and its consolidated subsidiaries (hereinafter referred to collectively as "we," "our," "us" and similar terms unless the context indicates otherwise) is one of the world's leading providers of advanced semiconductor solutions. Through our worldwide operations, we manufacture and market a full range of DRAM, NAND Flash and NOR Flash memory, as well as other innovative memory technologies, packaging solutions and semiconductor systems for use in leading-edge computing, consumer, networking, automotive, industrial, embedded and mobile products. The accompanying consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America consistent in all material respects with those applied in our Annual Report on Form 10-K for the year ended August 29, 2013. In the opinion of our management, the accompanying unaudited consolidated financial statements contain all adjustments necessary to present fairly our consolidated financial position and our consolidated results of operations and cash flows. Certain reclassifications have been made to prior period amounts to conform to current period presentation.
	Our fiscal year is the 52 or 53-week period ending on the Thursday closest to August 31. Our first quarters of fiscal 2014 and 2013 ended on November 28, 2013 and November 29, 2012, respectively. All period references are to our fiscal periods unless otherwise indicated. These interim financial statements should be read in conjunction with the consolidated financial statements and accompanying notes included in our Annual Report on Form 10-K for the year ended August 29, 2013.

Variable_Interest_Entities

Variable Interest Entities	3 Months Ended
	Nov. 28, 2013
Disclosure Text Block [Abstract]	'
Variable Interest Entities	'
	Variable Interest Entities
	We have interests in entities that are Variable Interest Entities ("VIEs"). If we are the primary beneficiary of a VIE, we are required to consolidate it. To determine if we are the primary beneficiary, we evaluate whether we have the power to direct the activities that most significantly impact the VIE's economic performance and the obligation to absorb losses or the right to receive benefits of the VIE that could potentially be significant to the VIE. Our evaluation includes identification of significant activities and an assessment of our ability to direct those activities based on governance provisions and arrangements to provide or receive product and process technology, product supply, operations services, equity funding, financing and other applicable agreements and circumstances. Our assessments of whether we are the primary beneficiary of our VIEs require significant assumptions and judgments.
	Unconsolidated Variable Interest Entities
	Inotera: Inotera Memories, Inc. ("Inotera") is a VIE because its equity is not sufficient to permit it to finance its activities without additional support from its shareholders. We have determined that we do not have the power to direct the activities of Inotera that most significantly impact its economic performance, primarily due to (1) limitations on our governance rights that require the consent of other parties for key operating decisions and (2) Inotera's dependence on Nanya for financing and the ability of Inotera to operate in Taiwan. Therefore, we do not consolidate Inotera and we account for our interest under the equity method.
	For further information regarding our VIEs that we account for under the equity method, see "Equity Method Investments" note.
	EQUVO Entities: EQUVO HK Limited and EQUVA Capital 1 Pte. Ltd. (together, the "EQUVO Entities") are special purpose entities created to facilitate equipment sale-leaseback financing transactions between us and a consortium of financial institutions that funded a series of sale-leaseback transactions ("Financing Entities"). Neither we nor the Financing Entities have an equity interest in the EQUVO Entities. The EQUVO Entities are VIEs because their equity is not sufficient to permit them to finance their activities without additional support from the Financing Entities and because the third-party equity holder lacks characteristics of a controlling financial interest. By design, the arrangements with the EQUVO Entities are merely financing vehicles and we do not bear any significant risks from variable interests with the EQUVO Entities. Therefore, we have determined that we do not have the power to direct the activities of the EQUVO Entities that most significantly impact their economic performance and we do not consolidate the EQUVO Entities.
	SC Hiroshima Energy Corporation: SC Hiroshima Energy Corporation ("SCHE") is an entity created to construct and operate a cogeneration, electrical power plant to support our wafer manufacturing facility in Hiroshima, Japan. SCHE is a VIE due to the nature of its tolling agreements with us and our purchase and call options for SCHE's assets. We do not have an equity ownership interest in SCHE. We do not control the operation and maintenance of the plant, which we have determined are the activities of SCHE that most significantly impacts its economic performance. Therefore, we do not consolidate SCHE.
	Consolidated Variable Interest Entities
	IMFT: IM Flash Technologies, LLC ("IMFT") is a VIE because all of its costs are passed to us and its other member, Intel Corporation ("Intel"), through product purchase agreements and IMFT is dependent upon us or Intel for any additional cash requirements.  We determined that we have the power to direct the activities of IMFT that most significantly impact its economic performance.  The primary activities of IMFT are driven by the constant introduction of product and process technology.  Because we perform a significant majority of the technology development, we have the power to direct its key activities.  In addition, IMFT manufactures certain products exclusively for us using our technology.  We also determined that we have the obligation to absorb losses and the right to receive benefits from IMFT that could potentially be significant to it.  Therefore, we consolidate IMFT.
	MP Mask: MP Mask Technology Center, LLC ("MP Mask") is a VIE because substantially all of its costs are passed to us and its other member, Photronics, Inc. ("Photronics"), through product purchase agreements and MP Mask is dependent upon us or Photronics for any additional cash requirements.  We determined that we have the power to direct the activities of MP Mask that most significantly impact its economic performance, primarily because (1) of our tie-breaking voting rights over key operating decisions and (2) nearly all key MP Mask activities are driven by our supply needs.  We also determined that we have the obligation to absorb losses and the right to receive benefits from MP Mask that could potentially be significant to it.  Therefore, we consolidate MP Mask.
	For further information regarding our consolidated VIEs, see "Consolidated Variable Interest Entities" note.

Recently_Issued_Accounting_Sta

Recently Issued Accounting Standards	3 Months Ended
	Nov. 28, 2013
Disclosure Text Block [Abstract]	'
Recently Issued Accounting Standards	'
	Recently Issued Accounting Standards
	There have been no recently issued accounting pronouncements that have had or are expected to have a material impact on our financial statements.

Elpida_Memory_Inc

Elpida Memory, Inc. (Elpida Company [Member])	3 Months Ended
	Nov. 28, 2013
Elpida Company [Member]	'
Business Acquisition [Line Items]	'
Elpida Memory, Inc.	'
	Elpida Memory, Inc.
	On July 31, 2013, we acquired Elpida Memory, Inc. ("Elpida") and an additional 24% ownership interest in Rexchip Electronics Corporation ("Rexchip"), now known as Micron Memory Taiwan Co., Ltd. ("MMT"). Both Elpida and MMT manufacture semiconductor memory products including mobile DRAM targeted toward mobile phones and tablets. We paid $615 million and $334 million for the acquisition of Elpida and the additional Rexchip shares, respectively. Elpida owns, directly and indirectly through a subsidiary, approximately 65% of MMT's outstanding common stock. Therefore, as a result of the consummation of our acquisition of Elpida and the Rexchip shares, we own approximately 89% ownership interest in MMT.
	In connection with the acquisition, we recorded net assets of $2,601 million and noncontrolling interest of $168 million. Because the fair value of the net assets acquired less noncontrolling interests exceeded the purchase price, we recognized a gain on the acquisition of $1,484 million.
	The following unaudited pro forma financial information presents the combined results of operations as if the Elpida acquisition had occurred on September 2, 2011.  The pro forma financial information includes the accounting effects of the business combination, including adjustments to the amortization of intangible assets, depreciation of property, plant and equipment, interest expense and elimination of intercompany activities.  The unaudited pro forma financial information below is not necessarily indicative of either future results of operations or results that might have been achieved had the Elpida acquisition occurred on September 2, 2011.
	Quarter ended	November 29,
		2012
	Net sales	$	2,619
	Net income (loss)	(226		)
	Net income (loss) attributable to Micron	(237		)
	Earnings (loss) per share:
	Basic	$	(0.23	)
	Diluted	(0.23		)
	The unaudited pro forma financial information for the first quarter of 2013 includes our results for the quarter ended November 29, 2012 and the results of Elpida, including the adjustments described above, for the quarter ended September 30, 2012.

Investments

Investments	3 Months Ended
	Nov. 28, 2013
Disclosure Text Block [Abstract]	'
Investments [Text Block]	'
	Investments
	As of November 28, 2013 and August 29, 2013, available-for-sale investments, including cash equivalents, were as follows:
	As of	November 28, 2013								August 29, 2013
		Amortized Cost		Gross Unrealized Gains		Gross Unrealized Losses		Fair Value		Amortized Cost		Gross Unrealized Gains		Gross Unrealized Losses			Fair Value
	Money market funds	$	1,677	$	—	$	—	$	1,677	$	1,188	$	—	$	—		$	1,188
	Certificates of deposit	558		—		—		558		349		—		—			349
	Corporate bonds	441		1		—		442		414		1		(1		)	414
	Government securities	133		—		—		133		168		—		—			168
	Asset-backed securities	107		—		—		107		97		—		—			97
	Commercial paper	63		—		—		63		61		—		—			61
	Marketable equity securities	6		—		—		6		6		—		—			6
		$	2,985	$	1	$	—	$	2,986	$	2,283	$	1	$	(1	)	$	2,283
	The table below presents the amortized cost and fair value of available-for-sale debt securities, including cash equivalents, as of November 28, 2013 by contractual maturity:
		Amortized Cost		Fair
				Value
	Money market funds not due at a single maturity date	$	1,677	$	1,677
	Due in 1 year or less	771		771
	Due in 1 - 2 years	257		258
	Due in 2 - 4 years	262		262
	Due after 4 years	12		12
		$	2,979	$	2,980
	Proceeds from the sales of available-for-sale securities for the first quarters of 2014 and 2013 were $113 million and $93 million, respectively. Gross realized gains and losses for the first quarters of 2014 and 2013 were not significant. As of November 28, 2013, no available-for-sale security had been in a loss position for longer than 12 months.

Receivables

Receivables	3 Months Ended
	Nov. 28, 2013
Disclosure Text Block [Abstract]	'
Receivables	'
	Receivables
	As of	November 28,		August 29,
		2013		2013
	Trade receivables (net of allowance for doubtful accounts of $5 and $5, respectively)	$	2,533	$	2,069
	Income and other taxes	65		74
	Other	235		186
		$	2,833	$	2,329
	As of November 28, 2013 and August 29, 2013, other receivables included $68 million and $34 million, respectively, due from Intel for amounts related to NAND Flash and certain emerging memory technologies product design and process development activities under cost-sharing agreements.  (See "Consolidated Variable Interest Entities" note.)

Inventories

Inventories	3 Months Ended
	Nov. 28, 2013
Disclosure Text Block [Abstract]	'
Inventories	'
	Inventories
	As of	November 28,		August 29,
		2013		2013
	Finished goods	$	836	$	796
	Work in process	1,462		1,719
	Raw materials and supplies	161		134
		$	2,459	$	2,649

Property_Plant_and_Equipment

Property, Plant and Equipment	3 Months Ended
	Nov. 28, 2013
Disclosure Text Block [Abstract]	'
Property, Plant and Equipment	'
	Property, Plant and Equipment
	As of	November 28,			August 29,
		2013			2013
	Land	$	86		$	86
	Buildings	4,892			4,835
	Equipment	15,909			15,600
	Construction in progress	195			84
	Software	319			315
		21,401			20,920
	Accumulated depreciation	(13,668		)	(13,294		)
		$	7,733		$	7,626
	Depreciation expense was $468 million and $437 million for the first quarters of 2014 and 2013, respectively. Other noncurrent assets included buildings, equipment, and other assets classified as held for sale of $49 million as of November 28, 2013 and $22 million as of August 29, 2013. Other noncurrent assets also included land held for development of $55 million as of November 28, 2013 and $54 million as of August 29, 2013.

Equity_Method_Investments

Equity Method Investments	3 Months Ended
	Nov. 28, 2013
Disclosure Text Block [Abstract]	'
Equity Method Investments	'
	Equity Method Investments
	As of	November 28, 2013					August 29, 2013
		Investment Balance		Ownership Percentage			Investment Balance		Ownership Percentage
	Inotera	$	437	35	%		$	344	35	%
	Tera Probe	42		40	%		40		40	%
	Other	11		Various			12		Various
		$	490				$	396
	We recognize our share of earnings or losses from these entities under the equity method, generally on a two-month lag.  Equity in net income (loss) of equity method investees, net of tax, included the following:
	Quarter ended	November 28,		November 29,
		2013		2012
	Inotera	$	84	$	(53	)
	Tera Probe	2		—
	Other	—		1
		$	86	$	(52	)
	As of November 28, 2013, our maximum exposure to loss from our involvement with our equity method investments that were VIEs was $437 million and primarily included our Inotera investment balance.  We may also incur losses in connection with our rights and obligations to purchase substantially all of Inotera's wafer production capacity under a supply agreement with Inotera.
	Inotera
	We have partnered with Nanya in Inotera, a Taiwanese DRAM memory company, since the first quarter of 2009.  As of November 28, 2013, we held a 35% ownership interest, Nanya and certain of its affiliates held a 36% ownership interest and the remaining ownership interest in Inotera was publicly held.
	As of November 28, 2013 the market value of our equity interest in Inotera was $1.47 billion based on the closing trading price of its shares in an active market. As of November 28, 2013 and August 29, 2013, there were gains of $50 million and $44 million, respectively, in accumulated other comprehensive income (loss) for cumulative translation adjustments from our equity investment in Inotera.
	As of September 30, 2013, Inotera's current liabilities exceeded its current assets by $766 million, which exposes Inotera to liquidity risk. As of June 30, 2013, Inotera was not in compliance with certain of its loan covenants, and had not been in compliance for the past several years, which gives the lenders the right under the agreements to require the repayment of such loans. Inotera received a waiver from complying with the June 30, 2013 financial covenants. Inotera's management has implemented plans to improve its liquidity and for the nine-month period ended September 30, 2013, Inotera generated net income of $333 million; however, there can be no assurance that Inotera will be successful in sufficiently improving its liquidity and complying with their loan covenants, which may result in its lenders requiring repayment of such loans during the next year.
	In the second quarter of 2013, we entered into agreements with Nanya and Inotera to amend the joint venture relationship involving Inotera. The amendments included a new supply agreement (the "Inotera Supply Agreement") between us and Inotera under which we are obligated to purchase for an initial period through January 2016, substantially all of Inotera's output at a purchase price based on a discount from market prices for our comparable components. The Inotera Supply Agreement contemplates annual negotiations with respect to potential successive one-year extensions and if in any year the parties do not agree to an extension, the agreement will terminate following the end of the then-existing term plus a subsequent three-year wind-down period. Our share of Inotera's capacity would decline over the three year wind-down period. In December 2013, we renewed our supply agreement with Inotera, which extended the initial period through January 2017. Effective through December 31, 2012, we had rights and obligations to purchase 50% of Inotera's wafer production capacity based on a margin-sharing formula among Nanya, Inotera and us. Under these agreements, we purchased $587 million and $201 million of DRAM products in the first quarters of 2014 and 2013, respectively.
	Pursuant to a cost-sharing arrangement with Nanya effective through December 31, 2012, our research and development ("R&D") costs were reduced by $15 million in the first quarter of 2013. Nanya ceased participating in the joint development program in the second quarter of 2013.
	Tera Probe
	In the fourth quarter of 2013, we acquired, as an asset of Elpida, a 40% interest in Tera Probe, Inc. ("Tera Probe"), a Japanese-based company mainly engaged in wafer testing and contract wafer-level package testing services. The net carrying value of our investment was less than our proportionate share of Tera Probe's equity at the time of our investment, and the difference is being amortized as a net credit to earnings through equity in net income (loss) of equity method investees (the "Tera Probe Amortization"). As of November 28, 2013, $34 million of unamortized Tera Probe Amortization was being recognized over a weighted-average period of 6 years.
	As of November 28, 2013, based on the closing trading price of Tera Probe's shares in an active market, the market value of our equity interest was $36 million. We evaluated our investment in Tera Probe and concluded that the decline in the market value below carrying value was not an other-than-temporary impairment primarily because of the limited amount of time the fair value was below the carrying value and historical volatility of the stock price.
	Tera Probe performs probe services for certain of our manufacturing processes. Included in cost of goods sold for the first quarter of 2014 is $33 million for probe services performed by Tera Probe.
	Other
	Transform: In the second quarter of 2010, we acquired a 50% interest in Transform, a developer, manufacturer and marketer of photovoltaic technology and solar panels, from Origin Energy Limited ("Origin"). As of November 28, 2013, we and Origin each held a 50% ownership interest in Transform.  In the third quarter of 2012, the Board of Directors of Transform approved a liquidation plan. In the first quarter of 2013, Transform terminated a fully-paid lease to a portion of our Boise manufacturing facilities and, as a result, we recognized a restructure gain of $25 million in the first quarter of 2013.
	Aptina: Other equity method investments included a 30% equity interest in Aptina. The amount of cumulative loss we recognized from our investment in Aptina through the second quarter of 2012 reduced our investment balance to zero and we ceased recognizing our proportionate share of Aptina's losses.
	In the first quarter of 2013, we recognized net sales of $61 million and cost of goods sold of $81 million from products sold to Aptina under a wafer supply agreement. In the third quarter of 2013, in connection with our sale of Micron Technology Italia, S.r.l. ("MIT") to LFoundry, we assigned to LFoundry our supply agreement with Aptina to manufacture image sensors at MIT. In 2013, we also loaned $45 million to Aptina under a short-term, interest-free, unsecured agreement. In the first quarter of 2014, Aptina repaid $15 million of the loan and as of November 28, 2013, other current assets included $30 million for the outstanding amount, which was repaid to us in the second quarter of 2014.

Intangible_Assets

Intangible Assets	3 Months Ended
	Nov. 28, 2013
Disclosure Text Block [Abstract]	'
Intangible Assets	'
	Intangible Assets
	As of	November 28, 2013					August 29, 2013
		Gross		Accumulated			Gross		Accumulated
		Amount		Amortization			Amount		Amortization
	Product and process technology	$	647	$	(288	)	$	642	$	(269	)
	Customer relationships	127		(118		)	127		(114		)
		$	774	$	(406	)	$	769	$	(383	)
	During the first quarters of 2014 and 2013, we capitalized $6 million and $9 million, respectively, for product and process technology with weighted-average useful lives of 9 years. Amortization expense was $23 million and $20 million for the first quarters of 2014 and 2013, respectively.  Annual amortization expense is estimated to be $90 million for 2014, $74 million for 2015, $66 million for 2016, $56 million for 2017 and $45 million for 2018.

Accounts_Payable_and_Accrued_E

Accounts Payable and Accrued Expenses	3 Months Ended
	Nov. 28, 2013
Disclosure Text Block [Abstract]	'
Accounts Payable and Accrued Liabilities Disclosure	'
	Accounts Payable and Accrued Expenses
	As of	November 28,		August 29,
		2013		2013
	Accounts payable	$	1,164	$	1,048
	Related party payables	605		374
	Salaries, wages and benefits	337		267
	Customer advances	192		140
	Income and other taxes	42		47
	Other	290		239
		$	2,630	$	2,115
	As of November 28, 2013 and August 29, 2013, related party payables included $578 million and $345 million, respectively, due to Inotera primarily for the purchase of DRAM products under the Inotera Supply Agreement. As of November 28, 2013 and August 29, 2013, respectively, related party payables also included $27 million and $29 million due to Tera Probe for probe services performed. (See "Equity Method Investments" note.)
	As of November 28, 2013 and August 29, 2013, customer advances included $100 million and $134 million, respectively, for amounts received from Intel to be applied to Intel's future purchases under a NAND Flash supply agreement. (See "Consolidated Variable Interest Entities – IMFT" note.)
	As of November 28, 2013 customer advances also included $90 million for amounts received from a customer in the first quarter of 2014 under a DRAM supply agreement to be applied to purchases through September 2016. In addition, as of November 28, 2013, other noncurrent liabilities included $158 million from this agreement.
	As of November 28, 2013 and August 29, 2013, other accounts payable and accrued expenses included $11 million and $8 million, respectively, due to Intel for NAND Flash product design and process development and licensing fees pursuant to cost-sharing agreements. (See "Consolidated Variable Interest Entities – IMFT" note.)

Debt

Debt	3 Months Ended
	Nov. 28, 2013
Disclosure Text Block [Abstract]	'
Debt	'
	Debt
	As of	November 28,			August 29,
		2013			2013
	Capital lease obligations	$	1,107		$	1,252
	Elpida creditor installment payments	1,095			1,644
	2014 convertible senior notes, due June 2014(1)	471			465
	2027 convertible senior notes, due June 2027	160			147
	2031A convertible senior notes, due August 2031	284			277
	2031B convertible senior notes, due August 2031	104			253
	2032C convertible senior notes, due May 2032(1)	467			463
	2032D convertible senior notes, due May 2032(1)	371			369
	2033E convertible senior notes, due February 2033	273			272
	2033F convertible senior notes, due February 2033	261			260
	2043G convertible senior notes, due November 2043(1)	628			—
	Other notes payable	582			635
		5,803			6,037
	Less current portion	1,543			1,585
		$	4,260		$	4,452
	(1) For these notes, we have the option to pay cash for the aggregate amount due upon conversion. It is our current intent to settle the principal amount of these notes in cash upon conversion. As a result, the notes are considered in diluted earnings per share under the treasury stock method.
	Elpida Creditor Installment Payments
	As of November 28, 2013, under the terms and conditions of the respective plans of reorganization of Elpida and Akita Elpida Memory, Inc. ("Akita" and, together with Elpida, the "Elpida Companies"), we are obligated to pay 142 billion yen (or the equivalent of $1,388 million based on exchange rates as of November 28, 2013) to the external creditors of the Elpida Companies (the "Elpida Creditor Installment Payments"). In October 2013, we made the first installment payments of $534 million to the external creditors of the Elpida Companies from funds that had been held in a restricted cash account since the acquisition date. The remaining payments are payable at the end of each calendar year beginning in 2014 through 2019.
	Debt Restructure
	In November 2013, we initiated a series of actions resulting in the restructure of certain of our series of convertible notes as follows:
	Exchange Transactions: On November 12, 2013, we exchanged with various note holders in a series of separate non-cash transactions an aggregate principal amount of $440 million of 2027 Notes, 2031A Notes and 2031B Notes (the "Exchanged Notes") into 3.00% Convertible Senior Notes due 2043 (the "2043G Notes") (the "Exchange Transactions").
	In the Exchange Transactions, we exchanged $80 million in principal amount of our 2027 Notes, $155 million in principal amount of our 2031A Notes and $205 million in principal amount of our 2031B Notes into $820 million aggregate issue price of 2043G Notes. The principal amount of 2043G Notes will accrete from their issue price to an aggregate principal amount at maturity of $1,025 million. The liability and equity components of the Exchanged Notes had previously been stated separately within debt and additional capital in our consolidated balance sheet. Accordingly, the Exchange Transaction resulted in derecognition for the Exchanged Notes of $345 million of carrying value of debt (which was the aggregate principal amount of $440 million, net of $95 million of unamortized debt discount) and $411 million of additional capital. In connection with the Exchange Transactions, we recognized a loss of $38 million based on the difference between the fair value and carrying value of the debt component of the Exchanged Notes (Level 2 fair value measurements). In addition, we recognized $11 million of interest expense to pay a "make-whole premium," which was included in the non-cash exchanges into 2043G Notes.
	Termination of Conversion Rights: On November 7, 2013, we gave notice to (1) terminate the conversion rights of the remaining 2027 Notes, not participating in the Exchange Transactions, effective as of December 13, 2013 and (2) settle entirely in cash any conversions of the 2027 Notes that occur prior to the conversion right termination date (the "Termination of Conversion Rights"). Through December 13, 2013, all holders of the 2027 Notes notified us of the exercise of their option to convert their 2027 Notes entirely (convertible into approximately 9 million shares of our common stock). Based on our notice to settle entirely in cash any conversions of the remaining 2027 Notes, the settlement obligation constituted a derivative instrument subject to mark-to-market accounting treatment. Therefore, we reclassified the $58 million fair value (Level 2 fair value measurement) of the equity component of the remaining 2027 Notes from additional capital to a derivative debt liability as of November 7, 2013, which resulted in an aggregate carrying value of the remaining 2027 Notes on that date of $138 million.
	Under the terms of the indenture of the 2027 Notes, the final cash settlement amount is determined based on the shares underlying the remaining 2027 Notes multiplied by the volume-weighted-average price of our common stock over a period of 20 consecutive trading days. Through the end of our first quarter of 2014, we recognized a loss of $22 million, included in other non-operating expense, on our derivative settlement obligations based on an increase in the settlement amounts. The carrying value of the remaining 2027 Notes was $160 million as of November 28, 2013. Subsequent to the end of our first quarter of 2014, due to a further increase in the settlement amounts, we paid the holders of the remaining 2027 Notes $179 million to settle our conversion obligations. As a result, our second quarter of 2014 will include an additional loss of $19 million in other non-operating expense related to the Termination of Conversion Rights.
	Redemption Notice: On November 7, 2013, we gave notice of our intent to redeem the remaining 2031A Notes, not participating in the Exchange Transactions, on December 7, 2013 (the "Redemption Notice"). In connection therewith, we recognized $5 million of interest expense to pay a "make-whole premium" upon redemption of the remaining 2031A Notes. From November 7, 2013 through the end of our first quarter of 2014, holders of $112 million principal amount of 2031A Notes (convertible into approximately 12 million shares of our common stock) notified us of the exercise of their option to convert their 2031A Notes entirely. For each of these conversion notices, we elected to settle the conversions entirely in cash. Based on our elections to settle amounts in cash, the settlement obligations became derivative instruments subject to mark-to-market accounting treatment and we therefore reclassified an aggregate of $115 million of fair value (Level 2 fair value measurements) of the equity components from additional capital to a derivative debt liability.
	Under the terms of the indenture of the 2031A Notes, the final cash settlement amount is determined based on the underlying shares multiplied by the volume-weighted-average price of our common stock over a period of 20 consecutive trading days. Through the end of our first quarter of 2014, we recognized a loss of $15 million, included in other non-operating expense, on our derivative settlement obligations based on an increase in the settlement amounts. The carrying value of the remaining 2031A Notes was $284 million as of November 28, 2013. Subsequent to the end of our first quarter of 2014, holders of the remaining $78 million principal amount of the 2031A Notes (convertible into approximately 8 million shares of our common stock) notified us of the exercise of their option to convert their 2031A Notes entirely. For each of these conversion notices, we elected to settle the conversions entirely in cash. Based on our elections to settle amounts in cash, the settlement obligations became derivative instruments and we therefore reclassified the $102 million fair value of the equity component from additional capital to a derivative debt liability. As a result, we estimate that our second quarter of 2014 will include an additional loss of $49 million in other non-operating expense related to conversions effective in the first quarter in response to the Redemption Notice.
	2043G Notes
	In connection with the Exchange Transactions, on November 12, 2013, we issued $1,025 million of 2043G Notes. Each $1,000 principal amount at maturity has an issue price of $800 for purposes of the indenture. An amount equal to the difference between the issue price and the principal amount at maturity will accrete in accordance with a schedule set forth in the indenture.  The issue price plus such accretion is the accreted principal amount. The initial conversion rate for the 2043 Notes is 34.2936 shares of common stock per $1,000 principal amount at maturity, equivalent to an initial conversion price of approximately $29.16 per share of common stock. Issuance costs for the 2043 Notes totaled $7 million. Interest is payable in May and November of each year.
	Upon issuance of the 2043G Notes, we recorded $627 million of debt, $173 million of additional capital and $5 million of deferred debt issuance costs (included in other noncurrent assets). The amount recorded as debt was based on the fair value of the debt component as a standalone instrument and was determined using an average interest rate for similar nonconvertible debt issued by entities with credit ratings comparable to ours at the time of issuance (Level 2 fair value measurements). We recorded a debt discount of $398 million for the difference between the debt recorded at inception and the principal amount at maturity. Holders of the 2043G Notes have the right to require us to repurchase all or a portion of their notes in November 2028 at the accreted principal amount which is scheduled to be $917 million.
	Conversion Rights: Holders may convert their 2043G Notes under the following circumstances: (1) if the 2043G Notes are called for redemption; (2) during any calendar quarter if the closing price of our common stock for at least 20 trading days in the 30 consecutive trading days ending on the last trading day of the preceding calendar quarter is more than 130% of the conversion price (approximately $37.91 per share) of the 2043G Notes; (3) if the trading price of the 2043G Notes is less than 98% of the product of the closing price of our common stock and the conversion rate of the 2043G Notes during the periods specified in the indenture; (4) if specified distributions or corporate events occur, as set forth in the indenture for the 2043G Notes; or (5) at any time after August 15, 2043.
	We have the option to pay cash, issue shares of common stock or any combination thereof for the aggregate amount due upon conversion. It is our intent to settle the principal amount of the 2043G Notes in cash upon conversion. As a result, upon conversion of the 2043G Notes, only the amounts payable in excess of the principal amounts of the 2043G Notes are considered in diluted earnings per share under the treasury stock method.
	Cash Redemption at Our Option: We may redeem for cash the 2043G Notes prior to November 20, 2018 if the closing price of our common stock is more than 130% of the conversion price for at least 20 trading days in the 30 consecutive trading days ending within five trading days prior to the date on which we provide notice of redemption. The redemption price will equal the principal amount at maturity plus accrued and unpaid interest. We may redeem for cash the 2043G Notes on or after November 20, 2018 without regard to the closing price of our common stock. The redemption price will equal the accreted principal amount plus accrued and unpaid interest. If we redeem the 2043G Notes prior to November 20, 2018, we will also pay a make-whole premium in cash, as specified in the indenture to the 2043G Notes.
	Cash Repurchase at the Option of the Holder: We may be required by the holders of the 2043G Notes to repurchase for cash all or a portion of the 2043G Notes on November 15, 2028. The repurchase price is equal to the accreted principal amount plus accrued and unpaid interest. Upon a change in control or a termination of trading, as defined in the indenture, holders of the 2043G Notes may require us to repurchase for cash all or a portion of their 2043G Notes at a repurchase price equal to the accreted principal amount plus accrued and unpaid interest.
	Convertible Notes With Debt and Equity Components
	The accounting standards for convertible debt instruments that may be fully or partially settled in cash upon conversion require the debt and equity components to be separately accounted for in a manner that reflects our nonconvertible borrowing rate when interest expense is recognized in subsequent periods. The amount recorded as debt is based on the fair value of the debt component as a standalone instrument, determined using an average interest rate for similar nonconvertible debt issued by entities with credit ratings comparable to ours at the time of issuance. The difference between the debt recorded at inception and its principal amount is to be accreted to principal through interest expense through the estimated life of the note.
				Date Holders Can Put Back to Us(2)		Interest Rate				Discount as of
		Term				Stated		Effective		28-Nov-13		August 29,
		(Years)(1)										2013
	2014 Notes	Less than 1		—		1.875	%	7.9	%	$	14	$	20
	2027 Notes(3)	Less than 1		N/A		1.875	%	6.9	%	14		28
	2031A Notes(3)	Less than 1		N/A		1.5	%	6.5	%	36		68
	2031B Notes	7		Aug-20		1.875	%	7	%	36		92
	2032C Notes	5		May-19		2.375	%	6	%	83		87
	2032D Notes	7		May-21		3.125	%	6.3	%	79		81
	2033E Notes	4		Feb-18		1.625	%	4.5	%	27		28
	2033F Notes	6		Feb-20		2.125	%	4.9	%	39		40
	2043G Notes	15		Nov-28		3	%	6.8	%	397		—
	(1) Expected term for amortization of the remaining debt discount as of November 28, 2013. For the 2043G Notes,
	$289 million of debt discount is expected to be amortized over the 15-year expected term. See "2043G Notes" above.
	(2) Holders of these notes have the right to require us to repurchase all or a portion of their notes on the dates specified.
	(3) In connection with the November 2013 debt restructure transactions, all holders exercised their option to convert their notes in the second quarter of 2014.
	Conversion prices per share and the conversion value in excess of principal for our convertible notes were as follows:
		Initial Conversion							Conversion Price Per Share Threshold(2)	Conversion Value
										in Excess of Principal
		Outstanding Principal			Price Per Share		Number of Shares(1)			November 28, 2013(3)		August 29, 2013(4)
	2014 Notes	$	485		14.23		34		18.5	$	237	$	—
	2027 Notes	95			10.9		9		14.17	89		43
	2031A Notes	190			9.5		20		12.35	233		148
	2031B Notes	140			9.5		15		12.35	172		148
	2032C Notes	550			9.63		57		12.52	659		225
2032D Notes	450			9.98		45		12.97	504		162
2033E Notes	300			10.93		27		14.21	281		72
2033F Notes	300			10.93		27		14.21	281		72
2043G Notes	1,025			29.16		35		37.91	—		—
	$	3,535				269			$	2,456	$	870
(1)Shares issuable, upon conversion, for the principal amount of the notes.
(2)Holders may convert their notes during any calendar quarter if the closing price of our common stock for at least 20 trading days in a 30 trading day period ending on the last trading day of the immediately preceding calendar quarter is 130% of the initial conversion price per share.
(3)Based on our closing share price of $21.17 and outstanding principal balances as of November 28, 2013.
(4)Based on our closing share price of $13.57 and outstanding principal balances as of August 29, 2013. The principal balances were not reduced by the amount of the Exchange Transactions that occurred in the first quarter of 2014 as described below.
Subsequent Event - Financing
On December 20, 2013, we issued $462 million in aggregate principal amount of 1.258% Secured Notes due 2019 (the "2019 Notes").  The 2019 Notes mature on January 15, 2019 and bear interest at a rate of 1.258% per annum, payable semi-annually in arrears in January and July of each year, commencing in January 2014. The principal amount of the 2019 Notes are payable in 10 consecutive semi-annual installments payable in arrears in January and July of each year, commencing in July 2014. The Notes are collateralized by certain equipment. The Export-Import Bank of the United States ("Ex-Im Bank") guaranteed payment of all regularly scheduled installment payments of principal of, and interest on, the 2019 Notes. We paid $23 million to Ex-Im Bank for their guarantee upon issuance of the 2019 Notes.
At any time prior to the maturity date of the 2019 Notes, we may redeem the 2019 Notes, in whole or in part, at a price equal to the principal amount of the 2019 Notes to be redeemed plus a "make-whole premium" as described in the indenture, together with accrued and unpaid interest and any other unpaid amounts then due under the indenture, to the date of redemption. If we or certain related persons described in the indenture are or become a person to whom Ex-Im Bank is prohibited by law from providing financing or other credit support, we will be required to redeem the 2019 Notes in whole, at a price equal to the principal amount of the 2019 Notes plus a "make-whole premium," together with accrued and unpaid interest and any other unpaid amounts then due to the date of redemption.
The indenture for the 2019 Notes contains covenants which are customary for financings of this type, including negative covenants that limit or restrict our ability to create liens or dispose of the equipment securing the 2019 Notes. Events of default also include, among others, the occurrence of any event or circumstance that, in the reasonable judgment of Ex-Im Bank, is likely materially and adversely to affect our ability to perform any payment obligation, or all or any of our other obligations which are material obligations, under the indenture, the 2019 Notes or under any other related transaction documents to which it is a party.
Maturities of Notes Payable and Future Minimum Lease Payments
As of November 28, 2013, maturities of notes payable, excluding the 2019 Notes which were issued subsequent to November 28, 2013, were as follows:
As of November 28, 2013	Notes Payable
Remainder of 2014	$	1,110
2015	359
2016	348
2017	317
2018	516
2019 and thereafter(1)	2,960
Discounts(1)	(914		)
	$	4,696
(1) Includes $917 million of scheduled accreted principal amount and $289 million of discount for the 2043G Notes. See "2043G Notes" above.

Contingencies

Contingencies	3 Months Ended
	Nov. 28, 2013
Disclosure Text Block [Abstract]	'
Contingencies	'
	Contingencies
	We have accrued a liability and charged operations for the estimated costs of adjudication or settlement of various asserted and unasserted claims existing as of the balance sheet date, including those described below. We are currently a party to other legal actions arising from the normal course of business, none of which is expected to have a material adverse effect on our business, results of operations or financial condition.
	Rambus
	On May 5, 2004, Rambus, Inc. ("Rambus") filed a complaint in the Superior Court of the State of California (San Francisco County) against us and other DRAM suppliers which alleged that the defendants harmed Rambus by engaging in concerted and unlawful efforts affecting Rambus DRAM by eliminating competition and stifling innovation in the market for computer memory technology and computer memory chips.  Rambus' complaint alleged various causes of action under California state law including, among other things, a conspiracy to restrict output and fix prices, a conspiracy to monopolize, intentional interference with prospective economic advantage, and unfair competition. Rambus sought a judgment for damages of approximately $3.9 billion, joint and several liability, trebling of damages awarded, punitive damages, a permanent injunction enjoining the defendants from the conduct alleged in the complaint, interest, and attorneys' fees and costs. Trial began on June 20, 2011, and the case went to the jury on September 21, 2011. On November 16, 2011, the jury found for us on all claims. On April 2, 2012, Rambus filed a notice of appeal to the California 1st District Court of Appeal.
	We were engaged in litigation with Rambus relating to certain of Rambus' patents and certain of our claims and defenses. Our lawsuits with Rambus related to patent matters were pending in the U.S. District Court for the District of Delaware, U.S. District Court for the Northern District of California, Germany, France, and Italy.
	In December 2013, subsequent to the end of our first fiscal quarter of 2014, we settled all pending litigation between us and Rambus, including all antitrust and patent matters.  We also entered into a 7-year term patent cross-license agreement with Rambus that allows us to avoid costs of patent-related litigation during the term.  We agreed to pay Rambus up to $10 million per quarter over 7 years, for a total of $280 million.  The primary benefits we received from these arrangements were (1) the settlement and termination of all existing litigation, (2) the avoidance of future litigation expenses and (3) the avoidance of future management and customer disruptions.  As a result, other operating expense for the quarter ended November 28, 2013 included a $233 million charge to accrue a liability, which reflects the discounted value of amounts due under this arrangement.
	Patent Matters
	As is typical in the semiconductor and other high technology industries, from time to time others have asserted, and may in the future assert, that our products or manufacturing processes infringe their intellectual property rights.
	On September 1, 2011, HSM Portfolio LLC and Technology Properties Limited LLC filed a patent infringement action in the U.S. District Court for the District of Delaware against us and seventeen other defendants, including Elpida Memory, Inc. and Elpida Memory (USA) Inc. (collectively “Elpida”).  On August 22, 2013, the plaintiffs filed a third amended complaint. The third amended complaint alleges that certain of our DRAM and image sensor products infringe four U.S. patents and that certain Elpida DRAM products infringe two U.S. patents and seeks damages, attorneys' fees, and costs. On March 23, 2012, Elpida filed a Notice of Filing and Hearing on Petition Under Chapter 15 of the U.S. Bankruptcy Code and Issuance of Provisional Relief that included an order of the U.S. Bankruptcy Court for the District of Delaware staying judicial proceedings against Elpida. Accordingly, the plaintiffs' case against Elpida is stayed.
	On December 5, 2011, the Board of Trustees for the University of Illinois filed a patent infringement action against us in the U.S. District Court for the Central District of Illinois. The complaint alleges that unspecified semiconductor products of ours infringe three U.S. patents and seeks injunctive relief, damages, attorneys' fees, and costs. We have filed three petitions for inter-partes review by the Patent and Trademark Office, challenging the validity of each of the patents in suit. The Patent Trial and Appeal Board held a hearing in connection with the three petitions on December 9, 2013. A final decision is expected by the end of March 2014. The District Court has stayed the litigation pending the outcome of the inter-partes review by the Patent Office.
	On April 27, 2012, Semcon Tech, LLC filed a patent infringement action against us in the U.S. District Court for the District of Delaware. The complaint alleges that our use of various chemical mechanical planarization systems purchased from Applied Materials and others infringes a single U.S. patent and seeks injunctive relief, damages, attorneys' fees, and costs. On September 24, 2013, the Court entered an order staying our case pending the resolution of co-pending cases brought by Semcon Tech, LLC against Applied Materials and Ebara Technologies, Inc.
	On December 7, 2007, Tessera, Inc. filed a patent infringement against Elpida Memory, Inc., Elpida Memory (USA) Inc. (collectively "Elpida"), and numerous other defendants, in the United States District Court for the Eastern District of Texas. The complaint alleges that certain Elpida products infringe four U.S. patents and seeks injunctive relief, damages, attorneys' fees, and costs. Prior to answering the complaint, Elpida and other defendants filed motions to stay the case pending final resolution of a case before the International Trade Commission ("ITC") against Elpida and other respondents, alleging infringement of the same patents asserted in the Eastern District of Texas case (In The Matter of Certain Semiconductor Chips with Minimized Chip Package Size and Products Containing Same (III), ITC No. 337-TA-630 (the "ITC Action")). On February 25, 2008, the Eastern District of Texas Court granted the defendants' motion to stay the action. On December 29, 2009, the ITC issued a Notice of Final Determination in the ITC Action finding no violation by Elpida. Tessera Inc. subsequently appealed the matter to the U.S. Court of Appeals for the Federal Circuit. On May 23, 2011, the Federal Circuit affirmed the ITC's Final Determination. The Eastern District of Texas case currently remains stayed.
	Among other things, the above lawsuits pertain to certain of our DDR, DDR2, DDR3, SDR SDRAM, PSRAM, RLDRAM, LPSDR, NAND Flash, image sensor products and certain other memory products we manufacture, which account for a significant portion of our net sales.
	We are unable to predict the outcome of assertions of infringement made against us and therefore cannot estimate the range of possible loss. A court determination that our products or manufacturing processes infringe the intellectual property rights of others could result in significant liability and/or require us to make material changes to our products and/or manufacturing processes. Any of the foregoing could have a material adverse effect on our business, results of operations or financial condition.
	Antitrust Matters
	At least sixty-eight purported class action price-fixing lawsuits have been filed against us and other DRAM suppliers in various federal and state courts in the United States and in Puerto Rico on behalf of indirect purchasers alleging a conspiracy to increase DRAM prices in violation of federal and state antitrust laws and state unfair competition law, and/or unjust enrichment relating to the sale and pricing of DRAM products during the period from April 1999 through at least June 2002. The complaints seek joint and several damages, trebled, in addition to restitution, costs and attorneys' fees. A number of these cases were removed to federal court and transferred to the U.S. District Court for the Northern District of California for consolidated pre-trial proceedings. In July, 2006, the Attorneys General for approximately forty U.S. states and territories filed suit in the U.S. District Court for the Northern District of California. The complaints allege, among other things, violations of the Sherman Act, Cartwright Act, and certain other states' consumer protection and antitrust laws and seek joint and several damages, trebled, as well as injunctive and other relief. On October 3, 2008, the California Attorney General filed a similar lawsuit in California Superior Court, purportedly on behalf of local California government entities, alleging, among other things, violations of the Cartwright Act and state unfair competition law. On June 23, 2010, we executed a settlement agreement resolving these purported class-action indirect purchaser cases and the pending cases of the Attorneys General relating to alleged DRAM price-fixing in the United States. Subject to certain conditions, including final court approval of the class settlements, we agreed to pay approximately $67 million in aggregate in three equal installments over a two-year period. We paid the full amount into an escrow account by the end of the first quarter of 2013 in accordance with the settlement agreement.
	On June 21, 2010, the Brazil Secretariat of Economic Law of the Ministry of Justice ("SDE") announced that it had initiated an investigation relating to alleged anticompetitive activities within the DRAM industry. The SDE's Notice of Investigation names various DRAM manufacturers and certain executives, including us, and focuses on the period from July 1998 to June 2002.
	We are unable to predict the outcome of these matters and therefore cannot estimate the range of possible loss, except as noted in the above discussion of the U.S. indirect purchaser cases. The final resolution of these alleged violations of antitrust laws could result in significant liability and could have a material adverse effect on our business, results of operations or financial condition.
	Securities Matters
	On July 12, 2013, seven former shareholders of Elpida Memory, Inc. ("Elpida") filed a complaint against Messrs. Sakamoto, Adachi, Gomi, Shirai, Tsay-Jiu, Wataki, Kinoshita, and Takahasi in their capacity as members of the board of directors of Elpida as of February 2013. The complaint alleges that the defendants engaged in various acts and misrepresentations to hide the financial condition of Elpida and deceive shareholders prior to Elpida filing a petition for corporate reorganization on February 27, 2013. The plaintiffs seek joint and several damages equal to the market value of shares owned by each of the plaintiffs on February 23, 2013, along with attorneys’ fees and interest. At a hearing on September 25, 2013, the plaintiffs withdrew the complaint against Mr. Tsay-Jiu.
	We are unable to predict the outcome of this matter and therefore cannot estimate the range of possible loss.  The final resolution of this matter could result in significant liability and could have a material adverse effect on our business, results of operations or financial condition.
	Commercial Matters
	On January 20, 2011, Dr. Michael Jaffé, administrator for Qimonda AG ("Qimonda") insolvency proceedings, filed suit against us and Micron Semiconductor B.V., our Netherlands subsidiary, in the District Court of Munich, Civil Chamber. The complaint seeks to void under Section 133 of the German Insolvency Act a share purchase agreement between us and Qimonda signed in fall 2008 pursuant to which we purchased all of Qimonda's shares of Inotera Memories, Inc. and seeks an order requiring us to retransfer the Inotera shares purchased from Qimonda to the Qimonda estate. The complaint also seeks to terminate under Sections 103 or 133 of the German Insolvency Code a patent cross-license between us and Qimonda entered into at the same time as the share purchase agreement. A three-judge panel will render a decision after a series of hearings with pleadings, arguments and witnesses. The most recent hearing was held on November 12, 2013 and an additional hearing is scheduled in January 2014. We are unable to predict the outcome of this lawsuit and therefore cannot estimate the range of possible loss. The final resolution of this lawsuit could result in the loss of the Inotera shares or equivalent monetary damages and the termination of the patent cross-license, which could have a material adverse effect on our business, results of operation or financial condition. As of November 28, 2013, the Inotera shares purchased from Qimonda had a carrying value of $241 million and a market value of $814 million.
	Other
	In the normal course of business, we are a party to a variety of agreements pursuant to which we may be obligated to indemnify the other party. It is not possible to predict the maximum potential amount of future payments under these types of agreements due to the conditional nature of our obligations and the unique facts and circumstances involved in each particular agreement. Historically, our payments under these types of agreements have not had a material adverse effect on our business, results of operations or financial condition.

Micron_Shareholders_Equity_and

Micron Shareholders' Equity and Noncontrolling Interests in Subsidiaries	3 Months Ended
	Nov. 28, 2013
Disclosure Text Block [Abstract]	'
Micron Shareholders' Equity and Noncontrolling Interests in Subsidiaries	'
	Micron Shareholders' Equity and Noncontrolling Interests in Subsidiaries
	Changes in the components of equity were as follows:
			Quarter Ended November 28, 2013									Quarter Ended November 29, 2012
			Attributable to Micron			Noncontrolling Interests			Total Equity			Attributable to Micron			Noncontrolling Interests			Total Equity
	Beginning balance		$	9,142		$	864		$	10,006		$	7,700		$	717		$	8,417
	Net income (loss)		358			23			381			(275		)	—			(275		)
	Other comprehensive income (loss)		5			—			5			3			—			3
	Comprehensive income (loss)		363			23			386			(272		)	—			(272		)
	Contribution from noncontrolling interests		—			49			49			—			—			—
	Distributions to noncontrolling interests		—			(9		)	(9		)	—			—			—
	Capital and other transactions attributable to Micron		(286		)	—			(286		)	41			—			41
	Ending balance		$	9,219		$	927		$	10,146		$	7,469		$	717		$	8,186
	Capped Calls
	Issued and Outstanding Capped Calls: We have entered into a series of capped call transactions intended to reduce the effect of potential dilution upon conversion of the 2031, 2032 and 2033 Notes which may be settled in shares or cash, at our election. The capped calls transactions are considered capital transactions and the related cost was recorded as a charge to additional capital.
	The following table presents information related to the issued and outstanding capped calls as of November 28, 2013.
	Capped Calls					Strike Price(1)			Cap Price Range						Common Shares Covered		Value at Expiration(2)
			Expiration Dates						Low			High					Minimum				Maximum
	2031		Jul-14	-	Feb-16	$	9.5		$	11.4		$	13.17		73		$	—			$	207
	2032C		May-16	-	Nov-17	9.8			14.26			15.69			56		—				307
	2032D		Nov-16	-	May-18	10.16			14.62			16.04			44		—				244
	2033E		Jan-18	-	Feb-18	10.93			14.51			14.51			27		—				98
	2033F		Jan-20	-	Feb-20	10.93			14.51			14.51			27		—				98
															227		$	—			$	954
	(1)	Initial strike prices are subject to certain adjustments.
	(2)	Settlement in cash on the respective expiration dates would result in us receiving an amount ranging from zero, if the market price per share of our common stock is at or below the respective low strike price, to the respective maximum amount if the market price per share of our common stock is at or above the respective high cap price. If share settlement were elected, the number of shares repurchased would be determined by the value of the capped calls at the time of settlement divided by the share price on the settlement date.
	Accumulated Other Comprehensive Income (Loss)
	The changes in accumulated other comprehensive income (loss) by component in the first quarter of 2014 were as follows:
			Cumulative Foreign Currency Translation Adjustments			Gains (Losses) on Derivative Instruments, Net			Gains (Losses) on Investments, Net			Pension Liability Adjustments			Total
	August 29, 2013		$	44		$	21		$	—		$	(2	)	$	63
	Other comprehensive income before reclassifications		6			(2		)	1			—			5
	Net other comprehensive income (loss)		6			(2		)	1			—			5
	November 28, 2013		$	50		$	19		$	1		$	(2	)	$	68
	In the first quarter of 2014, amounts reclassified from accumulated other comprehensive income were de minimis. Gains on derivative instruments in accumulated other comprehensive income (loss) reclassified to cost of goods sold were $3 million in the first quarter of 2013.

Derivative_Instruments

Derivative Instruments	3 Months Ended
	Nov. 28, 2013
Disclosure Text Block [Abstract]	'
Derivative Financial Instruments	'
	Derivative Instruments
	We are exposed to currency exchange rate risk for monetary assets and liabilities held or denominated in foreign currencies, primarily the euro, shekel, Singapore dollar and yen.  We are also exposed to currency exchange rate risk for capital expenditures and operating cash flows, primarily denominated in the euro and yen.  Additionally, we are exposed to interest rate fluctuation risk on our four-year note payable, under which we borrowed $312 million on August 27, 2013 at a variable interest rate. We use derivative instruments to manage a portion of our exposures to changes in currency exchange rates and variable interest rates.  For exposures associated with our monetary assets and liabilities, our primary objective in entering into currency derivatives is to reduce the volatility that changes in currency exchange rates have on our earnings.  For exposures associated with our capital expenditures and operating cash flows, our primary objective of entering into currency derivatives is to reduce the volatility that changes in currency exchange rates have on future cash flows. For exposures associated with our variable-rate debt, our primary objective is to reduce the volatility that changes in interest rates have on interest expense.
	Our currency derivatives consist primarily of forward contracts and currency options and our interest rate derivatives consist of interest rate swap agreements.  These derivative instruments expose us to credit risk to the extent the counterparties may be unable to meet the terms of the derivative instrument.  As of November 28, 2013, our maximum exposure to loss due to credit risk if counterparties fail completely to perform according to the terms of the contracts was generally equal to the fair value of our assets for these contracts as listed in the tables below.  We seek to mitigate such risk by limiting our counterparties to major financial institutions and by spreading risk across multiple major financial institutions.  In addition, we monitor the potential risk of loss with any one counterparty resulting from this type of credit risk on an ongoing basis.  We also seek to mitigate risk through entering into master netting arrangements with our counterparties (see "Master Netting Arrangements" below).
	We have the following risk management programs:
	Derivative Instruments without Hedge Accounting Designation
	We utilize a rolling hedge strategy with currency forward contracts that generally mature within 35 days to hedge our exposure to changes in currency exchange rates from our monetary assets and liabilities.  At the end of each reporting period, monetary assets and liabilities held or denominated in currencies other than the U.S. dollar are remeasured in U.S. dollars and the associated outstanding forward contracts are marked-to-market.  Currency forward contracts are valued at fair values based on the middle of bid and ask prices of dealers or exchange quotations (Level 2 fair value measurements). Currency options are valued at their fair value using a modified Black-Scholes option valuation model using inputs of the current spot rate, strike price, risk-free interest rate, maturity, volatility and credit-risk spread (Level 2 fair value measurements).  These options are marked-to-market at the end of each reporting period. Realized and unrealized gains and losses on derivative instruments without hedge accounting designation as well as the change in the underlying monetary assets and liabilities due to changes in currency exchange rates are included in other non-operating income (expense).
	In connection with the currency exchange rate risk associated with our acquisition of Elpida and the Rexchip shares, we entered into currency exchange transactions (the "Elpida Hedges" and the "Rexchip Hedges" and, together, the "Elpida Acquisition Hedges"). The Elpida Acquisition Hedges were not designated for hedge accounting and were remeasured at fair value each period with gains and losses reflected in other non-operating income (expense). We recorded losses from the Elpida Acquisition Hedges of $62 million in the first quarter of 2013. To mitigate the risk that increases in exchange rates have on the payments due in 2014 and 2015, we entered into forward contracts to purchase 20 billion yen on November 28, 2014 and 10 billion yen on November 27, 2015.
	In connection with the Termination of Conversion Rights and Redemption Notice on November 7, 2013, our settlement obligations for the 2027 Notes and 2031A Notes were treated as derivative instruments without hedge accounting designation from November 7, 2013 through their settlement dates, which range between December 10, 2013 and January 9, 2014. The fair values of the underlying conversion options were initially determined using the Black-Scholes option valuation model (Level 2 fair value measurements). The Black-Scholes model requires the input of assumptions, including the stock price, expected stock-price volatility, estimated option life, risk-free interest rate and dividend rate. Subsequent measurements through November 28, 2013 of our convertible notes settlement obligations were based on the value-weighted average stock price (Level 1 fair value measurements). Changes in fair values of the derivative settlement obligations were included in other non-operating income (expense).
	We are party to interest rate swap contracts that mature in August 2017 to hedge against the variability of future interest payments due on $312 million of floating-rate debt, which effectively converts the floating-rate debt to fixed-rate debt. As of November 28, 2013, the principle balance on the floating-rate debt was $293 million. We designated 80% of the swaps as cash flow hedges and the remaining 20% were not designated for hedge accounting treatment. Changes in the fair value of the undesignated portion are included in interest income (expense). The fair values of the interest rate swaps are calculated by discounting the expected future cash flows based on inputs that are readily available in publicly quoted markets (Level 2 fair value measurements).
	Total gross notional amounts and fair values for derivative instruments without hedge accounting designation were as follows:
	As of November 28, 2013		Notional Amount(1)			Fair Value of
						Current Assets(2)			Noncurrent Assets(3)			(Current Liabilities)(4)			(Noncurrent Liabilities)(5)
	Currency forward contracts:
	Yen		$	496		$	—		$	—		$	(13	)	$	(4	)
	Singapore dollar		265			—			—			(2		)	—
	Shekel		81			—			—			—			—
	Euro		58			—			—			(1		)	—
	Interest rate swap contracts		59			—			—			—			—
			$	959
	Convertible notes settlement obligations		21			—			—			(444		)	—
						$	—		$	—		$	(460	)	$	(4	)
	As of August 29, 2013
	Forward contracts:
	Yen		$	336		$	1		$	3		$	—		$	—
	Singapore dollar		218			—			—			—			—
	Shekel		78			—			—			(1		)	—
	Euro		217			1			—			(1		)	—
	Interest rate swap contracts		62			—			—			—			—
	Currency options:
	New Taiwan dollar		351			—			—			—			—
			$	1,262		$	2		$	3		$	(2	)	$	—
	-1	Notional amounts of forward, option and interest rate swap contracts in U.S. dollars and convertible notes settlement obligations in shares.
	(2)	Included in receivables – other.
	(3)	Included in other noncurrent assets.
	(4)	Included in accounts payable and accrued expenses – other for forward, option and interest rate swap contracts and in current portion of long-term debt for convertible notes settlement obligations.
	(5)	Included in other noncurrent liabilities.
	For derivative instruments without hedge accounting designation, we recognized net losses in the first quarter of 2014 of $37 million for the convertible notes settlement obligations and $14 million for the foreign exchange contracts. We recognized net losses in the first quarter of 2013 of $51 million for foreign exchange contracts. Gains (losses) on foreign exchange contracts and convertible notes settlement obligations were included in other non-operating income (expense). Gains (losses) recognized from interest rate swap contracts in the first quarter of 2014 were not significant and were included in interest expense.
	Derivative Instruments with Cash Flow Hedge Accounting Designation
	We utilize currency forward contracts that generally mature within 12 months and currency options that generally mature from 12 to 18 months to hedge our exposure to changes in cash flows from changes in currency exchange rates for certain capital expenditures and forecasted operating cash flows.  Currency forward contracts are valued at their fair values based on market-based observable inputs including currency exchange spot and forward rates, interest rate and credit risk spread (Level 2 fair value measurements).  Currency options are valued at their fair value using a modified Black-Scholes option valuation model using inputs of the current spot rate, strike price, risk-free interest rate, maturity, volatility and credit-risk spread (Level 2 fair value measurements). We are party to interest rate swap contracts that mature in August 2017 to hedge against the variability in future interest payments due on $312 million of floating-rate debt and designated 80% of the swaps as cash flow hedges. As of November 28, 2013, the principle balance on the floating-rate debt was $293 million. The fair values of the interest rate swaps have been calculated by discounting the expected future cash flows based on inputs that are readily available in publicly quoted markets (Level 2 fair value measurements).
	For derivative instruments designated as cash flow hedges, the effective portion of the realized and unrealized gain or loss on the derivatives is included as a component of accumulated other comprehensive income (loss).  For derivative instruments hedging capital expenditures, the amounts in accumulated other comprehensive income (loss) for these cash flow hedges are reclassified into earnings in the same line items of the consolidated statements of operation and in the same periods in which the underlying transactions affect earnings. Amounts in accumulated other comprehensive income (loss) for inventory purchases are reclassified to earnings when inventory is sold. Amounts in accumulated other comprehensive income (loss) for interest rate swaps are reclassified to earnings when the related interest payments affect earnings. The ineffective or excluded portion of the realized and unrealized gain or loss is included in other non-operating income (expense).  Total gross notional amounts and fair values for derivative instruments with cash flow hedge accounting designation were as follows:
	As of November 28, 2013		Notional Amount			Fair Value of Current Liabilities (1)
			(in U.S. Dollars)
	Currency forward contracts:
	Euro		$	15		$	—
	Yen		12			—
	Currency options:
	Yen		11			(1		)
	Interest swap contracts:		234			(2		)
			$	272		$	(3	)
	As of August 29, 2013
	Currency forward contracts:
	Yen		$	6		$	(1	)
	Euro		6			—
	Currency options:
	Yen		21			(2		)
	Interest swap contracts:		250			—
			$	283		$	(3	)
	(1)	Included in accounts payable and accrued expenses – other.
	For the first quarters of 2014 and 2013, we recognized $2 million and $4 million, respectively, of net pre-tax losses in accumulated other comprehensive income (loss) from the effective portion of cash flow hedges.  The ineffective and excluded portions of cash flow hedges recognized in other non-operating income (expense) were not significant for the first quarters of 2014 and 2013.  In the first quarter of 2013, $3 million of net gains for foreign exchange contracts were reclassified from accumulated other comprehensive income (loss) to cost of goods sold. As of November 28, 2013, the amount of pre-tax net cash flow hedge gains included in accumulated other accumulated comprehensive income (loss) expected to be reclassified into earnings in the next 12 months was $6 million.
	Master Netting Arrangements
	We seek to enter into master netting arrangements with our counterparties to mitigate credit risk in derivative hedge transactions. These master netting arrangements allow us and our counterparties to net settle amounts owed to each other. Derivative assets and liabilities that can be net settled under these arrangements have been presented in our consolidated balance sheet on a net basis. The following table presents the gross amounts of our derivative assets and liabilities and the net amounts recorded in our consolidated balance sheet:
	As of November 28, 2013		Current Assets(1)			(Current Liabilities)(2)			(Noncurrent Liabilities)(3)
	Gross amount		$	1		$	(463	)	$	(4	)
Gross amounts offset in the statement of financial position		(1		)	1			—
Net amounts presented in the statement of financial position		$	—		$	(462	)	$	(4	)
(1) Included in receivables – other.
(2) Included in current portion of long-term debt and accounts payable and accrued expenses – other.
(3) Included in other noncurrent liabilities.

Fair_Value_Measurements

Fair Value Measurements	3 Months Ended
	Nov. 28, 2013
Disclosure Text Block [Abstract]	'
Fair Value Measurements	'
	Fair Value Measurements
	Accounting standards establish three levels of inputs that may be used to measure fair value: quoted prices in active markets for identical assets or liabilities (referred to as Level 1), inputs other than Level 1 that are observable for the asset or liability either directly or indirectly (referred to as Level 2) and unobservable inputs to the valuation methodology that are significant to the measurement of fair value of assets or liabilities (referred to as Level 3).
	Fair Value Measurements on a Recurring Basis
	All marketable debt and equity investments are classified as available-for-sale and are carried at fair value. Assets measured at fair value on a recurring basis were as follows:
	As of	November 28, 2013								August 29, 2013
		Level 1		Level 2		Level 3		Total		Level 1		Level 2		Level 3		Total
	Cash equivalents:
	Money market funds	$	1,677	$	—	$	—	$	1,677	$	1,188	$	—	$	—	$	1,188
	Certificates of deposit	—		543		—		543		—		38		—		38
	Commercial paper	—		5		—		5		—		35		—		35
		1,677		548		—		2,225		1,188		73		—		1,261
	Short-term investments:
	Corporate bonds	—		112		—		112		—		112		—		112
	Commercial paper	—		58		—		58		—		26		—		26
	Government securities	—		37		—		37		—		72		—		72
	Certificates of deposit	—		8		—		8		—		9		—		9
	Asset-backed securities	—		1		—		1		—		2		—		2
		—		216		—		216		—		221		—		221
	Long-term marketable investments:
	Corporate bonds	—		330		—		330		—		302		—		302
	Asset-backed securities	—		106		—		106		—		95		—		95
	Government securities	—		96		—		96		—		96		—		96
	Marketable equity securities	6		—		—		6		6		—		—		6
		6		532		—		538		6		493		—		499
	Restricted cash:
	Certificates of deposit	—		7		—		7		—		302		—		302
		—		7		—		7		—		302		—		302
		$	1,683	$	1,303	$	—	$	2,986	$	1,194	$	1,089	$	—	$	2,283
	Government securities consist of securities issued directly by or deemed to be guaranteed by government entities such as U.S and non U.S. agency securities, government bonds and treasury securities. Level 2 securities are valued using information obtained from pricing services, which obtain quoted market prices for similar instruments, non-binding market consensus prices that are corroborated by observable market data, or various other methodologies, to determine the appropriate value at the measurement date. We perform supplemental analysis to validate information obtained from our pricing services. As of November 28, 2013, no adjustments were made to such pricing information.
	Fair Value Measurements on a Nonrecurring Basis
	In connection with the Exchange Transactions, we determined the fair value of the debt component of the Exchanged Notes as if it were a stand-alone instrument using an average interest rate for similar nonconvertible debt issued by entities with credit ratings comparable to ours at the time of issuance.
	In connection with the Termination of Conversion Rights and Redemption Notice on November 7, 2013, our settlement obligations for the 2027 Notes and 2031A Notes were treated as derivative instruments without hedge accounting designation from November 7, 2013 through their settlement dates, which range between December 10, 2013 and January 9, 2014. The fair values of the underlying conversion options were initially determined using the Black-Scholes option valuation model (Level 2 fair value measurements). The Black-Scholes model requires the input of assumptions, including the stock price, expected stock-price volatility, estimated option life, risk-free interest rate and dividend rate. The subsequent measurements as of November 28, 2013 of our convertible notes settlement obligations were based on the value-weighted average stock price (Level 1 fair value measurements). Changes in fair values of the derivative settlement obligations were included in other non-operating income (expense).
	Fair Value of Financial Instruments
	Amounts reported as cash and equivalents, receivables, and accounts payable and accrued expenses approximate fair value. The estimated fair value and carrying value of debt instruments (carrying value excludes the equity components of our convertible notes classified in equity) were as follows:
	As of	November 28, 2013				August 29, 2013
		Fair		Carrying		Fair		Carrying
		Value		Value		Value		Value
	Convertible notes	$	6,076	$	3,019	$	4,167	$	2,506
	Elpida creditor installment payments and other notes	1,680		1,677		2,269		2,279
	The fair values of our convertible debt instruments were determined based on inputs that are observable in the market or that could be derived from, or corroborated with, observable market data, including our stock price and interest rates based on similar debt issued by parties with credit ratings similar to ours (Level 2).  The fair value of our other debt instruments was estimated based on discounted cash flows using inputs that are observable in the market or that could be derived from, or corroborated with, observable market data, including interest rates based on similar debt issued by parties with credit ratings similar to ours (Level 2).

Equity_Plans

Equity Plans	3 Months Ended
	Nov. 28, 2013
Disclosure Text Block [Abstract]	'
Equity Plans	'
	Equity Plans
	As of November 28, 2013, we had an aggregate of 140 million shares of common stock reserved for the issuance of stock options and restricted stock awards, of which 67 million shares were subject to outstanding awards and 73 million shares were available for future awards.  Awards are subject to terms and conditions as determined by our Board of Directors.
	Stock Options
	We granted 2 million and 4 million stock options during the first quarters of 2014 and 2013, respectively, with weighted-average grant-date fair values per share of $7.58 and $2.99, respectively.
	The fair values of option awards were estimated at each grant date using the Black-Scholes option valuation model.  The Black-Scholes model requires the input of assumptions, including the expected stock-price volatility and estimated option life.  The expected volatilities utilized were based on implied volatilities from traded options on our stock and on historical volatility.  The expected lives of options granted were based, in part, on historical experience and on the terms and conditions of the options.  The risk-free interest rates utilized were based on the U.S. Treasury yield in effect at each grant date.  No dividends were assumed in estimated option values.  Assumptions used in the Black-Scholes model are presented below:
	Quarter Ended	November 28,		November 29,
		2013		2012
	Average expected life in years	4.8		5
	Weighted-average expected volatility	50	%	62	%
	Weighted-average risk-free interest rate	1.3	%	0.7	%
	Restricted Stock and Restricted Stock Units ("Restricted Stock Awards")
	As of November 28, 2013, there were 10 million shares of Restricted Stock Awards outstanding, of which 1 million were performance-based Restricted Stock Awards.  For service-based Restricted Stock Awards, restrictions generally lapse in one-fourth increments during each year of employment after the grant date.  For performance-based Restricted Stock Awards, vesting is contingent upon meeting certain performance goals.  Restricted Stock Awards granted for the first quarters of 2014 and 2013 were as follows:
	Quarter ended	November 28,			November 29,
		2013			2012
	Service-based awards	1			2
	Performance-based awards	1			1
	Weighted-average grant-date fair values per share	$	17.31		$	5.73
	Stock-based Compensation Expense
	Quarter ended	November 28,			November 29,
		2013			2012
	Stock-based compensation expense by caption:
	Cost of goods sold	$	7		$	6
	Selling, general and administrative	11			9
	Research and development	4			4
		$	22		$	19
	Stock-based compensation expense by type of award:
	Stock options	$	14		$	13
	Restricted stock awards	8			6
		$	22		$	19
	As of November 28, 2013, $166 million of total unrecognized compensation costs, net of estimated forfeitures, related to non-vested awards was expected to be recognized through the first quarter of 2018, resulting in a weighted-average period of 1.3 years. Stock-based compensation expense in the above presentation does not reflect any significant income tax benefits, which is consistent with our treatment of income or loss from our U.S. operations.  (See "Income Taxes" note.)

Restucture_and_Asset_Impairmen

Restucture and Asset Impairments	3 Months Ended
	Nov. 28, 2013
Disclosure Text Block [Abstract]	'
Restructuring and Asset Impairments	'
	Restructure and Asset Impairments
	Quarter ended	November 28,			November 29,
		2013			2012
	Gain on termination of lease to Transform	$	—		$	(25	)
	Other	(3		)	4
		$	(3	)	$	(21	)
	As of November 28, 2013 and August 29, 2013, we had accrued $1 million and $12 million, respectively, for unpaid other restructure activities related to workforce optimization activities. As of November 28, 2013, we do not anticipate incurring any significant additional costs for these restructure activities.
	In May 2012, the Board of Directors of Transform approved a liquidation plan. In connection therewith, Transform terminated a lease to a portion of our manufacturing facilities in Boise, Idaho and we recognized a gain of $25 million in the first quarter of 2013.

Other_Operating_Income_Expense

Other Operating (Income) Expense, Net	3 Months Ended
	Nov. 28, 2013
Disclosure Text Block [Abstract]	'
Other Operating (Income) Expense, Net	'
	Other Operating (Income) Expense, Net
	Quarter ended	November 28,			November 29,
		2013			2012
	Rambus settlement	$	233		$	—
	(Gain) loss on disposition of property, plant and equipment	8			(5		)
	Other	(4		)	(3		)
		$	237		$	(8	)
	In December 2013, subsequent to the end of our first fiscal quarter of 2014, we settled all pending litigation between us and Rambus, including all antitrust and patent matters.  As a result, other operating expense for the quarter ended November 28, 2013 included a $233 million charge to accrue a liability, which reflects the discounted value of amounts due under this arrangement. (See "Contingencies" note.)

Other_NonOperating_Income_Expe

Other Non-Operating Income (Expense), Net	3 Months Ended
	Nov. 28, 2013
Disclosure Text Block [Abstract]	'
Other Non-Operating Income Expense, Net [Text Block]	'
	Other Non-Operating Income (Expense), Net
	Quarter ended	28-Nov-13			29-Nov-12
	Loss on restructure of debt	$	(75	)	$	—
	Gain (loss) from changes in currency exchange rates	(6		)	(59		)
	Other	1			—
		$	(80	)	$	(59	)
	Loss on restructure of debt for the first quarter of 2014 resulted from a series of transactions with holders of our 2027 Notes, 2031A Notes and 2031B Notes. We estimate that our second quarter of 2014 will include an aggregate additional loss of $68 million as a result of the debt conversions relating to the Termination of Conversion Rights for the 2027 Notes and the Redemption Notice for the remaining 2031A Notes. (See "Debt" note.)
	Other non-operating expense in the first quarter of 2013 included currency losses of $62 million from changes in the market value of yen currency hedges executed in connection with our planned acquisition of Elpida Memory, Inc. (See "Derivative Instruments" note.)

Income_Taxes

Income Taxes	3 Months Ended
	Nov. 28, 2013
Disclosure Text Block [Abstract]	'
Income Taxes	'
	Income Taxes
	Income taxes for the first quarter of 2014 included a tax provision of $73 million primarily related to the utilization of deferred tax assets as a result of Elpida's operations.  Remaining taxes for the first quarters of 2014 and 2013 primarily reflect taxes on our non-U.S. operations. We have a full valuation allowance for our net deferred tax asset associated with our U.S. operations.  The provision (benefit) for taxes on U.S. operations in the first quarters of 2014 and 2013 was substantially offset by changes in the valuation allowance.
	We currently operate in several tax jurisdictions where we have arrangements that allow us to compute our tax provision at rates below the local statutory rates that expire in whole or in part at various dates through 2026.  These arrangements benefitted our tax provision in the first quarters of 2014 and 2013 by $76 million ($0.06 per diluted share) and $11 million ($0.01 per diluted share), respectively.

Earnings_Per_Share

Earnings Per Share	3 Months Ended
	Nov. 28, 2013
Disclosure Text Block [Abstract]	'
Earnings Per Share	'
	Earnings Per Share
	Basic earnings per share is computed based on the weighted-average number of common shares outstanding.  Diluted earnings per share is computed based on the weighted-average number of common shares outstanding plus the dilutive effects of equity awards and convertible notes.  Potential common shares that would increase earnings per share amounts or decrease loss per share amounts are antidilutive and are therefore excluded from diluted earnings per share calculations.  Antidilutive potential common shares that could dilute basic earnings per share in the future were 38 million and 357 million for the first quarters of 2014 and 2013, respectively.
	Quarter ended	November 28,		November 29,
		2013		2012
	Net income (loss) available to Micron shareholders – Basic and Diluted	$	358	$	(275	)
	Weighted-average common shares outstanding – Basic	1,046		1,014
	Net effect of dilutive equity awards and convertible notes	150		—
	Weighted-average common shares outstanding – Diluted	1,196		1,014
	Earnings (loss) per share:
	Basic	$	0.34	$	(0.27	)
	Diluted	0.3		(0.27		)

Consolidated_Variable_Interest

Consolidated Variable Interest Entities	3 Months Ended
	Nov. 28, 2013
Disclosure Text Block [Abstract]	'
Consolidated Variable Interest Entities	'
	Consolidated Variable Interest Entities
	IMFT
	Since its inception in 2006 through November 28, 2013, we have owned 51% of IMFT, a venture between us and Intel to manufacture NAND Flash memory products and certain emerging memory technologies, for the exclusive use of the members. IMFT is governed by a Board of Managers and the number of managers appointed by each member to the board varies based on the members' respective ownership interests, which is based on cumulative contributions to IMFT. The IMFT joint venture agreement extends through 2024 and includes certain buy-sell rights, commencing in 2015, pursuant to which Intel may elect to sell to us, or we may elect to purchase from Intel, Intel's interest in IMFT. If Intel elects to sell to us, we would set the closing date of the transaction within two years following such election and could elect to receive financing of the purchase price from Intel for one to two years from the closing date.
	IMFT manufactures NAND Flash memory products using designs and technology we develop with Intel. We generally share with Intel the cost of product design, other NAND Flash R&D costs and R&D cost of certain emerging memory technologies. Our R&D expenses were reduced by reimbursements from Intel of $29 million and $32 million for the first quarters of 2014 and 2013, respectively.
	We sell a portion of our products to Intel through our IMFT joint venture at long-term negotiated prices approximating cost. Sales of NAND Flash products to Intel under this arrangement were $101 million and $99 million for the first quarters of 2014 and 2013, respectively. Receivables from Intel for IMFT sales of NAND Flash products as of November 28, 2013 and August 29, 2013, were $59 million and $68 million, respectively.
	The following table presents the assets and liabilities of IMFT included in our consolidated balance sheets, excluding intercompany balances:
	As of	November 28,		August 29, 2013
		2013
	Assets
	Cash and equivalents	$	105	$	62
	Receivables	67		76
	Inventories	48		49
	Other current assets	4		4
	Total current assets	224		191
	Property, plant and equipment, net	1,364		1,382
	Other noncurrent assets	47		46
	Total assets	$	1,635	$	1,619
	Liabilities
	Accounts payable and accrued expenses	$	87	$	88
	Deferred income	9		9
	Equipment purchase contracts	4		78
	Current portion of long-term debt	6		6
	Total current liabilities	106		181
	Long-term debt	11		13
	Other noncurrent liabilities	114		118
	Total liabilities	$	231	$	312
	Amounts exclude intercompany balances that were eliminated in our consolidated balance sheets.
	Our ability to access IMFT's cash and other assets through cash dividends, loans or advances, including to finance our other operations, is subject to agreement by Intel. Creditors of IMFT have recourse only to its assets and do not have recourse to any other of our assets.
	The following table presents IMFT's distributions to and contributions from its shareholders:
	Quarter Ended	November 28,		November 29,
		2013		2012
	IMFT distributions to Micron	$	—	$	—
	IMFT distributions to Intel	—		—
	Micron contributions to IMFT	51		—
	Intel contributions to IMFT	49		—
	MP Mask
	In 2006, we formed a joint venture with Photronics to produce photomasks for leading-edge and advanced next generation semiconductors.  At inception and through November 28, 2013, we owned 50.01% and Photronics owned 49.99% of MP Mask. In connection with the formation of the joint venture, we received $72 million in 2006 in exchange for entering into a license agreement with Photronics, which is being recognized over the term of the 10-year agreement.  Deferred income and other noncurrent liabilities included an aggregate of $18 million and $19 million as of November 28, 2013 and August 29, 2013, respectively, related to this agreement. We purchase a substantial majority of the reticles produced by MP Mask pursuant to a supply arrangement.
	Total MP Mask assets and liabilities included in our consolidated balance sheets were as follows:
	As of	November 28,		August 29, 2013
		2013
	Current assets	$	32	$	26
	Noncurrent assets (primarily property, plant and equipment)	176		182
	Current liabilities	24		25
	Amounts exclude intercompany balances that were eliminated in our consolidated balance sheets.
	Creditors of MP Mask have recourse only to the assets of MP Mask and do not have recourse to any other of our assets.

Segment_Information

Segment Information	3 Months Ended
	Nov. 28, 2013
Disclosure Text Block [Abstract]	'
Segment Information	'
	Segment Information
	Segment information reported herein is consistent with how it is reviewed and evaluated by our chief operating decision makers.  Factors used to identify our segments include, among others, products, technologies and customers.  We have the following four reportable segments:
	DRAM Solutions Group ("DSG"): Includes DRAM products sold to the PC, consumer electronics, networking and server markets.
	Wireless Solutions Group ("WSG"): Includes DRAM, NAND Flash and NOR Flash products, including multi-chip packages, sold to the mobile device market.
	NAND Solutions Group ("NSG"): Includes high-volume NAND Flash products sold into data storage, personal music players, and the high-density computing market, as well as NAND Flash products sold to Intel through our IMFT joint venture.
	Embedded Solutions Group ("ESG"): Includes DRAM, NAND Flash and NOR Flash products sold into automotive and industrial applications, as well as NOR and NAND Flash sold to consumer electronics, networking, PC and server markets.
	Our other operations do not meet the quantitative thresholds of a reportable segment and are reported under All Other.
	Certain operating expenses directly associated with the activities of a specific reportable segment are charged to that segment. Other indirect operating expenses (income) are generally allocated to the reportable segments based on their respective percentage of cost of goods sold or forecasted wafer production. We did not allocate the Rambus settlement to our segments.
	We do not identify or report internally our assets or capital expenditures by segment, nor do we allocate gains and losses from equity method investments, interest, other non-operating income or expense items or taxes to operating segments.  There are no differences in the accounting policies for segment reporting and our consolidated results of operations.
	Quarter ended	November 28,			November 29,
		2013			2012
	Net sales:
	DSG	$	1,785		$	600
	WSG	1,054			263
	NSG	806			617
	ESG	366			278
	All Other	31			76
		$	4,042		$	1,834
	Operating income (loss):
	DSG	$	432		$	(112	)
	WSG	176			(64		)
	NSG	95			13
	ESG	66			78
	All Other	15			(12		)
	Unallocated	(233		)	—
		$	551		$	(97	)

Certain_Concentrations

Certain Concentrations	3 Months Ended
	Nov. 28, 2013
Disclosure Text Block [Abstract]	'
Certain Concentrations	'
	Certain Concentrations
	Market Concentrations: Markets with a concentration of at least 10 percent of net sales were as follows:
	For the quarter ended	28-Nov-13		29-Nov-12
	Computing (including desktop PCs, servers, notebooks and workstations)	35	%	20	%
	Mobile	25	%	15	%
	Consumer electronics	10	%	20	%
	Solid state drives	10	%	10	%
	Networking and storage	10	%	10	%
	Customer Concentrations: Customer concentrations in the first quarter of 2014 included net sales to Apple Inc. ("Apple") of 13% of our total net sales. Substantially all of our sales to Apple are included in the WSG and DSG segments.

Business_and_Basis_of_Presenta1

Business and Basis of Presentation (Policies)	3 Months Ended
	Nov. 28, 2013
Policy Text Block [Abstract]	'
Basis of Presentation	'
	Micron Technology, Inc. and its consolidated subsidiaries (hereinafter referred to collectively as "we," "our," "us" and similar terms unless the context indicates otherwise) is one of the world's leading providers of advanced semiconductor solutions. Through our worldwide operations, we manufacture and market a full range of DRAM, NAND Flash and NOR Flash memory, as well as other innovative memory technologies, packaging solutions and semiconductor systems for use in leading-edge computing, consumer, networking, automotive, industrial, embedded and mobile products. The accompanying consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America consistent in all material respects with those applied in our Annual Report on Form 10-K for the year ended August 29, 2013. In the opinion of our management, the accompanying unaudited consolidated financial statements contain all adjustments necessary to present fairly our consolidated financial position and our consolidated results of operations and cash flows.
Reclassification	'
	Certain reclassifications have been made to prior period amounts to conform to current period presentation.
Fiscal Period	'
	Our fiscal year is the 52 or 53-week period ending on the Thursday closest to August 31. Our first quarters of fiscal 2014 and 2013 ended on November 28, 2013 and November 29, 2012, respectively. All period references are to our fiscal periods unless otherwise indicated. These interim financial statements should be read in conjunction with the consolidated financial statements and accompanying notes included in our Annual Report on Form 10-K for the year ended August 29, 2013.

Variable_Interest_Entities_Pol

Variable Interest Entities (Policies)	3 Months Ended
	Nov. 28, 2013
Policy Text Block [Abstract]	'
Variable Interest Entities	'
	We have interests in entities that are Variable Interest Entities ("VIEs"). If we are the primary beneficiary of a VIE, we are required to consolidate it. To determine if we are the primary beneficiary, we evaluate whether we have the power to direct the activities that most significantly impact the VIE's economic performance and the obligation to absorb losses or the right to receive benefits of the VIE that could potentially be significant to the VIE. Our evaluation includes identification of significant activities and an assessment of our ability to direct those activities based on governance provisions and arrangements to provide or receive product and process technology, product supply, operations services, equity funding, financing and other applicable agreements and circumstances. Our assessments of whether we are the primary beneficiary of our VIEs require significant assumptions and judgments.

Elpida_Memory_Inc_Elpida_Memor

Elpida Memory, Inc. Elpida Memories, Inc. (Tables)	3 Months Ended
	Nov. 28, 2013
Business Acquisition [Line Items]	'
Business Acquisition, Pro Forma Information [Table Text Block]	'
	The following unaudited pro forma financial information presents the combined results of operations as if the Elpida acquisition had occurred on September 2, 2011.  The pro forma financial information includes the accounting effects of the business combination, including adjustments to the amortization of intangible assets, depreciation of property, plant and equipment, interest expense and elimination of intercompany activities.  The unaudited pro forma financial information below is not necessarily indicative of either future results of operations or results that might have been achieved had the Elpida acquisition occurred on September 2, 2011.
	Quarter ended	November 29,
		2012
	Net sales	$	2,619
	Net income (loss)	(226		)
	Net income (loss) attributable to Micron	(237		)
	Earnings (loss) per share:
	Basic	$	(0.23	)
	Diluted	(0.23		)
	The unaudited pro forma financial information for the first quarter of 2013 includes our results for the quarter ended November 29, 2012 and the results of Elpida, including the adjustments described above, for the quarter ended September 30, 2012.

Investments_Tables

Investments (Tables)	3 Months Ended
	Nov. 28, 2013
Table Text Block [Abstract]	'
Schedule of Available-for-sale Securities Reconciliation [Table Text Block]	'
	As of November 28, 2013 and August 29, 2013, available-for-sale investments, including cash equivalents, were as follows:
	As of	November 28, 2013								August 29, 2013
		Amortized Cost		Gross Unrealized Gains		Gross Unrealized Losses		Fair Value		Amortized Cost		Gross Unrealized Gains		Gross Unrealized Losses			Fair Value
	Money market funds	$	1,677	$	—	$	—	$	1,677	$	1,188	$	—	$	—		$	1,188
	Certificates of deposit	558		—		—		558		349		—		—			349
	Corporate bonds	441		1		—		442		414		1		(1		)	414
	Government securities	133		—		—		133		168		—		—			168
	Asset-backed securities	107		—		—		107		97		—		—			97
	Commercial paper	63		—		—		63		61		—		—			61
	Marketable equity securities	6		—		—		6		6		—		—			6
		$	2,985	$	1	$	—	$	2,986	$	2,283	$	1	$	(1	)	$	2,283
Investments Classified by Contractual Maturity Date [Table Text Block]	'
	The table below presents the amortized cost and fair value of available-for-sale debt securities, including cash equivalents, as of November 28, 2013 by contractual maturity:
		Amortized Cost		Fair
				Value
	Money market funds not due at a single maturity date	$	1,677	$	1,677
	Due in 1 year or less	771		771
	Due in 1 - 2 years	257		258
	Due in 2 - 4 years	262		262
	Due after 4 years	12		12
		$	2,979	$	2,980

Receivables_Tables

Receivables (Tables)	3 Months Ended
	Nov. 28, 2013
Table Text Block [Abstract]	'
Schedule of Receivables	'
	As of	November 28,		August 29,
		2013		2013
	Trade receivables (net of allowance for doubtful accounts of $5 and $5, respectively)	$	2,533	$	2,069
	Income and other taxes	65		74
	Other	235		186
		$	2,833	$	2,329

Inventories_Tables

Inventories (Tables)	3 Months Ended
	Nov. 28, 2013
Table Text Block [Abstract]	'
Schedule Of Inventory	'
	As of	November 28,		August 29,
		2013		2013
	Finished goods	$	836	$	796
	Work in process	1,462		1,719
	Raw materials and supplies	161		134
		$	2,459	$	2,649

Property_Plant_and_Equipment_T

Property, Plant and Equipment (Tables)	3 Months Ended
	Nov. 28, 2013
Table Text Block [Abstract]	'
Schedule of Property, Plant and Equipment	'
	As of	November 28,			August 29,
		2013			2013
	Land	$	86		$	86
	Buildings	4,892			4,835
	Equipment	15,909			15,600
	Construction in progress	195			84
	Software	319			315
		21,401			20,920
	Accumulated depreciation	(13,668		)	(13,294		)
		$	7,733		$	7,626

Equity_Method_Investments_Tabl

Equity Method Investments (Tables)	3 Months Ended
	Nov. 28, 2013
Table Text Block [Abstract]	'
Equity Method Investments	'
	As of	November 28, 2013					August 29, 2013
		Investment Balance		Ownership Percentage			Investment Balance		Ownership Percentage
	Inotera	$	437	35	%		$	344	35	%
	Tera Probe	42		40	%		40		40	%
	Other	11		Various			12		Various
		$	490				$	396
	We recognize our share of earnings or losses from these entities under the equity method, generally on a two-month lag.  Equity in net income (loss) of equity method investees, net of tax, included the following:
	Quarter ended	November 28,		November 29,
		2013		2012
	Inotera	$	84	$	(53	)
	Tera Probe	2		—
	Other	—		1
		$	86	$	(52	)

Intangible_Assets_Tables

Intangible Assets (Tables)	3 Months Ended
	Nov. 28, 2013
Table Text Block [Abstract]	'
Schedule Of Finite Lived Intangible Assets By Major Class	'
	As of	November 28, 2013					August 29, 2013
		Gross		Accumulated			Gross		Accumulated
		Amount		Amortization			Amount		Amortization
	Product and process technology	$	647	$	(288	)	$	642	$	(269	)
	Customer relationships	127		(118		)	127		(114		)
		$	774	$	(406	)	$	769	$	(383	)

Accounts_Payable_and_Accrued_E1

Accounts Payable and Accrued Expenses (Tables)	3 Months Ended
	Nov. 28, 2013
Table Text Block [Abstract]	'
Accounts Payable And Accrued Liabilities Schedule	'
	As of	November 28,		August 29,
		2013		2013
	Accounts payable	$	1,164	$	1,048
	Related party payables	605		374
	Salaries, wages and benefits	337		267
	Customer advances	192		140
	Income and other taxes	42		47
	Other	290		239
		$	2,630	$	2,115

Debt_Tables

Debt (Tables)	3 Months Ended
	Nov. 28, 2013
Table Text Block [Abstract]	'
Schedule of Debt	'
	As of	November 28,			August 29,
		2013			2013
	Capital lease obligations	$	1,107		$	1,252
	Elpida creditor installment payments	1,095			1,644
	2014 convertible senior notes, due June 2014(1)	471			465
	2027 convertible senior notes, due June 2027	160			147
	2031A convertible senior notes, due August 2031	284			277
	2031B convertible senior notes, due August 2031	104			253
	2032C convertible senior notes, due May 2032(1)	467			463
	2032D convertible senior notes, due May 2032(1)	371			369
	2033E convertible senior notes, due February 2033	273			272
	2033F convertible senior notes, due February 2033	261			260
	2043G convertible senior notes, due November 2043(1)	628			—
	Other notes payable	582			635
		5,803			6,037
	Less current portion	1,543			1,585
		$	4,260		$	4,452
	(1) For these notes, we have the option to pay cash for the aggregate amount due upon conversion. It is our current intent to settle the principal amount of these notes in cash upon conversion. As a result, the notes are considered in diluted earnings per share under the treasury stock method.
Schedule Of Convertible Debt Instruments With Debt And Equity Components [Text Block]	'
	The difference between the debt recorded at inception and its principal amount is to be accreted to principal through interest expense through the estimated life of the note.
				Date Holders Can Put Back to Us(2)		Interest Rate				Discount as of
		Term				Stated		Effective		28-Nov-13		August 29,
		(Years)(1)										2013
	2014 Notes	Less than 1		—		1.875	%	7.9	%	$	14	$	20
	2027 Notes(3)	Less than 1		N/A		1.875	%	6.9	%	14		28
	2031A Notes(3)	Less than 1		N/A		1.5	%	6.5	%	36		68
	2031B Notes	7		Aug-20		1.875	%	7	%	36		92
	2032C Notes	5		May-19		2.375	%	6	%	83		87
	2032D Notes	7		May-21		3.125	%	6.3	%	79		81
	2033E Notes	4		Feb-18		1.625	%	4.5	%	27		28
	2033F Notes	6		Feb-20		2.125	%	4.9	%	39		40
	2043G Notes	15		Nov-28		3	%	6.8	%	397		—
	(1) Expected term for amortization of the remaining debt discount as of November 28, 2013. For the 2043G Notes,
	$289 million of debt discount is expected to be amortized over the 15-year expected term. See "2043G Notes" above.
	(2) Holders of these notes have the right to require us to repurchase all or a portion of their notes on the dates specified.
	(3) In connection with the November 2013 debt restructure transactions, all holders exercised their option to convert their notes in the second quarter of 2014.
	Conversion prices per share and the conversion value in excess of principal for our convertible notes were as follows:
		Initial Conversion							Conversion Price Per Share Threshold(2)	Conversion Value
										in Excess of Principal
		Outstanding Principal			Price Per Share		Number of Shares(1)			November 28, 2013(3)		August 29, 2013(4)
	2014 Notes	$	485		14.23		34		18.5	$	237	$	—
	2027 Notes	95			10.9		9		14.17	89		43
	2031A Notes	190			9.5		20		12.35	233		148
	2031B Notes	140			9.5		15		12.35	172		148
	2032C Notes	550			9.63		57		12.52	659		225
	2032D Notes	450			9.98		45		12.97	504		162
	2033E Notes	300			10.93		27		14.21	281		72
	2033F Notes	300			10.93		27		14.21	281		72
	2043G Notes	1,025			29.16		35		37.91	—		—
		$	3,535				269			$	2,456	$	870
	(1)Shares issuable, upon conversion, for the principal amount of the notes.
	(2)Holders may convert their notes during any calendar quarter if the closing price of our common stock for at least 20 trading days in a 30 trading day period ending on the last trading day of the immediately preceding calendar quarter is 130% of the initial conversion price per share.
	(3)Based on our closing share price of $21.17 and outstanding principal balances as of November 28, 2013.
	(4)Based on our closing share price of $13.57 and outstanding principal balances as of August 29, 2013. The principal balances were not reduced by the amount of the Exchange Transactions that occurred in the first quarter of 2014 as described below.
Schedule of Maturities of Long-term Debt [Table Text Block]	'
	As of November 28, 2013, maturities of notes payable, excluding the 2019 Notes which were issued subsequent to November 28, 2013, were as follows:
	As of November 28, 2013	Notes Payable
	Remainder of 2014	$	1,110
	2015	359
	2016	348
	2017	317
	2018	516
	2019 and thereafter(1)	2,960
	Discounts(1)	(914		)
		$	4,696
	(1) Includes $917 million of scheduled accreted principal amount and $289 million of discount for the 2043G Notes. See "2043G Notes" above.

Micron_Shareholders_Equity_and1

Micron Shareholders' Equity and Noncontrolling Interests in Subsidiaries (Tables)	3 Months Ended
	Nov. 28, 2013
Table Text Block [Abstract]	'
Schedule of Stockholders Equity [Table Text Block]	'
	Changes in the components of equity were as follows:
			Quarter Ended November 28, 2013									Quarter Ended November 29, 2012
			Attributable to Micron			Noncontrolling Interests			Total Equity			Attributable to Micron			Noncontrolling Interests			Total Equity
	Beginning balance		$	9,142		$	864		$	10,006		$	7,700		$	717		$	8,417
	Net income (loss)		358			23			381			(275		)	—			(275		)
	Other comprehensive income (loss)		5			—			5			3			—			3
	Comprehensive income (loss)		363			23			386			(272		)	—			(272		)
	Contribution from noncontrolling interests		—			49			49			—			—			—
	Distributions to noncontrolling interests		—			(9		)	(9		)	—			—			—
	Capital and other transactions attributable to Micron		(286		)	—			(286		)	41			—			41
	Ending balance		$	9,219		$	927		$	10,146		$	7,469		$	717		$	8,186
Schedule of Options Indexed to Issuer's Equity [Table Text Block]	'
	The following table presents information related to the issued and outstanding capped calls as of November 28, 2013.
	Capped Calls					Strike Price(1)			Cap Price Range						Common Shares Covered		Value at Expiration(2)
			Expiration Dates						Low			High					Minimum				Maximum
	2031		Jul-14	-	Feb-16	$	9.5		$	11.4		$	13.17		73		$	—			$	207
	2032C		May-16	-	Nov-17	9.8			14.26			15.69			56		—				307
	2032D		Nov-16	-	May-18	10.16			14.62			16.04			44		—				244
	2033E		Jan-18	-	Feb-18	10.93			14.51			14.51			27		—				98
	2033F		Jan-20	-	Feb-20	10.93			14.51			14.51			27		—				98
															227		$	—			$	954
	(1)	Initial strike prices are subject to certain adjustments.
	(2)	Settlement in cash on the respective expiration dates would result in us receiving an amount ranging from zero, if the market price per share of our common stock is at or below the respective low strike price, to the respective maximum amount if the market price per share of our common stock is at or above the respective high cap price. If share settlement were elected, the number of shares repurchased would be determined by the value of the capped calls at the time of settlement divided by the share price on the settlement date.
Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block]	'
	The changes in accumulated other comprehensive income (loss) by component in the first quarter of 2014 were as follows:
			Cumulative Foreign Currency Translation Adjustments			Gains (Losses) on Derivative Instruments, Net			Gains (Losses) on Investments, Net			Pension Liability Adjustments			Total
	August 29, 2013		$	44		$	21		$	—		$	(2	)	$	63
	Other comprehensive income before reclassifications		6			(2		)	1			—			5
	Net other comprehensive income (loss)		6			(2		)	1			—			5
	November 28, 2013		$	50		$	19		$	1		$	(2	)	$	68

Derivative_Instruments_Tables

Derivative Instruments (Tables)	3 Months Ended
	Nov. 28, 2013
Table Text Block [Abstract]	'
Schedule of Other Derivatives Not Designated as Hedging Instruments, Statements of Financial Performance and Financial Position, Location [Table Text Block]	'
	Total gross notional amounts and fair values for derivative instruments without hedge accounting designation were as follows:
	As of November 28, 2013		Notional Amount(1)			Fair Value of
						Current Assets(2)			Noncurrent Assets(3)			(Current Liabilities)(4)			(Noncurrent Liabilities)(5)
	Currency forward contracts:
	Yen		$	496		$	—		$	—		$	(13	)	$	(4	)
	Singapore dollar		265			—			—			(2		)	—
	Shekel		81			—			—			—			—
	Euro		58			—			—			(1		)	—
	Interest rate swap contracts		59			—			—			—			—
			$	959
	Convertible notes settlement obligations		21			—			—			(444		)	—
						$	—		$	—		$	(460	)	$	(4	)
	As of August 29, 2013
	Forward contracts:
	Yen		$	336		$	1		$	3		$	—		$	—
	Singapore dollar		218			—			—			—			—
	Shekel		78			—			—			(1		)	—
	Euro		217			1			—			(1		)	—
	Interest rate swap contracts		62			—			—			—			—
	Currency options:
	New Taiwan dollar		351			—			—			—			—
			$	1,262		$	2		$	3		$	(2	)	$	—
	-1	Notional amounts of forward, option and interest rate swap contracts in U.S. dollars and convertible notes settlement obligations in shares.
	(2)	Included in receivables – other.
	(3)	Included in other noncurrent assets.
	(4)	Included in accounts payable and accrued expenses – other for forward, option and interest rate swap contracts and in current portion of long-term debt for convertible notes settlement obligations.
	(5)	Included in other noncurrent liabilities.
Schedule of Cash Flow Hedging Instruments, Statements of Financial Performance and Financial Position, Location [Table Text Block]	'
	Total gross notional amounts and fair values for derivative instruments with cash flow hedge accounting designation were as follows:
	As of November 28, 2013		Notional Amount			Fair Value of Current Liabilities (1)
			(in U.S. Dollars)
	Currency forward contracts:
	Euro		$	15		$	—
	Yen		12			—
	Currency options:
	Yen		11			(1		)
	Interest swap contracts:		234			(2		)
			$	272		$	(3	)
	As of August 29, 2013
	Currency forward contracts:
	Yen		$	6		$	(1	)
	Euro		6			—
	Currency options:
	Yen		21			(2		)
	Interest swap contracts:		250			—
			$	283		$	(3	)
	(1)	Included in accounts payable and accrued expenses – other.
Derivative Master Netting Arrangements [Table Text Block]	'
	The following table presents the gross amounts of our derivative assets and liabilities and the net amounts recorded in our consolidated balance sheet:
	As of November 28, 2013		Current Assets(1)			(Current Liabilities)(2)			(Noncurrent Liabilities)(3)
	Gross amount		$	1		$	(463	)	$	(4	)
	Gross amounts offset in the statement of financial position		(1		)	1			—
	Net amounts presented in the statement of financial position		$	—		$	(462	)	$	(4	)
	(1) Included in receivables – other.
	(2) Included in current portion of long-term debt and accounts payable and accrued expenses – other.
	(3) Included in other noncurrent liabilities.

Fair_Value_Measurements_Tables

Fair Value Measurements (Tables)	3 Months Ended
	Nov. 28, 2013
Table Text Block [Abstract]	'
Assets measured at fair value on a recurring basis	'
	Assets measured at fair value on a recurring basis were as follows:
	As of	November 28, 2013								August 29, 2013
		Level 1		Level 2		Level 3		Total		Level 1		Level 2		Level 3		Total
	Cash equivalents:
	Money market funds	$	1,677	$	—	$	—	$	1,677	$	1,188	$	—	$	—	$	1,188
	Certificates of deposit	—		543		—		543		—		38		—		38
	Commercial paper	—		5		—		5		—		35		—		35
		1,677		548		—		2,225		1,188		73		—		1,261
	Short-term investments:
	Corporate bonds	—		112		—		112		—		112		—		112
	Commercial paper	—		58		—		58		—		26		—		26
	Government securities	—		37		—		37		—		72		—		72
	Certificates of deposit	—		8		—		8		—		9		—		9
	Asset-backed securities	—		1		—		1		—		2		—		2
		—		216		—		216		—		221		—		221
	Long-term marketable investments:
	Corporate bonds	—		330		—		330		—		302		—		302
	Asset-backed securities	—		106		—		106		—		95		—		95
	Government securities	—		96		—		96		—		96		—		96
	Marketable equity securities	6		—		—		6		6		—		—		6
		6		532		—		538		6		493		—		499
	Restricted cash:
	Certificates of deposit	—		7		—		7		—		302		—		302
		—		7		—		7		—		302		—		302
		$	1,683	$	1,303	$	—	$	2,986	$	1,194	$	1,089	$	—	$	2,283
Estimated fair value and carrying value of debt instruments	'
	The estimated fair value and carrying value of debt instruments (carrying value excludes the equity components of our convertible notes classified in equity) were as follows:
	As of	November 28, 2013				August 29, 2013
		Fair		Carrying		Fair		Carrying
		Value		Value		Value		Value
	Convertible notes	$	6,076	$	3,019	$	4,167	$	2,506
	Elpida creditor installment payments and other notes	1,680		1,677		2,269		2,279

Equity_Plans_Tables

Equity Plans (Tables)	3 Months Ended
	Nov. 28, 2013
Table Text Block [Abstract]	'
Assumptions used in Black-Scholes option valuation model	'
	Assumptions used in the Black-Scholes model are presented below:
	Quarter Ended	November 28,		November 29,
		2013		2012
	Average expected life in years	4.8		5
	Weighted-average expected volatility	50	%	62	%
	Weighted-average risk-free interest rate	1.3	%	0.7	%
Schedule of restricted stock awards activity	'
	Restricted Stock Awards granted for the first quarters of 2014 and 2013 were as follows:
	Quarter ended	November 28,			November 29,
		2013			2012
	Service-based awards	1			2
	Performance-based awards	1			1
	Weighted-average grant-date fair values per share	$	17.31		$	5.73
Stock-based compensation expense	'
	Stock-based Compensation Expense
	Quarter ended	November 28,			November 29,
		2013			2012
	Stock-based compensation expense by caption:
	Cost of goods sold	$	7		$	6
	Selling, general and administrative	11			9
	Research and development	4			4
		$	22		$	19
	Stock-based compensation expense by type of award:
	Stock options	$	14		$	13
	Restricted stock awards	8			6
		$	22		$	19

Restucture_and_Asset_Impairmen1

Restucture and Asset Impairments Restructuring and Asset Impairments (Tables)	3 Months Ended
	Nov. 28, 2013
Restructuring and Related Activities [Abstract]	'
Schedule of Restructuring and Related Costs [Table Text Block]	'
	Quarter ended	November 28,			November 29,
		2013			2012
	Gain on termination of lease to Transform	$	—		$	(25	)
	Other	(3		)	4
		$	(3	)	$	(21	)

Other_Operating_Income_Expense1

Other Operating (Income) Expense, Net (Tables)	3 Months Ended
	Nov. 28, 2013
Table Text Block [Abstract]	'
Schedule of Other operating (income) expense, net	'
	Quarter ended	November 28,			November 29,
		2013			2012
	Rambus settlement	$	233		$	—
	(Gain) loss on disposition of property, plant and equipment	8			(5		)
	Other	(4		)	(3		)
		$	237		$	(8	)

Other_NonOperating_Income_Expe1

Other Non-Operating Income (Expense), Net (Tables)	3 Months Ended
	Nov. 28, 2013
Other Income and Expenses [Abstract]	'
Schedule of Other Nonoperating Income (Expense) [Table Text Block]	'
	Quarter ended	28-Nov-13			29-Nov-12
	Loss on restructure of debt	$	(75	)	$	—
	Gain (loss) from changes in currency exchange rates	(6		)	(59		)
	Other	1			—
		$	(80	)	$	(59	)

Earnings_Per_Share_Tables

Earnings Per Share (Tables)	3 Months Ended
	Nov. 28, 2013
Table Text Block [Abstract]	'
Basic and diluted earnings per share	'
	Quarter ended	November 28,		November 29,
		2013		2012
	Net income (loss) available to Micron shareholders – Basic and Diluted	$	358	$	(275	)
	Weighted-average common shares outstanding – Basic	1,046		1,014
	Net effect of dilutive equity awards and convertible notes	150		—
	Weighted-average common shares outstanding – Diluted	1,196		1,014
	Earnings (loss) per share:
	Basic	$	0.34	$	(0.27	)
	Diluted	0.3		(0.27		)

Consolidated_Variable_Interest1

Consolidated Variable Interest Entities (Tables)	3 Months Ended
	Nov. 28, 2013
Variable Interest Entity [Line Items]	'
IMFT's distributions to, and contributions from, shareholders	'
	The following table presents IMFT's distributions to and contributions from its shareholders:
	Quarter Ended	November 28,		November 29,
		2013		2012
	IMFT distributions to Micron	$	—	$	—
	IMFT distributions to Intel	—		—
	Micron contributions to IMFT	51		—
	Intel contributions to IMFT	49		—
IM Flash Technologies, LLC [Member]	'
Variable Interest Entity [Line Items]	'
Total IMFT and MP Mask assets and liabilities	'
	The following table presents the assets and liabilities of IMFT included in our consolidated balance sheets, excluding intercompany balances:
	As of	November 28,		August 29, 2013
		2013
	Assets
	Cash and equivalents	$	105	$	62
	Receivables	67		76
	Inventories	48		49
	Other current assets	4		4
	Total current assets	224		191
	Property, plant and equipment, net	1,364		1,382
	Other noncurrent assets	47		46
	Total assets	$	1,635	$	1,619
	Liabilities
	Accounts payable and accrued expenses	$	87	$	88
	Deferred income	9		9
	Equipment purchase contracts	4		78
	Current portion of long-term debt	6		6
	Total current liabilities	106		181
	Long-term debt	11		13
	Other noncurrent liabilities	114		118
	Total liabilities	$	231	$	312
	Amounts exclude intercompany balances that were eliminated in our consolidated balance sheets.
MP Mask Technology Center LLC [Member]	'
Variable Interest Entity [Line Items]	'
Total IMFT and MP Mask assets and liabilities	'
	Total MP Mask assets and liabilities included in our consolidated balance sheets were as follows:
	As of	November 28,		August 29, 2013
		2013
	Current assets	$	32	$	26
	Noncurrent assets (primarily property, plant and equipment)	176		182
	Current liabilities	24		25
	Amounts exclude intercompany balances that were eliminated in our consolidated balance sheets.

Segment_Information_Tables

Segment Information (Tables)	3 Months Ended
	Nov. 28, 2013
Table Text Block [Abstract]	'
Segment Information	'
	Quarter ended	November 28,			November 29,
		2013			2012
	Net sales:
	DSG	$	1,785		$	600
	WSG	1,054			263
	NSG	806			617
	ESG	366			278
	All Other	31			76
		$	4,042		$	1,834
	Operating income (loss):
	DSG	$	432		$	(112	)
	WSG	176			(64		)
	NSG	95			13
	ESG	66			78
	All Other	15			(12		)
	Unallocated	(233		)	—
		$	551		$	(97	)

Certain_Concentrations_Certain

Certain Concentrations Certain Concentrations (Tables)	3 Months Ended
	Nov. 28, 2013
Risks and Uncertainties [Abstract]	'
Schedule of market concentration risk [Table Text Block]	'
	Markets with a concentration of at least 10 percent of net sales were as follows:
	For the quarter ended	28-Nov-13		29-Nov-12
	Computing (including desktop PCs, servers, notebooks and workstations)	35	%	20	%
	Mobile	25	%	15	%
	Consumer electronics	10	%	20	%
	Solid state drives	10	%	10	%
	Networking and storage	10	%	10	%

Elpida_Memory_Inc_Elpida_Memor1

Elpida Memory, Inc. Elpida Memories, Inc. (Details) (USD $)	3 Months Ended		0 Months Ended	12 Months Ended	0 Months Ended	3 Months Ended
In Millions, except Per Share data, unless otherwise specified	Nov. 29, 2012	Jul. 31, 2013	Jul. 31, 2013	Aug. 29, 2013	Jul. 31, 2013	Nov. 28, 2013
			Elpida Company [Member]	Elpida Company [Member]	Rexchip Electronics Corporation, now known as Micron Memory Taiwan Co., Ltd. [Member]	Rexchip Electronics Corporation, now known as Micron Memory Taiwan Co., Ltd. [Member]
Business Acquisition [Line Items]	'	'	'	'	'	'
Cash paid for the acquisition of Elpida	'	'	$615	'	$334	'
Rexchip Share Purchase Agreement [Abstract]	'	'	'	'	'	'
Percentage of equity acquired	'	'	'	'	24.00%	'
Business Acquisition, Equity Interest Held by Acquiree, Less than Wholly Owned Subsidiary, Ownership Percentage	'	'	65.00%	'	'	'
Ownership percentage after stock transactions during period (in hundredths)	'	'	'	'	'	89.00%
Total net assets acquired	'	2,601	'	'	'	'
Noncontrolling interests in Elpida	'	168	'	'	'	'
Gain on acquisition of Elpida	'	'	'	1,484	'	'
Business Acquisition, Pro Forma Information [Abstract]	'	'	'	'	'	'
Net sales	2,619	'	'	'	'	'
Net income (loss)	-226	'	'	'	'	'
Net income (loss) attributable to Micron	($237)	'	'	'	'	'
Earnings (loss) per share: [Abstract]	'	'	'	'	'	'
Basic (in dollars per share)	($0.23)	'	'	'	'	'
Diluted (in dollars per share)	($0.23)	'	'	'	'	'

Investments_Details

Investments (Details) (USD $)	3 Months Ended
In Millions, unless otherwise specified	Nov. 28, 2013	Nov. 29, 2012	Aug. 29, 2013
Schedule of Available-for-sale Securities [Line Items]	'	'	'
Amortized Cost	$2,985	'	$2,283
Gross Unrealized Gains	1	'	1
Gross Unrealized Losses	0	'	-1
Fair Value	2,986	'	2,283
Available-for-sale Securities, Debt Maturities, Amortized Cost Basis [Abstract]	'	'	'
Money market funds not due at a single maturity date	1,677	'	'
Due in 1 year or less	771	'	'
Due in 1-2 years	257	'	'
Due in 2-4 years	262	'	'
Due after 4 years	12	'	'
Debt Maturities, Amortized Cost Basis	2,979	'	'
Available-for-sale Securities, Debt Maturities, Fair Value [Abstract]	'	'	'
Money market funds not due at a single maturity date	1,677	'	'
Due in 1 year or less	771	'	'
Due in 1-2 years	258	'	'
Due in 2-4 years	262	'	'
Due after 4 years	12	'	'
Debt Securities, Fair Value	2,980	'	'
Available-for-sale Securities, Gross Realized Gain (Loss), Disclosures [Abstract]	'	'	'
Proceeds from the sale of available-for-sale securities	113	93	'
Money market funds [Member]	'	'	'
Schedule of Available-for-sale Securities [Line Items]	'	'	'
Amortized Cost	1,677	'	1,188
Gross Unrealized Gains	0	'	0
Gross Unrealized Losses	0	'	0
Fair Value	1,677	'	1,188
Certificates of deposit [Member]	'	'	'
Schedule of Available-for-sale Securities [Line Items]	'	'	'
Amortized Cost	558	'	349
Gross Unrealized Gains	0	'	0
Gross Unrealized Losses	0	'	0
Fair Value	558	'	349
Corporate bonds [Member]	'	'	'
Schedule of Available-for-sale Securities [Line Items]	'	'	'
Amortized Cost	441	'	414
Gross Unrealized Gains	1	'	1
Gross Unrealized Losses	0	'	-1
Fair Value	442	'	414
Government securities [Member]	'	'	'
Schedule of Available-for-sale Securities [Line Items]	'	'	'
Amortized Cost	133	'	168
Gross Unrealized Gains	0	'	0
Gross Unrealized Losses	0	'	0
Fair Value	133	'	168
Asset-backed securities [Member]	'	'	'
Schedule of Available-for-sale Securities [Line Items]	'	'	'
Amortized Cost	107	'	97
Gross Unrealized Gains	0	'	0
Gross Unrealized Losses	0	'	0
Fair Value	107	'	97
Commercial paper [Member]	'	'	'
Schedule of Available-for-sale Securities [Line Items]	'	'	'
Amortized Cost	63	'	61
Gross Unrealized Gains	0	'	0
Gross Unrealized Losses	0	'	0
Fair Value	63	'	61
Marketable equity securities [Member]	'	'	'
Schedule of Available-for-sale Securities [Line Items]	'	'	'
Amortized Cost	6	'	6
Gross Unrealized Gains	0	'	0
Gross Unrealized Losses	0	'	0
Fair Value	$6	'	$6

Receivables_Details

Receivables (Details) (USD $)	Nov. 28, 2013	Aug. 29, 2013
In Millions, unless otherwise specified
Receivables [Abstract]	'	'
Trade receivables (net of allowance for doubtful accounts of $5 and $5, respectively)	$2,533	$2,069
Income and other taxes	65	74
Other	235	186
Receivables	2,833	2,329
Allowance for doubtful accounts	5	5
Intel [Member]	'	'
Receivables [Abstract]	'	'
Other	$68	$34

Inventories_Details

Inventories (Details) (USD $)	Nov. 28, 2013	Aug. 29, 2013
In Millions, unless otherwise specified
Inventory, Net, Items Net of Reserve Alternative [Abstract]	'	'
Finished goods	$836	$796
Work in process	1,462	1,719
Raw materials and supplies	161	134
Inventories	$2,459	$2,649

Property_Plant_and_Equipment_D

Property, Plant and Equipment (Details) (USD $)	3 Months Ended
In Millions, unless otherwise specified	Nov. 28, 2013	Nov. 29, 2012	Aug. 29, 2013
Property, Plant and Equipment, Net, by Type [Abstract]	'	'	'
Property, Plant and Equipment, Gross	$21,401	'	$20,920
Accumulated depreciation	-13,668	'	-13,294
Property, Plant and Equipment, Net	7,733	'	7,626
Depreciation [Abstract]	'	'	'
Depreciation expense	468	437	'
Land [Member]	'	'	'
Property, Plant and Equipment, Net, by Type [Abstract]	'	'	'
Property, Plant and Equipment, Gross	86	'	86
Buildings [Member]	'	'	'
Property, Plant and Equipment, Net, by Type [Abstract]	'	'	'
Property, Plant and Equipment, Gross	4,892	'	4,835
Equipment [Member]	'	'	'
Property, Plant and Equipment, Net, by Type [Abstract]	'	'	'
Property, Plant and Equipment, Gross	15,909	'	15,600
Construction in progress [Member]	'	'	'
Property, Plant and Equipment, Net, by Type [Abstract]	'	'	'
Property, Plant and Equipment, Gross	195	'	84
Software [Member]	'	'	'
Property, Plant and Equipment, Net, by Type [Abstract]	'	'	'
Property, Plant and Equipment, Gross	319	'	315
Other noncurrent assets [Member]	'	'	'
Property, Plant and Equipment Assets Held-for-sale or held-for-development Disclosure [Abstract]	'	'	'
Property, plant and equipment classified as held for sale	49	'	22
Land held for development	$55	'	$54

Equity_Method_Investments_Deta

Equity Method Investments (Details) (USD $)

3 Months Ended

3 Months Ended

9 Months Ended

12 Months Ended

3 Months Ended

3 Months Ended

3 Months Ended

3 Months Ended

In Millions, unless otherwise specified

Nov. 28, 2013

Nov. 29, 2012

Aug. 29, 2013

Nov. 28, 2013

Nov. 28, 2013

Nov. 29, 2012

Sep. 30, 2013

Dec. 31, 2012

Aug. 29, 2013

Nov. 28, 2013

Nov. 28, 2013

Nov. 29, 2012

Nov. 28, 2013

Nov. 29, 2012

Aug. 29, 2013

Aug. 29, 2013

Nov. 28, 2013

Nov. 29, 2012

Aug. 29, 2013

Mar. 04, 2010

Nov. 28, 2013

Nov. 28, 2013

Nov. 28, 2013

Mar. 01, 2012

Nov. 29, 2012

Primarily Inotera [Member]

Inotera [Member]

Inotera [Member]

Inotera [Member]

Inotera [Member]

Inotera [Member]

Inotera [Member]

Inotera [Member]

Inotera [Member]

Tera Probe [Member]

Tera Probe [Member]

Tera Probe [Member]

Tera Probe [Member]

Other [Member]

Other [Member]

Other [Member]

Other [Member]

Other [Member]

Other [Member]

Other [Member]

Other [Member]

Nanya [Member]

Nanya [Member]

Inventories [Member]

Inventories [Member]

Elpida Company [Member]

Transform [Member]

Transform [Member]

Transform [Member]

Aptina [Member]

Aptina [Member]

Origin Energy Limited [Member]

Schedule of Equity Method Investments [Line Items]

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Investment Balance

$490

'

$396

'

$437

'

'

'

$344

'

'

'

$42

'

$40

'

$11

'

$12

'

'

'

'

$0

'

Ownership Percentage (in hundredths)

'

'

'

'

35.00%

'

'

'

35.00%

'

'

'

40.00%

'

40.00%

'

'

'

'

'

50.00%

'

30.00%

'

'

Equity in net income (loss) of equity method investees, net of tax

86

-52

'

'

84

-53

'

'

'

'

'

'

2

0

'

'

0

1

'

'

'

'

'

'

'

Maximum exposure to loss related to variable interest entities

'

'

'

437

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Percentage interest held by a third party (in hundredths)

'

'

'

'

'

'

'

'

'

36.00%

'

'

'

'

'

'

'

'

'

'

'

50.00%

'

'

'

Market value of equity interests

'

'

'

'

1,470

'

'

'

'

'

'

'

36

'

'

'

'

'

'

'

'

'

'

'

'

Amount in accumulated other comprehensive income (loss) for cumulative translation adjustments on its investment

'

'

'

'

50

'

'

'

44

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Equity Method Investment, Summarized Financial Information [Abstract]

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Inotera current liabilities that exceed current assets

'

'

'

'

'

'

766

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Inotera net income (loss)

'

'

'

'

'

'

333

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Percentage of Inotera's wafer production previously obligated to purchase (in hundredths)

'

'

'

'

'

'

'

50.00%

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Purchases of DRAM products from Inotera

'

'

'

'

'

'

'

'

'

'

587

201

'

'

'

'

'

'

'

'

'

'

'

'

'

Reduction in research and development costs under cost sharing arrangement

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

15

Equity [Abstract]

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Ownership percentage after stock transactions during period (in hundredths)

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

40.00%

'

'

'

50.00%

'

'

'

'

'

Difference between cost of Tera Probe investment and underlying equity

'

'

'

'

'

'

'

'

'

'

'

'

$34

'

'

'

'

'

'

'

'

'

'

'

'

Weighted-average period for remaining basis difference amortization (in years)

'

'

'

'

'

'

'

'

'

'

'

'

'6 years

'

'

'

'

'

'

'

'

'

'

'

'

Equity_Method_Investments_2_De

Equity Method Investments - 2 (Details) (USD $)	3 Months Ended			12 Months Ended	3 Months Ended		3 Months Ended
In Millions, unless otherwise specified	Nov. 29, 2012	Nov. 29, 2012	Nov. 28, 2013	Aug. 29, 2013	Feb. 27, 2014	Nov. 28, 2013	Nov. 28, 2013
	Transform [Member]	Aptina [Member]	Aptina [Member]	Aptina [Member]	Aptina [Member]	Aptina [Member]	Tera Probe [Member]
			Short-term interest free loan to Aptina [Member]	Short-term interest free loan to Aptina [Member]	Short-term interest free loan to Aptina [Member]	Short-term interest free loan to Aptina [Member]	Cost of Goods Sold [Member]
					Scenario, Forecast [Member]	Other current assets [Member]
Related Party Transaction [Line Items]	'	'	'	'	'	'	'
Related party purchases from Tera Probe	'	'	'	'	'	'	$33
Gain on lease termination	25	'	'	'	'	'	'
Revenues from transactions with related party	'	61	'	'	'	'	'
Cost of goods sold from transactions with related party	'	81	'	'	'	'	'
Amount loaned to Aptina	'	'	'	45	'	'	'
Repayments received from Aptina	'	'	15	'	30	'	'
Outstanding balance of loan to Aptina	'	'	'	'	'	$30	'

Intangible_Assets_Details

Intangible Assets (Details) (USD $)	3 Months Ended
In Millions, unless otherwise specified	Nov. 28, 2013	Nov. 29, 2012	Aug. 29, 2013
Intangible Assets [Abstract]	'	'	'
Gross Amount	$774	'	$769
Accumulated Amortization	-406	'	-383
Amortization expense for intangible assets	23	20	'
Finite-Lived Intangible Assets, Future Amortization Expense [Abstract]	'	'	'
Annual amortization for 2014	90	'	'
Annual amortization for 2015	74	'	'
Annual amortization for 2016	66	'	'
Annual amortization for 2017	56	'	'
Annual amortization for 2018	45	'	'
Product and process technology [Member]	'	'	'
Intangible Assets [Abstract]	'	'	'
Gross Amount	647	'	642
Accumulated Amortization	-288	'	-269
Product and process technology intangible asset capitalized during period	6	9	'
Product and process technology intangible asset capitalized during period, weighted-average useful lives (in years)	'9 years	'9 years	'
Customer relationships [Member]	'	'	'
Intangible Assets [Abstract]	'	'	'
Gross Amount	127	'	127
Accumulated Amortization	($118)	'	($114)

Accounts_Payable_and_Accrued_E2

Accounts Payable and Accrued Expenses (Details) (USD $)	Nov. 28, 2013	Aug. 29, 2013
In Millions, unless otherwise specified
Accounts payable	$1,164	$1,048
Related party payables	605	374
Salaries, wages and benefits	337	267
Customer advances	192	140
Income and other taxes	42	47
Other	290	239
Total accounts payable and accrued expenses	2,630	2,115
Other Liabilities, Noncurrent [Abstract]	'	'
Other noncurrent liabilities	875	535
DRAM [Member]	'	'
Customer advances	90	'
DRAM [Member] | Customer advances [Member]	'	'
Other Liabilities, Noncurrent [Abstract]	'	'
Other noncurrent liabilities	158	'
Intel [Member]	'	'
Other	11	8
Intel [Member] | NAND Flash [Member]	'	'
Customer advances	100	134
Inotera [Member]	'	'
Related party payables	578	345
Tera Probe [Member]	'	'
Related party payables	$27	$29

Debt_Schedule_of_Longterm_Debt

Debt - Schedule of Long-term Debt (Details)

3 Months Ended

1 Months Ended

3 Months Ended

3 Months Ended

Share data in Millions, except Per Share data, unless otherwise specified

Nov. 28, 2013

Nov. 29, 2012

Aug. 29, 2013

Nov. 28, 2013

Aug. 29, 2013

Oct. 31, 2013

Nov. 28, 2013

Aug. 29, 2013

Nov. 28, 2013

Nov. 28, 2013

Nov. 28, 2013

Aug. 29, 2013

Nov. 28, 2013

Aug. 29, 2013

Nov. 28, 2013

Aug. 29, 2013

Nov. 28, 2013

Aug. 29, 2013

Nov. 28, 2013

Aug. 29, 2013

Nov. 28, 2013

Aug. 29, 2013

Nov. 28, 2013

Aug. 29, 2013

Nov. 28, 2013

Aug. 29, 2013

Nov. 28, 2013

Aug. 29, 2013

Nov. 28, 2013

Aug. 29, 2013

Nov. 12, 2013

Nov. 28, 2013

Nov. 12, 2013

Nov. 15, 2028

Nov. 28, 2013

Aug. 29, 2013

Feb. 27, 2014

Dec. 20, 2013

Nov. 28, 2013

USD ($)

USD ($)

USD ($)

Capital Lease Obligations [Member]

Capital Lease Obligations [Member]

Reorganization obligation [Member]

Reorganization obligation [Member]

Reorganization obligation [Member]

Reorganization obligation [Member]

Reorganization obligation [Member]

Convertible Debt [Member]

Convertible Debt [Member]

Convertible Debt [Member]

Convertible Debt [Member]

Convertible Debt [Member]

Convertible Debt [Member]

Convertible Debt [Member]

Convertible Debt [Member]

Convertible Debt [Member]

Convertible Debt [Member]

Convertible Debt [Member]

Convertible Debt [Member]

Convertible Debt [Member]

Convertible Debt [Member]

Convertible Debt [Member]

Convertible Debt [Member]

Convertible Debt [Member]

Convertible Debt [Member]

Convertible Debt [Member]

Convertible Debt [Member]

Convertible Debt [Member]

Convertible Debt [Member]

Convertible Debt [Member]

Convertible Debt [Member]

Notes Payable, Other Payables [Member]

Notes Payable, Other Payables [Member]

Notes Payable, Other Payables [Member]

Notes Payable, Other Payables [Member]

Loans Payable [Member]

USD ($)

USD ($)

USD ($)

USD ($)

USD ($)

Scenario, Plan [Member]

Scenario, Plan [Member]

USD ($)

USD ($)

2014 convertible senior notes [Member]

2014 convertible senior notes [Member]

2027 convertible senior notes [Member]

2027 convertible senior notes [Member]

2031A convertible senior notes [Member]

2031A convertible senior notes [Member]

2031B convertible senior notes [Member]

2031B convertible senior notes [Member]

2032C convertible senior notes [Member]

2032C convertible senior notes [Member]

2032D convertible senior notes [Member]

2032D convertible senior notes [Member]

2033E convertible senior notes [Member]

2033E convertible senior notes [Member]

2033F convertible senior note [Member]

2033F convertible senior note [Member]

2043G convertible senior notes [Member]

2043G convertible senior notes [Member]

2043G convertible senior notes [Member]

2043G convertible senior notes [Member]

2043G convertible senior notes [Member]

2043G convertible senior notes [Member]

USD ($)

USD ($)

Secured Debt 4 [Member]

Secured Debt 4 [Member]

USD ($)

USD ($)

JPY (¥)

USD ($)

USD ($)

USD ($)

USD ($)

USD ($)

USD ($)

USD ($)

USD ($)

USD ($)

USD ($)

USD ($)

USD ($)

USD ($)

USD ($)

USD ($)

USD ($)

USD ($)

USD ($)

USD ($)

Expected To Be Accreted [Member]

Other noncurrent assets [Member]

Scenario, Forecast [Member]

Secured Debt [Member]

Secured Debt [Member]

integer

integer

integer

USD ($)

USD ($)

USD ($)

Scenario, Forecast [Member]

Scenario, Forecast [Member]

USD ($)

USD ($)

integer

Debt Instrument [Line Items]

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Long-term Debt, Gross

$5,803,000,000

'

$6,037,000,000

$1,107,000,000

$1,252,000,000

'

$1,095,000,000

$1,644,000,000

'

'

'

'

$471,000,000

[1]

$465,000,000

[1]

$160,000,000

$147,000,000

$284,000,000

$277,000,000

$104,000,000

$253,000,000

$467,000,000

[1]

$463,000,000

[1]

$371,000,000

[1]

$369,000,000

[1]

$273,000,000

$272,000,000

$261,000,000

$260,000,000

$628,000,000

[1]

$0

[1]

$627,000,000

'

'

'

$582,000,000

$635,000,000

'

'

$4,696,000,000

Less current portion

1,543,000,000

'

1,585,000,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Long-term debt

4,260,000,000

'

4,452,000,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Due date

'

'

'

'

'

'

'

'

'

'

'

'

30-Jun-14

'

30-Jun-27

'

31-Aug-31

'

31-Aug-31

'

31-May-32

'

31-May-32

'

28-Feb-33

'

28-Feb-33

'

30-Nov-43

'

'

'

'

'

'

'

'

'

'

Reorganization Plan Future Payments

'

'

'

'

'

'

'

'

1,388,000,000

142,000,000,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Repayments of debt

737,000,000

52,000,000

'

'

'

534,000,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Convertible Debt [Abstract]

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Expected term for amortization of the remaining debt discount (in years)

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'7 years

[2]

'

'5 years

[2]

'

'7 years

[2]

'

'4 years

[2]

'

'6 years

[2]

'

'15 years

[2]

'

'

'

'

'

'

'

'

'

'

Debt Instrument, Put Date, Earliest

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

31-Aug-20

[3]

'

31-May-19

[3]

'

31-May-21

[3]

'

28-Feb-18

[3]

'

28-Feb-20

[3]

'

30-Nov-28

[3]

'

'

'

'

'

'

'

'

'

'

Stated interest rate (in hundredths)

'

'

'

'

'

'

'

'

'

'

'

'

1.88%

'

1.88%

'

1.50%

'

1.88%

'

2.38%

'

3.13%

'

1.63%

'

2.13%

'

3.00%

'

'

'

'

'

'

'

'

1.26%

'

Debt Instrument, Interest Rate, Effective Percentage

'

'

'

'

'

'

'

'

'

'

'

'

7.90%

'

6.90%

'

6.50%

'

7.00%

'

6.00%

'

6.30%

'

4.50%

'

4.90%

'

6.80%

'

'

'

'

'

'

'

'

'

'

Debt Instrument, Unamortized Discount

'

'

'

'

'

'

'

'

'

'

'

'

14,000,000

20,000,000

14,000,000

[4]

28,000,000

[4]

36,000,000

[4]

68,000,000

[4]

36,000,000

92,000,000

83,000,000

87,000,000

79,000,000

81,000,000

27,000,000

28,000,000

39,000,000

40,000,000

397,000,000

0

398,000,000

289,000,000

'

'

'

'

'

'

914,000,000

[5]

Stated principal amount of debt instrument

'

'

'

'

'

'

'

'

'

'

3,535,000,000

'

485,000,000

'

95,000,000

'

190,000,000

'

140,000,000

'

550,000,000

'

450,000,000

'

300,000,000

'

300,000,000

'

1,025,000,000

'

'

'

'

'

'

'

'

462,000,000

'

Initial conversion, price per share

'

'

'

'

'

'

'

'

'

'

'

'

$14.23

'

$10.90

'

$9.50

'

$9.50

'

$9.63

'

$9.98

'

$10.93

'

$10.93

'

$29.16

'

'

'

'

'

'

'

'

'

'

Initial conversion, number of shares

'

'

'

'

'

'

'

'

'

'

269

[6]

'

34

[6]

'

9

[6]

'

20

[6]

'

15

[6]

'

57

[6]

'

45

[6]

'

27

[6]

'

27

[6]

'

35

[6]

'

'

'

'

'

'

'

'

'

'

Conversion price per share threshold (dollars per share)

'

'

'

'

'

'

'

'

'

'

'

'

$18.50

[7]

'

$14.17

[7]

'

$12.35

[7]

'

$12.35

[7]

'

$12.52

[7]

'

$12.97

[7]

'

$14.21

[7]

'

$14.21

[7]

'

$37.91

[7]

'

'

'

'

'

'

'

'

'

'

Conversion value in excess of principal

'

'

'

'

'

'

'

'

'

'

2,456,000,000

[8]

870,000,000

[9]

237,000,000

[8]

0

[9]

89,000,000

[8]

43,000,000

[9]

233,000,000

[8]

148,000,000

[9]

172,000,000

[8]

148,000,000

[9]

659,000,000

[8]

225,000,000

[9]

504,000,000

[8]

162,000,000

[9]

281,000,000

[8]

72,000,000

[9]

281,000,000

[8]

72,000,000

[9]

0

[8]

0

[9]

'

'

'

'

'

'

'

'

'

Share Price (in dollars per share)

$21.17

'

$13.57

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Convertible Debt Issuances [Abstract]

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Debt Instrument, Discounted Issue Price Per Debenture

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

800

'

'

'

'

'

'

'

'

'

'

Conversion rate (in shares)

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

34.2936

'

'

'

'

'

'

'

'

'

'

Principal amount per debenture used In coversion rate

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

1,000

'

'

'

'

'

'

'

'

'

'

Payments of debt issuance costs

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

7,000,000

'

'

'

'

'

'

'

'

'

'

Additional paid in capital equity component of convertible debt

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

173,000,000

'

'

'

'

'

'

'

'

Unamortized deferred debt issuance costs

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

5,000,000

'

'

'

'

'

'

Debt Instrument, Scheduled Accreted Principal Amount

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

917,000,000

'

'

'

'

'

Conversion rights, minimum number of trading days (in days)

'

'

'

'

'

'

'

'

'

'

'

'

'

'

20

'

20

'

'

'

'

'

'

'

'

'

'

'

20

'

'

'

'

'

'

'

'

'

'

Conversion rights, consecutive trading period (in days)

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'30 days

'

'

'

'

'

'

'

'

'

'

Conversion rights, threshold percentage of applicable conversion price (in hundredths)

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

130.00%

'

'

'

'

'

'

'

'

'

'

Conversion rights, maximum percentage of product of stock price and conversion rate (in hundredths)

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

98.00%

'

'

'

'

'

'

'

'

'

'

Debt Instruments Number Of Periodic Payments

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

10

'

Debt Instrument, Third Party Credit Enhancement Fee

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

23,000,000

'

'

Long-term Debt, Fiscal Year Maturity [Abstract]

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Remainder of 2014

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

1,110,000,000

2015

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

359,000,000

2016

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

348,000,000

2017

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

317,000,000

2018

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

516,000,000

2019 and thereafter

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

$2,960,000,000

[5]

[1]

(1) For these notes, we have the option to pay cash for the aggregate amount due upon conversion. It is our current intent to settle the principal amount of these notes in cash upon conversion. As a result, the notes are considered in diluted earnings per share under the treasury stock method.

[2]

(1) Expected term for amortization of the remaining debt discount as of NovemberB 28, 2013. For the 2043G Notes,$289 million of debt discount is expected to be amortized over the 15-year expected term. See "2043G Notes" above.

[3]

(2) Holders of these notes have the right to require us to repurchase all or a portion of their notes on the dates specified.

[4]

In connection with the November 2013 debt restructure transactions, all holders exercised their option to convert their notes in the second quarter of 2014.

[5]

(1) Includes $917 million of scheduled accreted principal amount and $289 million of discount for the 2043G Notes. See "2043G Notes" above.

[6]

(1)Shares issuable, upon conversion, for the principal amount of the notes.

[7]

(2)Holders may convert their notes during any calendar quarter if the closing price of our common stock for at least 20 trading days in a 30 trading day period ending on the last trading day of the immediately preceding calendar quarter is 130% of the initial conversion price per share.

[8]

(3)Based on our closing share price of $21.17 and outstanding principal balances as of November 28, 2013

[9]

(4)Based on our closing share price of $13.57 and outstanding principal balances as of August 29, 2013. The principal balances were not reduced by the amount of the Exchange Transactions that occurred in the first quarter of 2014 as described below.

Debt_Extinguishment_of_Debt_De

Debt - Extinguishment of Debt (Details) (USD $)

3 Months Ended

3 Months Ended

0 Months Ended

3 Months Ended

3 Months Ended

0 Months Ended

1 Months Ended

3 Months Ended

0 Months Ended

3 Months Ended

3 Months Ended

In Millions, unless otherwise specified

Nov. 28, 2013

Nov. 29, 2012

Aug. 29, 2013

Nov. 28, 2013

Nov. 12, 2013

Nov. 12, 2013

Nov. 28, 2013

Nov. 07, 2013

Nov. 28, 2013

Nov. 12, 2013

Nov. 28, 2013

Nov. 28, 2013

Nov. 12, 2013

Feb. 27, 2014

Feb. 27, 2014

Nov. 28, 2013

Nov. 12, 2013

Aug. 29, 2013

Nov. 12, 2013

Nov. 15, 2028

Nov. 28, 2013

Nov. 28, 2013

Nov. 28, 2013

Feb. 27, 2014

Feb. 27, 2014

Nov. 28, 2013

Nov. 28, 2013

Convertible Debt [Member]

Convertible Debt [Member]

Convertible Debt [Member]

Convertible Debt [Member]

Convertible Debt [Member]

Convertible Debt [Member]

Convertible Debt [Member]

Convertible Debt [Member]

Convertible Debt [Member]

Convertible Debt [Member]

Convertible Debt [Member]

Convertible Debt [Member]

2043G convertible senior notes [Member]

2043G convertible senior notes [Member]

2043G convertible senior notes [Member]

2043G convertible senior notes [Member]

2043G convertible senior notes [Member]

Other Non-Operating Income Expense Net [Member]

Other Non-Operating Income Expense Net [Member]

Other Non-Operating Income Expense Net [Member]

Other Non-Operating Income Expense Net [Member]

Other Non-Operating Income Expense Net [Member]

Interest Expense [Member]

Interest Expense [Member]

Exchanged [Member]

2027 convertible senior notes [Member]

2027 convertible senior notes [Member]

2027 convertible senior notes [Member]

2027 convertible senior notes [Member]

2031A convertible senior notes [Member]

2031A convertible senior notes [Member]

2031A convertible senior notes [Member]

2031B convertible senior notes [Member]

Scenario, Forecast [Member]

Scenario, Forecast [Member]

Convertible Debt [Member]

Convertible Debt [Member]

Convertible Debt [Member]

Convertible Debt [Member]

Convertible Debt [Member]

Exchanged [Member]

Convertible Debt [Member]

Convertible Debt [Member]

Convertible Debt [Member]

Convertible Debt [Member]

Convertible Debt [Member]

Convertible Debt [Member]

Exchanged [Member]

Termination Of Conversion Rights [Member]

Termination Of Conversion Rights [Member]

Termination Of Conversion Rights [Member]

Exchanged [Member]

Redemption Notice [Member]

Redemption Notice [Member]

Exchanged [Member]

2027 convertible senior notes [Member]

2031A convertible senior notes [Member]

integer

Exchanged [Member]

Scenario, Forecast [Member]

2027 convertible senior notes [Member]

2031A convertible senior notes [Member]

Scenario, Forecast [Member]

Scenario, Forecast [Member]

Exchanged [Member]

2031A convertible senior notes [Member]

Level 2 [Member]

Level 2 [Member]

Termination Of Conversion Rights [Member]

Redemption Notice [Member]

Termination Of Conversion Rights [Member]

Redemption Notice [Member]

2027 convertible senior notes [Member]

2031A convertible senior notes [Member]

Redemption Notice [Member]

Termination Of Conversion Rights [Member]

Redemption Notice [Member]

Extinguishment of Debt [Line Items]

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Extinquishment of Debt, Amount

'

'

'

'

$440

$80

'

'

'

$155

'

'

$205

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Repayments of convertible debt

'

'

'

'

'

'

'

'

'

'

'

'

'

179

'

'

'

'

'

'

'

'

'

'

'

'

'

Long-term Debt, Gross

5,803

'

6,037

'

'

'

'

138

'

'

'

'

'

'

'

628

[1]

627

0

[1]

'

'

'

'

'

'

'

'

'

Conversion rights, minimum number of trading days (in days)

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

20

'

'

'

'

'

'

'

'

'

'

'

Long-term debt, gross amount derecognized

'

'

'

'

345

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Debt Instrument, Unamortized Discount Derecognized

'

'

'

'

95

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Additional paid in capital equity component of convertible debt derecognized

'

'

'

'

411

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Loss on restructure of debt

-75

0

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

-38

-22

-15

-19

-49

'

'

Debt Instrument Convertible Interest Expense Make Whole

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

11

5

Debt Instrument, Face Amount, Holder Notification

'

'

'

'

'

'

'

'

'

'

112

'

'

'

78

'

'

'

'

'

'

'

'

'

'

'

'

Initial conversion, number of shares

'

'

'

269

[2]

'

'

9

'

'

'

12

'

'

'

8

35

[2]

'

'

'

'

'

'

'

'

'

'

'

Debt Instrument, Convertible, Derivative Reclassification

'

'

'

'

'

'

'

'

58

'

'

115

'

'

102

'

'

'

'

'

'

'

'

'

'

'

'

Debt Instrument, Scheduled Accreted Principal Amount

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

$820

$917

'

'

'

'

'

'

'

[1]

(1) For these notes, we have the option to pay cash for the aggregate amount due upon conversion. It is our current intent to settle the principal amount of these notes in cash upon conversion. As a result, the notes are considered in diluted earnings per share under the treasury stock method.

[2]

(1)Shares issuable, upon conversion, for the principal amount of the notes.

Contingencies_Details

Contingencies (Details) (USD $)

3 Months Ended

1 Months Ended

3 Months Ended

0 Months Ended

1 Months Ended

3 Months Ended

29 Months Ended

3 Months Ended

In Millions, unless otherwise specified

Nov. 28, 2013

Nov. 29, 2012

Nov. 28, 2013

Nov. 28, 2013

Dec. 31, 2013

Nov. 28, 2013

Nov. 28, 2013

Nov. 28, 2013

Nov. 28, 2013

Nov. 28, 2013

Nov. 28, 2013

Jun. 23, 2010

Jul. 31, 2006

Nov. 28, 2013

Nov. 29, 2012

Nov. 28, 2013

Nov. 28, 2013

Rambus Settlement [Member]

Rambus Settlement [Member]

Rambus Settlement [Member]

Patent Matters [Member]

Patent Matters [Member]

Patent Matters [Member]

Patent Matters [Member]

Patent Matters [Member]

Antitrust Matters [Member]

Antitrust Matters [Member]

Antitrust Matters [Member]

Antitrust Matters [Member]

Antitrust Matters [Member]

Securities Matter [Member]

Commercial Matters [Member]

Legal Settlement [Member]

Legal Settlement [Member]

HSM Portfolio LLC and Technology Properties LLC [Member]

HSM Portfolio LLC and Technology Properties LLC [Member]

Board Of Trustees For The University Of Illinois [Member]

Semcon Tech, LLC [Member]

Tessera, Inc. [Member]

Rambus DRAM Complaint [Member]

DRAM Purported Class Action Price-fixing Lawsuit [Member]

DRAM Purported Class Action Price-fixing Lawsuit [Member]

DRAM Purported Class Action Price-fixing Lawsuit [Member]

DRAM Purported Class Action Price-fixing Lawsuit [Member]

Former Shareholders of Elpida Memory, Inc [Member]

Qimonda AG Inotera Share Purchase Proceedings [Member]

Scenario, Forecast [Member]

integer

Elpida Company [Member]

integer

integer

Elpida Company [Member]

integer

integer

integer

Elpida Company [Member]

Inotera [Member]

integer

integer

integer

Loss Contingencies [Line Items]

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Approximation of damages claimed

'

'

'

'

'

'

'

'

'

'

$3,900

'

'

'

'

'

'

Settlement agreement execution date

'

'

'

'December 31, 2013

'

'

'

'

'

'

'

'

'

'June 23, 2010

'

'

'

Settlement Agreement, Maximum Quarterly Installment Payment

'

'

'

'

10

'

'

'

'

'

'

'

'

'

'

'

'

Settlement agreement number of years for installment payments (in years)

'

'

'

'

'7 years

'

'

'

'

'

'

'2 years

'

'

'

'

'

Settlement agreement amount

'

'

'

'

280

'

'

'

'

'

'

67

'

'

'

'

'

Rambus settlement

233

0

233

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Number of lawsuits filed

'

'

'

'

'

'

'

'

'

'

'

'

'

68

'

'

'

Allegedly number of patents infringed

'

'

'

'

'

4

2

3

1

4

'

'

'

'

'

'

'

Approximate number of U.S. states and territories filing suit

'

'

'

'

'

'

'

'

'

'

'

'

40

'

'

'

'

Settlement agreement number of installment payments

'

'

'

'

'

'

'

'

'

'

'

3

'

'

'

'

'

Amount paid into an escrow account in connection with settlement

'

'

'

'

'

'

'

'

'

'

'

'

'

'

67

'

'

Number of other defendants

'

'

'

'

'

17

'

'

'

'

'

'

'

'

'

'

'

Loss Contingency Number Of Petitions Submitted For Inter-Partes Review

'

'

'

'

'

'

'

3

'

'

'

'

'

'

'

'

'

Loss Contingency, Number of Plaintiffs

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

7

'

Equity method investment carrying value of shares acquired from Qimonda

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

241

Equity method investment quoted market value of shares acquired from Qimonda

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

$814

Micron_Shareholders_Equity_and2

Micron Shareholders' Equity and Noncontrolling Interests in Subsidiaries Micron Shareholders' Equity and Noncontrolling Interests in Subsidiaries - Changes in Components of Equity (Details) (USD $)	3 Months Ended
In Millions, unless otherwise specified	Nov. 28, 2013	Nov. 29, 2012
Increase (Decrease) in Stockholders' Equity [Roll Forward]	'	'
Balance	$10,006	$8,417
Net income (loss)	381	-275
Other comprehensive income (loss)	5	3
Comprehensive income (loss)	386	-272
Contributions from noncontrolling interests	49	0
Distributions to noncontrolling interests	-9	0
Capital and other transactions attributable to Micron	-286	41
Balance	10,146	8,186
Attributable to Micron [Member]	'	'
Increase (Decrease) in Stockholders' Equity [Roll Forward]	'	'
Balance	9,142	7,700
Net income (loss)	358	-275
Other comprehensive income (loss)	5	3
Comprehensive income (loss)	363	-272
Contributions from noncontrolling interests	0	0
Distributions to noncontrolling interests	0	0
Capital and other transactions attributable to Micron	-286	41
Balance	9,219	7,469
Noncontrolling Interests [Member]	'	'
Increase (Decrease) in Stockholders' Equity [Roll Forward]	'	'
Balance	864	717
Net income (loss)	23	0
Other comprehensive income (loss)	0	0
Comprehensive income (loss)	23	0
Contributions from noncontrolling interests	49	0
Distributions to noncontrolling interests	-9	0
Capital and other transactions attributable to Micron	0	0
Balance	$927	$717

Micron_Shareholders_Equity_and3

Micron Shareholders' Equity and Noncontrolling Interests in Subsidiaries - Capped Call Transactions (Details) (Call Option [Member], Purchased options [Member], Convertible Debt [Member], USD $)	3 Months Ended
Share data in Millions, except Per Share data, unless otherwise specified	Nov. 28, 2013
Option Indexed to Issuer's Equity [Line Items]	'
Option indexed to issuer's equity, shares (in shares)	227
Minimum [Member]	'
Option Indexed to Issuer's Equity [Line Items]	'
Option indexed to issuers equity settlement proceeds	0	[1]
Maximum [Member]	'
Option Indexed to Issuer's Equity [Line Items]	'
Option indexed to issuers equity settlement proceeds	954,000,000	[1]
2031A and 2031B convertible senior notes [Member]	'
Option Indexed to Issuer's Equity [Line Items]	'
Option indexed to issuer's equity, strike price (in dollars per share)	9.5	[2]
Option indexed to issuer's equity, shares (in shares)	73
2031A and 2031B convertible senior notes [Member] | Minimum [Member]	'
Option Indexed to Issuer's Equity [Line Items]	'
Option Indexed to Issuer's Equity, stated cap price	11.4
Option indexed to issuers equity settlement proceeds	0	[1]
2031A and 2031B convertible senior notes [Member] | Maximum [Member]	'
Option Indexed to Issuer's Equity [Line Items]	'
Option Indexed to Issuer's Equity, stated cap price	13.17
Option indexed to issuers equity settlement proceeds	207,000,000	[1]
2032C convertible senior notes [Member]	'
Option Indexed to Issuer's Equity [Line Items]	'
Option indexed to issuer's equity, strike price (in dollars per share)	9.8	[2]
Option indexed to issuer's equity, shares (in shares)	56
2032C convertible senior notes [Member] | Minimum [Member]	'
Option Indexed to Issuer's Equity [Line Items]	'
Option Indexed to Issuer's Equity, stated cap price	14.26
Option indexed to issuers equity settlement proceeds	0	[1]
2032C convertible senior notes [Member] | Maximum [Member]	'
Option Indexed to Issuer's Equity [Line Items]	'
Option Indexed to Issuer's Equity, stated cap price	15.69
Option indexed to issuers equity settlement proceeds	307,000,000	[1]
2032D convertible senior notes [Member]	'
Option Indexed to Issuer's Equity [Line Items]	'
Option indexed to issuer's equity, strike price (in dollars per share)	10.16	[2]
Option indexed to issuer's equity, shares (in shares)	44
2032D convertible senior notes [Member] | Minimum [Member]	'
Option Indexed to Issuer's Equity [Line Items]	'
Option Indexed to Issuer's Equity, stated cap price	14.62
Option indexed to issuers equity settlement proceeds	0	[1]
2032D convertible senior notes [Member] | Maximum [Member]	'
Option Indexed to Issuer's Equity [Line Items]	'
Option Indexed to Issuer's Equity, stated cap price	16.04
Option indexed to issuers equity settlement proceeds	244,000,000	[1]
2033E convertible senior notes [Member]	'
Option Indexed to Issuer's Equity [Line Items]	'
Option indexed to issuer's equity, strike price (in dollars per share)	10.93	[2]
Option indexed to issuer's equity, shares (in shares)	27
2033E convertible senior notes [Member] | Minimum [Member]	'
Option Indexed to Issuer's Equity [Line Items]	'
Option Indexed to Issuer's Equity, stated cap price	14.51
Option indexed to issuers equity settlement proceeds	0	[1]
2033E convertible senior notes [Member] | Maximum [Member]	'
Option Indexed to Issuer's Equity [Line Items]	'
Option Indexed to Issuer's Equity, stated cap price	14.51
Option indexed to issuers equity settlement proceeds	98,000,000	[1]
2033F convertible senior note [Member]	'
Option Indexed to Issuer's Equity [Line Items]	'
Option indexed to issuer's equity, strike price (in dollars per share)	10.93	[2]
Option indexed to issuer's equity, shares (in shares)	27
2033F convertible senior note [Member] | Minimum [Member]	'
Option Indexed to Issuer's Equity [Line Items]	'
Option Indexed to Issuer's Equity, stated cap price	14.51
Option indexed to issuers equity settlement proceeds	0	[1]
2033F convertible senior note [Member] | Maximum [Member]	'
Option Indexed to Issuer's Equity [Line Items]	'
Option Indexed to Issuer's Equity, stated cap price	14.51
Option indexed to issuers equity settlement proceeds	98,000,000	[1]
[1]	2)B Settlement in cash on the respective expiration dates would result in us receiving an amount ranging from zero, if the market price per share of our common stock is at or below the respective low strike price, to the respective maximum amount if the market price per share of our common stock is at or above the respective high cap price. If share settlement were elected, the number of shares repurchased would be determined by the value of the capped calls at the time of settlement divided by the share price on the settlement date.
[2]	1)B Initial strike prices are subject to certain adjustments

Micron_Shareholders_Equity_and4

Micron Shareholders' Equity and Noncontrolling Interests in Subsidiaries - Accumulated Other Comprehensive Income (Details) (USD $)	3 Months Ended
In Millions, unless otherwise specified	Nov. 28, 2013	Nov. 29, 2012
Accumulated Other Comprehensive Income (Loss), Net of Tax [Abstract]	'	'
Accumulated other comprehensive income	$63	'
Other comprehensive income before reclassifications	5	'
Other comprehensive income (loss)	5	3
Accumulated other comprehensive income	68	'
Cumulative Foreign Currency Translation Adjustments [Member]	'	'
Accumulated Other Comprehensive Income (Loss), Net of Tax [Abstract]	'	'
Accumulated other comprehensive income	44	'
Other comprehensive income before reclassifications	6	'
Other comprehensive income (loss)	6	'
Accumulated other comprehensive income	50	'
Gains (Losses) on Derivative Instruments, Net [Member]	'	'
Accumulated Other Comprehensive Income (Loss), Net of Tax [Abstract]	'	'
Accumulated other comprehensive income	21	'
Other comprehensive income before reclassifications	-2	'
Other comprehensive income (loss)	-2	'
Accumulated other comprehensive income	19	'
Gains (Losses) on Investments, Net [Member]	'	'
Accumulated Other Comprehensive Income (Loss), Net of Tax [Abstract]	'	'
Accumulated other comprehensive income	0	'
Other comprehensive income before reclassifications	1	'
Other comprehensive income (loss)	1	'
Accumulated other comprehensive income	1	'
Pension Liability Adjustments [Member]	'	'
Accumulated Other Comprehensive Income (Loss), Net of Tax [Abstract]	'	'
Accumulated other comprehensive income	-2	'
Other comprehensive income before reclassifications	0	'
Other comprehensive income (loss)	0	'
Accumulated other comprehensive income	($2)	'

Micron_Shareholders_Equity_and5

Micron Shareholders' Equity and Noncontrolling Interests in Subsidiaries - Reclassification out of Accumulated Other Comprehensive Income (Details) (USD $)	3 Months Ended
In Millions, unless otherwise specified	Nov. 28, 2013	Nov. 29, 2012
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]	'	'
Cost of goods sold	$2,761	$1,617
Gains (Losses) on Derivative Instruments, Net [Member] | Foreign Exchange Contract [Member] | Reclassification out of Accumulated Other Comprehensive Income [Member]	'	'
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]	'	'
Cost of goods sold	'	($3)

Derivative_Instruments_Fair_Va

Derivative Instruments - Fair Values (Details)

Nov. 28, 2013

Aug. 29, 2013

Nov. 28, 2013

Aug. 29, 2013

Nov. 28, 2013

Aug. 27, 2013

Nov. 28, 2013

Nov. 28, 2013

Nov. 28, 2013

Nov. 28, 2013

Aug. 29, 2013

Nov. 28, 2013

Nov. 28, 2013

Aug. 29, 2013

Nov. 28, 2013

Nov. 28, 2013

Nov. 28, 2013

Aug. 29, 2013

Nov. 28, 2013

Aug. 29, 2013

Nov. 28, 2013

Aug. 29, 2013

Nov. 28, 2013

Aug. 29, 2013

Nov. 28, 2013

Aug. 29, 2013

Nov. 28, 2013

Aug. 29, 2013

Nov. 28, 2013

Aug. 29, 2013

Nov. 28, 2013

Aug. 29, 2013

Nov. 28, 2013

Aug. 29, 2013

Nov. 28, 2013

Aug. 29, 2013

Nov. 28, 2013

Aug. 29, 2013

Nov. 28, 2013

Aug. 29, 2013

Nov. 28, 2013

Aug. 29, 2013

Nov. 28, 2013

Aug. 29, 2013

Nov. 28, 2013

Aug. 29, 2013

Nov. 28, 2013

Aug. 29, 2013

Nov. 28, 2013

Aug. 29, 2013

Nov. 28, 2013

Aug. 29, 2013

Nov. 28, 2013

Aug. 29, 2013

Aug. 29, 2013

Nov. 28, 2013

Aug. 29, 2013

Nov. 28, 2013

Aug. 29, 2013

Nov. 28, 2013

Aug. 29, 2013

Nov. 28, 2013

Aug. 29, 2013

Nov. 28, 2013

Aug. 29, 2013

Aug. 29, 2013

Nov. 28, 2013

Nov. 28, 2013

Nov. 28, 2013

Aug. 29, 2013

Nov. 28, 2013

Aug. 29, 2013

Nov. 28, 2013

Aug. 29, 2013

Nov. 28, 2013

Aug. 29, 2013

Nov. 28, 2013

Aug. 29, 2013

Nov. 28, 2013

Aug. 29, 2013

Nov. 28, 2013

Aug. 29, 2013

Nov. 28, 2013

Aug. 29, 2013

Nov. 28, 2013

Nov. 28, 2013

Aug. 29, 2013

Nov. 28, 2013

Aug. 29, 2013

Nov. 28, 2013

Aug. 29, 2013

Nov. 28, 2013

Nov. 28, 2013

Nov. 28, 2013

Aug. 29, 2013

Nov. 28, 2013

Aug. 29, 2013

Nov. 28, 2013

Aug. 29, 2013

Nov. 28, 2013

Aug. 29, 2013

Nov. 28, 2013

Aug. 29, 2013

Nov. 28, 2013

Aug. 29, 2013

In Millions, unless otherwise specified

USD ($)

USD ($)

Notes Payable, Other Payables [Member]

Notes Payable, Other Payables [Member]

Secured Debt 2 [Member]

Secured Debt 2 [Member]

Accounts Receivable [Member]

Accounts payable and current portion of long-term debt [Member]

Other Noncurrent Liabilities [Member]

Not Designated as Hedging Instrument [Member]

Not Designated as Hedging Instrument [Member]

Not Designated as Hedging Instrument [Member]

Not Designated as Hedging Instrument [Member]

Not Designated as Hedging Instrument [Member]

Not Designated as Hedging Instrument [Member]

Not Designated as Hedging Instrument [Member]

Not Designated as Hedging Instrument [Member]

Not Designated as Hedging Instrument [Member]

Not Designated as Hedging Instrument [Member]

Not Designated as Hedging Instrument [Member]

Not Designated as Hedging Instrument [Member]

Not Designated as Hedging Instrument [Member]

Not Designated as Hedging Instrument [Member]

Not Designated as Hedging Instrument [Member]

Not Designated as Hedging Instrument [Member]

Not Designated as Hedging Instrument [Member]

Not Designated as Hedging Instrument [Member]

Not Designated as Hedging Instrument [Member]

Not Designated as Hedging Instrument [Member]

Not Designated as Hedging Instrument [Member]

Not Designated as Hedging Instrument [Member]

Not Designated as Hedging Instrument [Member]

Not Designated as Hedging Instrument [Member]

Not Designated as Hedging Instrument [Member]

Not Designated as Hedging Instrument [Member]

Not Designated as Hedging Instrument [Member]

Not Designated as Hedging Instrument [Member]

Not Designated as Hedging Instrument [Member]

Not Designated as Hedging Instrument [Member]

Not Designated as Hedging Instrument [Member]

Not Designated as Hedging Instrument [Member]

Not Designated as Hedging Instrument [Member]

Not Designated as Hedging Instrument [Member]

Not Designated as Hedging Instrument [Member]

Not Designated as Hedging Instrument [Member]

Not Designated as Hedging Instrument [Member]

Not Designated as Hedging Instrument [Member]

Not Designated as Hedging Instrument [Member]

Not Designated as Hedging Instrument [Member]

Not Designated as Hedging Instrument [Member]

Not Designated as Hedging Instrument [Member]

Not Designated as Hedging Instrument [Member]

Not Designated as Hedging Instrument [Member]

Not Designated as Hedging Instrument [Member]

Not Designated as Hedging Instrument [Member]

Not Designated as Hedging Instrument [Member]

Not Designated as Hedging Instrument [Member]

Not Designated as Hedging Instrument [Member]

Not Designated as Hedging Instrument [Member]

Not Designated as Hedging Instrument [Member]

Not Designated as Hedging Instrument [Member]

Not Designated as Hedging Instrument [Member]

Not Designated as Hedging Instrument [Member]

Not Designated as Hedging Instrument [Member]

Not Designated as Hedging Instrument [Member]

Not Designated as Hedging Instrument [Member]

Not Designated as Hedging Instrument [Member]

Not Designated as Hedging Instrument [Member]

Not Designated as Hedging Instrument [Member]

Not Designated as Hedging Instrument [Member]

Not Designated as Hedging Instrument [Member]

Not Designated as Hedging Instrument [Member]

Not Designated as Hedging Instrument [Member]

Not Designated as Hedging Instrument [Member]

Not Designated as Hedging Instrument [Member]

Not Designated as Hedging Instrument [Member]

Not Designated as Hedging Instrument [Member]

Not Designated as Hedging Instrument [Member]

Not Designated as Hedging Instrument [Member]

Not Designated as Hedging Instrument [Member]

Not Designated as Hedging Instrument [Member]

Not Designated as Hedging Instrument [Member]

Designated as Hedging Instrument [Member]

Designated as Hedging Instrument [Member]

Designated as Hedging Instrument [Member]

Designated as Hedging Instrument [Member]

Designated as Hedging Instrument [Member]

Designated as Hedging Instrument [Member]

Designated as Hedging Instrument [Member]

Designated as Hedging Instrument [Member]

Designated as Hedging Instrument [Member]

Designated as Hedging Instrument [Member]

Designated as Hedging Instrument [Member]

Designated as Hedging Instrument [Member]

Designated as Hedging Instrument [Member]

Designated as Hedging Instrument [Member]

Designated as Hedging Instrument [Member]

Designated as Hedging Instrument [Member]

Designated as Hedging Instrument [Member]

Designated as Hedging Instrument [Member]

Designated as Hedging Instrument [Member]

Designated as Hedging Instrument [Member]

Designated as Hedging Instrument [Member]

Designated as Hedging Instrument [Member]

Designated as Hedging Instrument [Member]

USD ($)

USD ($)

Notes Payable, Other Payables [Member]

Notes Payable, Other Payables [Member]

USD ($)

USD ($)

USD ($)

USD ($)

USD ($)

Forward Contracts [Member]

Forward Contracts [Member]

Forward Contracts [Member]

Forward Contracts [Member]

Forward Contracts [Member]

Forward Contracts [Member]

Forward Contracts [Member]

Forward Contracts [Member]

Forward Contracts [Member]

Forward Contracts [Member]

Forward Contracts [Member]

Interest Rate Swap [Member]

Interest Rate Swap [Member]

Convertible notes settlement obligations [Member]

Currency options [Member]

Accounts Receivable [Member]

Accounts Receivable [Member]

Accounts Receivable [Member]

Accounts Receivable [Member]

Accounts Receivable [Member]

Accounts Receivable [Member]

Accounts Receivable [Member]

Accounts Receivable [Member]

Accounts Receivable [Member]

Accounts Receivable [Member]

Accounts Receivable [Member]

Accounts Receivable [Member]

Accounts Receivable [Member]

Accounts Receivable [Member]

Other noncurrent assets [Member]

Other noncurrent assets [Member]

Other noncurrent assets [Member]

Other noncurrent assets [Member]

Other noncurrent assets [Member]

Other noncurrent assets [Member]

Other noncurrent assets [Member]

Other noncurrent assets [Member]

Other noncurrent assets [Member]

Other noncurrent assets [Member]

Other noncurrent assets [Member]

Other noncurrent assets [Member]

Other noncurrent assets [Member]

Other noncurrent assets [Member]

Accounts Payable [Member]

Accounts Payable [Member]

Accounts Payable [Member]

Accounts Payable [Member]

Accounts Payable [Member]

Accounts Payable [Member]

Accounts Payable [Member]

Accounts Payable [Member]

Accounts Payable [Member]

Accounts Payable [Member]

Accounts Payable [Member]

Accounts Payable [Member]

Short-term Debt [Member]

Accounts payable and current portion of long-term debt [Member]

Other Noncurrent Liabilities [Member]

Other Noncurrent Liabilities [Member]

Other Noncurrent Liabilities [Member]

Other Noncurrent Liabilities [Member]

Other Noncurrent Liabilities [Member]

Other Noncurrent Liabilities [Member]

Other Noncurrent Liabilities [Member]

Other Noncurrent Liabilities [Member]

Other Noncurrent Liabilities [Member]

Other Noncurrent Liabilities [Member]

Other Noncurrent Liabilities [Member]

Other Noncurrent Liabilities [Member]

Other Noncurrent Liabilities [Member]

Other Noncurrent Liabilities [Member]

Cash Flow Hedging [Member]

Cash Flow Hedging [Member]

Cash Flow Hedging [Member]

Cash Flow Hedging [Member]

Cash Flow Hedging [Member]

Cash Flow Hedging [Member]

Cash Flow Hedging [Member]

Cash Flow Hedging [Member]

Cash Flow Hedging [Member]

Cash Flow Hedging [Member]

Cash Flow Hedging [Member]

Cash Flow Hedging [Member]

Cash Flow Hedging [Member]

Cash Flow Hedging [Member]

Cash Flow Hedging [Member]

Cash Flow Hedging [Member]

Cash Flow Hedging [Member]

Cash Flow Hedging [Member]

Cash Flow Hedging [Member]

Cash Flow Hedging [Member]

Cash Flow Hedging [Member]

Cash Flow Hedging [Member]

Cash Flow Hedging [Member]

USD ($)

USD ($)

Yen

Yen

Yen

Yen

Singapore dollar

Singapore dollar

Shekel

Shekel

Euro

Euro

USD ($)

USD ($)

New Taiwan dollar

USD ($)

USD ($)

Forward Contracts [Member]

Forward Contracts [Member]

Forward Contracts [Member]

Forward Contracts [Member]

Forward Contracts [Member]

Forward Contracts [Member]

Forward Contracts [Member]

Forward Contracts [Member]

Interest Rate Swap [Member]

Interest Rate Swap [Member]

Convertible notes settlement obligations [Member]

Currency options [Member]

USD ($)

USD ($)

Forward Contracts [Member]

Forward Contracts [Member]

Forward Contracts [Member]

Forward Contracts [Member]

Forward Contracts [Member]

Forward Contracts [Member]

Forward Contracts [Member]

Forward Contracts [Member]

Interest Rate Swap [Member]

Interest Rate Swap [Member]

Convertible notes settlement obligations [Member]

Currency options [Member]

USD ($)

Forward Contracts [Member]

Forward Contracts [Member]

Forward Contracts [Member]

Forward Contracts [Member]

Forward Contracts [Member]

Forward Contracts [Member]

Forward Contracts [Member]

Forward Contracts [Member]

Interest Rate Swap [Member]

Interest Rate Swap [Member]

Currency options [Member]

Convertible notes settlement obligations [Member]

USD ($)

USD ($)

USD ($)

Forward Contracts [Member]

Forward Contracts [Member]

Forward Contracts [Member]

Forward Contracts [Member]

Forward Contracts [Member]

Forward Contracts [Member]

Forward Contracts [Member]

Forward Contracts [Member]

Interest Rate Swap [Member]

Interest Rate Swap [Member]

Convertible notes settlement obligations [Member]

Currency options [Member]

USD ($)

USD ($)

Forward Contracts [Member]

Forward Contracts [Member]

Forward Contracts [Member]

Forward Contracts [Member]

Forward Contracts [Member]

Interest Rate Swap [Member]

Interest Rate Swap [Member]

Currency options [Member]

Currency options [Member]

Currency options [Member]

Currency options [Member]

Accounts Payable [Member]

Accounts Payable [Member]

Accounts Payable [Member]

Accounts Payable [Member]

Accounts Payable [Member]

Accounts Payable [Member]

Accounts Payable [Member]

Accounts Payable [Member]

Accounts Payable [Member]

Accounts Payable [Member]

USD ($)

USD ($)

Reorganization obligation [Member]

Reorganization obligation [Member]

USD ($)

USD ($)

USD ($)

USD ($)

USD ($)

USD ($)

USD ($)

Yen

Yen

Singapore dollar

Singapore dollar

Shekel

Shekel

Euro

Euro

USD ($)

USD ($)

USD ($)

New Taiwan dollar

Yen

Yen

Singapore dollar

Singapore dollar

Shekel

Shekel

Euro

Euro

USD ($)

USD ($)

USD ($)

New Taiwan dollar

Yen

Yen

Singapore dollar

Singapore dollar

Shekel

Shekel

Euro

Euro

USD ($)

USD ($)

New Taiwan dollar

USD ($)

Yen

Yen

Singapore dollar

Singapore dollar

Shekel

Shekel

Euro

Euro

USD ($)

USD ($)

USD ($)

New Taiwan dollar

Yen

Yen

Euro

Euro

USD ($)

USD ($)

Minimum [Member]

Maximum [Member]

Yen

Yen

USD ($)

USD ($)

Forward Contracts [Member]

Forward Contracts [Member]

Forward Contracts [Member]

Forward Contracts [Member]

Interest Rate Swap [Member]

Interest Rate Swap [Member]

Currency options [Member]

Currency options [Member]

Less Than One Year From Balance Sheet Date [Member]

More Than One Year And Within Two Years From Balance Sheet Date [Member]

USD ($)

USD ($)

USD ($)

USD ($)

USD ($)

USD ($)

USD ($)

USD ($)

USD ($)

USD ($)

USD ($)

USD ($)

USD ($)

USD ($)

USD ($)

USD ($)

USD ($)

USD ($)

USD ($)

USD ($)

USD ($)

USD ($)

USD ($)

USD ($)

USD ($)

USD ($)

USD ($)

USD ($)

USD ($)

USD ($)

USD ($)

USD ($)

USD ($)

USD ($)

USD ($)

USD ($)

USD ($)

USD ($)

USD ($)

USD ($)

USD ($)

USD ($)

Yen

Yen

Euro

Euro

USD ($)

USD ($)

Yen

Yen

JPY (¥)

JPY (¥)

USD ($)

USD ($)

USD ($)

USD ($)

USD ($)

USD ($)

Interest Rate Derivatives [Abstract]

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Debt instrument, original term

'

'

'

'

'4 years

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Long-term Debt, Gross

$5,803

$6,037

$582

$635

$293

$312

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Hedging designation allocation

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

20.00%

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

80.00%

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Notional Disclosures [Abstract]

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Notional Amount Outstanding

'

'

'

'

'

'

'

'

'

959

[1]

1,262

[1]

'

496

[1]

336

[1]

20,000

10,000

265

[1]

218

[1]

81

[1]

78

[1]

58

[1]

217

[1]

59

[1]

62

[1]

'

351

[1]

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

272

283

'

12

6

15

6

234

250

'

'

11

21

'

'

'

'

'

'

'

'

'

'

Notional amount of convertible notes settlement obligations (in shares)

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

21

[1]

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Derivative, Fair Value, Net [Abstract]

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Fair Value of Asset

'

'

'

'

'

'

1

[2]

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

0

[3]

2

[3]

0

[3]

1

[3]

0

[3]

0

[3]

0

[3]

0

[3]

0

[3]

1

[3]

0

[3]

0

[3]

0

[3]

0

[3]

0

[4]

3

[4]

0

[4]

3

[4]

0

[4]

0

[4]

0

[4]

0

[4]

0

[4]

0

[4]

0

[4]

0

[4]

0

[4]

0

[4]

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Fair Value of Liability

'

'

'

'

'

'

'

($463)

[5]

($4)

[6]

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

($2)

[7]

($13)

[7]

$0

[7]

($2)

[7]

$0

[7]

$0

[7]

($1)

[7]

($1)

[7]

($1)

[7]

$0

[7]

$0

[7]

$0

[7]

($444)

[7]

($460)

[7]

($4)

[8]

$0

[8]

($4)

[8]

$0

[8]

$0

[8]

$0

[8]

$0

[8]

$0

[8]

$0

[8]

$0

[8]

$0

[8]

$0

[8]

$0

[8]

$0

[8]

'

'

'

'

'

'

'

'

'

'

'

'

'

($3)

[9]

($3)

[9]

$0

[9]

($1)

[9]

$0

[9]

$0

[9]

($2)

[9]

$0

[9]

($1)

[9]

($2)

[9]

Foreign Currency Cash Flow Hedges [Abstract]

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

General maturity of non-designated currency forward contracts (in days)

'

'

'

'

'

'

'

'

'

'

'

'35 days

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

General maturity of hedge contracts (in days or months)

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'12 months

'

'

'

'

'

'

'12 months

'18 months

'

'

'

'

'

'

'

'

'

'

'

'

[1]

(1)Notional amounts of forward, option and interest rate swap contracts in U.S. dollars and convertible notes settlement obligations in shares.

[2]

(1) Included in receivables b other.

[3]

(2)B Included in receivables b other.

[4]

(3)B Included in other noncurrent assets.

[5]

Included in current portion of long-term debt and accounts payable and accrued expenses b other.

[6]

(3) Included in other noncurrent liabilities.

[7]

(4)B Included in accounts payable and accrued expenses b other for forward, option and interest rate swap contracts and in current portion of long-term debt for convertible notes settlement obligations.

[8]

(5)B Included in other noncurrent liabilities.

[9]

Included in accounts payable and accrued expenses b other.

Derivative_Instruments_Hedging

Derivative Instruments - Hedging Relationship (Details) (USD $)	3 Months Ended
In Millions, unless otherwise specified	Nov. 28, 2013	Nov. 29, 2012
Derivative Instruments, Gain (Loss) [Line Items]	'	'
Derivative, Gain (Loss) on Derivative, Net	($14)	($51)
Cost of goods sold	-2,761	-1,617
Cash Flow Hedge Gain (Loss) to be Reclassified within Twelve Months	6	'
Not Designated as Hedging Instrument [Member] | Elpida Memory, Inc. and Rexchip Electronics Corporation [Member]	'	'
Derivative Instruments, Gain (Loss) [Line Items]	'	'
Derivative, Gain (Loss) on Derivative, Net	'	-62
Designated as Hedging Instrument [Member] | Cash Flow Hedging [Member]	'	'
Derivative Instruments, Gain (Loss) [Line Items]	'	'
Derivative Instruments, Gain (Loss) Recognized in Other Comprehensive Income, Effective Portion	-2	-4
Convertible notes settlement obligations [Member] | Not Designated as Hedging Instrument [Member] | Other Non-Operating Income Expense Net [Member]	'	'
Derivative Instruments, Gain (Loss) [Line Items]	'	'
Derivative, Gain (Loss) on Derivative, Net	-37	'
Foreign Exchange Contract [Member] | Gains (Losses) on Derivative Instruments, Net [Member] | Reclassification out of Accumulated Other Comprehensive Income [Member]	'	'
Derivative Instruments, Gain (Loss) [Line Items]	'	'
Cost of goods sold	'	3
Foreign Exchange Contract [Member] | Not Designated as Hedging Instrument [Member] | Other Non-Operating Income Expense Net [Member]	'	'
Derivative Instruments, Gain (Loss) [Line Items]	'	'
Derivative, Gain (Loss) on Derivative, Net	($14)	($51)

Derivative_Instruments_Fair_Va1

Derivative Instruments - Fair Value Derivatives Balance Sheet Location After Netting Arrangements Table (Details) (USD $)	Nov. 28, 2013
In Millions, unless otherwise specified
Accounts Receivable [Member]	'
Derivatives, Fair Value [Line Items]	'
Gross amount	$1	[1]
Gross amounts offset in the statement of financial position	-1	[1]
Net amounts presented in the statement of financial position	0	[1]
Accounts payable and current portion of long-term debt [Member]	'
Derivatives, Fair Value [Line Items]	'
Gross amount	-463	[2]
Gross amounts offset in the statement of financial position	1	[2]
Net amounts presented in the statement of financial position	462	[2]
Other Noncurrent Liabilities [Member]	'
Derivatives, Fair Value [Line Items]	'
Gross amount	-4	[3]
Gross amounts offset in the statement of financial position	0	[3]
Net amounts presented in the statement of financial position	$4	[3]
[1]	(1) Included in receivables b other.
[2]	Included in current portion of long-term debt and accounts payable and accrued expenses b other.
[3]	(3) Included in other noncurrent liabilities.

Fair_Value_Measurements_Assets

Fair Value Measurements - Assets measured (Details) (USD $)	Nov. 28, 2013	Aug. 29, 2013
In Millions, unless otherwise specified
Fair Value, Assets Measured on Recurring Basis, Financial Statement Captions [Line Items]	'	'
Short-term investments	$216	$221
Long-term marketable investments	538	499
Fair Value, Measurements, Recurring [Member]	'	'
Fair Value, Assets Measured on Recurring Basis, Financial Statement Captions [Line Items]	'	'
Cash equivalents	2,225	1,261
Short-term investments	216	221
Long-term marketable investments	538	499
Restricted cash	7	302
Total assets measured at fair value on a recurring basis	2,986	2,283
Fair Value, Measurements, Recurring [Member] | Money market funds [Member]	'	'
Fair Value, Assets Measured on Recurring Basis, Financial Statement Captions [Line Items]	'	'
Cash equivalents	1,677	1,188
Fair Value, Measurements, Recurring [Member] | Certificates of deposit [Member]	'	'
Fair Value, Assets Measured on Recurring Basis, Financial Statement Captions [Line Items]	'	'
Cash equivalents	543	38
Short-term investments	8	9
Restricted cash	7	302
Fair Value, Measurements, Recurring [Member] | Commercial paper [Member]	'	'
Fair Value, Assets Measured on Recurring Basis, Financial Statement Captions [Line Items]	'	'
Cash equivalents	5	35
Fair Value, Measurements, Recurring [Member] | Corporate bonds [Member]	'	'
Fair Value, Assets Measured on Recurring Basis, Financial Statement Captions [Line Items]	'	'
Short-term investments	112	112
Long-term marketable investments	330	302
Fair Value, Measurements, Recurring [Member] | Commercial Paper, Not Included with Cash and Cash Equivalents [Member]	'	'
Fair Value, Assets Measured on Recurring Basis, Financial Statement Captions [Line Items]	'	'
Short-term investments	58	26
Fair Value, Measurements, Recurring [Member] | Government securities [Member]	'	'
Fair Value, Assets Measured on Recurring Basis, Financial Statement Captions [Line Items]	'	'
Short-term investments	37	72
Long-term marketable investments	96	96
Fair Value, Measurements, Recurring [Member] | Asset-backed securities [Member]	'	'
Fair Value, Assets Measured on Recurring Basis, Financial Statement Captions [Line Items]	'	'
Short-term investments	1	2
Long-term marketable investments	106	95
Fair Value, Measurements, Recurring [Member] | Marketable equity securities [Member]	'	'
Fair Value, Assets Measured on Recurring Basis, Financial Statement Captions [Line Items]	'	'
Long-term marketable investments	6	6
Fair Value, Measurements, Recurring [Member] | Level 1 [Member]	'	'
Fair Value, Assets Measured on Recurring Basis, Financial Statement Captions [Line Items]	'	'
Cash equivalents	1,677	1,188
Short-term investments	0	0
Long-term marketable investments	6	6
Restricted cash	0	0
Total assets measured at fair value on a recurring basis	1,683	1,194
Fair Value, Measurements, Recurring [Member] | Level 1 [Member] | Money market funds [Member]	'	'
Fair Value, Assets Measured on Recurring Basis, Financial Statement Captions [Line Items]	'	'
Cash equivalents	1,677	1,188
Fair Value, Measurements, Recurring [Member] | Level 1 [Member] | Certificates of deposit [Member]	'	'
Fair Value, Assets Measured on Recurring Basis, Financial Statement Captions [Line Items]	'	'
Cash equivalents	0	0
Short-term investments	0	0
Restricted cash	0	0
Fair Value, Measurements, Recurring [Member] | Level 1 [Member] | Commercial paper [Member]	'	'
Fair Value, Assets Measured on Recurring Basis, Financial Statement Captions [Line Items]	'	'
Cash equivalents	0	0
Fair Value, Measurements, Recurring [Member] | Level 1 [Member] | Corporate bonds [Member]	'	'
Fair Value, Assets Measured on Recurring Basis, Financial Statement Captions [Line Items]	'	'
Short-term investments	0	0
Long-term marketable investments	0	0
Fair Value, Measurements, Recurring [Member] | Level 1 [Member] | Commercial Paper, Not Included with Cash and Cash Equivalents [Member]	'	'
Fair Value, Assets Measured on Recurring Basis, Financial Statement Captions [Line Items]	'	'
Short-term investments	0	0
Fair Value, Measurements, Recurring [Member] | Level 1 [Member] | Government securities [Member]	'	'
Fair Value, Assets Measured on Recurring Basis, Financial Statement Captions [Line Items]	'	'
Short-term investments	0	0
Long-term marketable investments	0	0
Fair Value, Measurements, Recurring [Member] | Level 1 [Member] | Asset-backed securities [Member]	'	'
Fair Value, Assets Measured on Recurring Basis, Financial Statement Captions [Line Items]	'	'
Short-term investments	0	0
Long-term marketable investments	0	0
Fair Value, Measurements, Recurring [Member] | Level 1 [Member] | Marketable equity securities [Member]	'	'
Fair Value, Assets Measured on Recurring Basis, Financial Statement Captions [Line Items]	'	'
Long-term marketable investments	6	6
Fair Value, Measurements, Recurring [Member] | Level 2 [Member]	'	'
Fair Value, Assets Measured on Recurring Basis, Financial Statement Captions [Line Items]	'	'
Cash equivalents	548	73
Short-term investments	216	221
Long-term marketable investments	532	493
Restricted cash	7	302
Total assets measured at fair value on a recurring basis	1,303	1,089
Fair Value, Measurements, Recurring [Member] | Level 2 [Member] | Money market funds [Member]	'	'
Fair Value, Assets Measured on Recurring Basis, Financial Statement Captions [Line Items]	'	'
Cash equivalents	0	0
Fair Value, Measurements, Recurring [Member] | Level 2 [Member] | Certificates of deposit [Member]	'	'
Fair Value, Assets Measured on Recurring Basis, Financial Statement Captions [Line Items]	'	'
Cash equivalents	543	38
Short-term investments	8	9
Restricted cash	7	302
Fair Value, Measurements, Recurring [Member] | Level 2 [Member] | Commercial paper [Member]	'	'
Fair Value, Assets Measured on Recurring Basis, Financial Statement Captions [Line Items]	'	'
Cash equivalents	5	35
Fair Value, Measurements, Recurring [Member] | Level 2 [Member] | Corporate bonds [Member]	'	'
Fair Value, Assets Measured on Recurring Basis, Financial Statement Captions [Line Items]	'	'
Short-term investments	112	112
Long-term marketable investments	330	302
Fair Value, Measurements, Recurring [Member] | Level 2 [Member] | Commercial Paper, Not Included with Cash and Cash Equivalents [Member]	'	'
Fair Value, Assets Measured on Recurring Basis, Financial Statement Captions [Line Items]	'	'
Short-term investments	58	26
Fair Value, Measurements, Recurring [Member] | Level 2 [Member] | Government securities [Member]	'	'
Fair Value, Assets Measured on Recurring Basis, Financial Statement Captions [Line Items]	'	'
Short-term investments	37	72
Long-term marketable investments	96	96
Fair Value, Measurements, Recurring [Member] | Level 2 [Member] | Asset-backed securities [Member]	'	'
Fair Value, Assets Measured on Recurring Basis, Financial Statement Captions [Line Items]	'	'
Short-term investments	1	2
Long-term marketable investments	106	95
Fair Value, Measurements, Recurring [Member] | Level 2 [Member] | Marketable equity securities [Member]	'	'
Fair Value, Assets Measured on Recurring Basis, Financial Statement Captions [Line Items]	'	'
Long-term marketable investments	0	0
Fair Value, Measurements, Recurring [Member] | Level 3 [Member]	'	'
Fair Value, Assets Measured on Recurring Basis, Financial Statement Captions [Line Items]	'	'
Cash equivalents	0	0
Short-term investments	0	0
Long-term marketable investments	0	0
Restricted cash	0	0
Total assets measured at fair value on a recurring basis	0	0
Fair Value, Measurements, Recurring [Member] | Level 3 [Member] | Money market funds [Member]	'	'
Fair Value, Assets Measured on Recurring Basis, Financial Statement Captions [Line Items]	'	'
Cash equivalents	0	0
Fair Value, Measurements, Recurring [Member] | Level 3 [Member] | Certificates of deposit [Member]	'	'
Fair Value, Assets Measured on Recurring Basis, Financial Statement Captions [Line Items]	'	'
Cash equivalents	0	0
Short-term investments	0	0
Restricted cash	0	0
Fair Value, Measurements, Recurring [Member] | Level 3 [Member] | Commercial paper [Member]	'	'
Fair Value, Assets Measured on Recurring Basis, Financial Statement Captions [Line Items]	'	'
Cash equivalents	0	0
Fair Value, Measurements, Recurring [Member] | Level 3 [Member] | Corporate bonds [Member]	'	'
Fair Value, Assets Measured on Recurring Basis, Financial Statement Captions [Line Items]	'	'
Short-term investments	0	0
Long-term marketable investments	0	0
Fair Value, Measurements, Recurring [Member] | Level 3 [Member] | Commercial Paper, Not Included with Cash and Cash Equivalents [Member]	'	'
Fair Value, Assets Measured on Recurring Basis, Financial Statement Captions [Line Items]	'	'
Short-term investments	0	0
Fair Value, Measurements, Recurring [Member] | Level 3 [Member] | Government securities [Member]	'	'
Fair Value, Assets Measured on Recurring Basis, Financial Statement Captions [Line Items]	'	'
Short-term investments	0	0
Long-term marketable investments	0	0
Fair Value, Measurements, Recurring [Member] | Level 3 [Member] | Asset-backed securities [Member]	'	'
Fair Value, Assets Measured on Recurring Basis, Financial Statement Captions [Line Items]	'	'
Short-term investments	0	0
Long-term marketable investments	0	0
Fair Value, Measurements, Recurring [Member] | Level 3 [Member] | Marketable equity securities [Member]	'	'
Fair Value, Assets Measured on Recurring Basis, Financial Statement Captions [Line Items]	'	'
Long-term marketable investments	$0	$0

Fair_Value_Measurements_Fair_a

Fair Value Measurements - Fair and Carrying Value (Details) (USD $)	Nov. 28, 2013	Aug. 29, 2013
In Millions, unless otherwise specified
Fair Value [Member] | Level 2 [Member]	'	'
Fair value disclosure [Line Items]	'	'
Fair value of convertible debt instruments	$6,076	$4,167
Elpida creditor installment payments and other debt instruments	1,680	2,269
Carrying Value [Member]	'	'
Fair value disclosure [Line Items]	'	'
Fair value of convertible debt instruments	3,019	2,506
Elpida creditor installment payments and other debt instruments	$1,677	$2,279

Equity_Plans_Share_Based_Compe

Equity Plans - Share Based Compensation (Details) (USD $)	3 Months Ended
In Millions, except Per Share data, unless otherwise specified	Nov. 28, 2013	Nov. 29, 2012	Nov. 28, 2013
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]	'	'	'
Number of shares of common stock reserved for issuance for stock options and restricted stock awards (in shares)	140	'	'
Number of shares subject to outstanding awards (in shares)	67	'	'
Number of shares available for future awards (in shares)	73	'	'
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross	2	4	'
Share-based Compensation Arrangement by Share-based Payment Award, Additional General Disclosures [Abstract]	'	'	'
Weighted-average grant-date fair values per share of options granted during period (in dollars per share)	$7.58	$2.99	'
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions and Methodology [Abstract]	'	'	'
Fair Value Assumptions, Method Used	'Black-Scholes	'	'
Average expected life (in years)	'4 years 10 months	'5 years 0 months	'
Weighted-average expected volatility (in hundredths)	50.00%	62.00%	'
Weighted-average risk-free interest rate (in hundredths)	1.30%	0.70%	'
Restricted Stock Awards activity	'	'	'
Number of Shares - Outstanding (in shares)	'	'	10
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Roll Forward]	'	'	'
Weighted Average Grant Date Fair Value Per Share - Granted (in dollars per share)	$17.31	$5.73	'
Service-based awards [Member]	'	'	'
Restricted Stock Awards activity	'	'	'
Number of Shares - Granted (in shares)	1	2	'
Performance-based shares [Member]	'	'	'
Restricted Stock Awards activity	'	'	'
Number of Shares - Outstanding (in shares)	'	'	1
Number of Shares - Granted (in shares)	1	1	'

Equity_Plans_Stockbased_compen

Equity Plans - Stock-based compensation expense (Details) (USD $)	3 Months Ended
In Millions, unless otherwise specified	Nov. 28, 2013	Nov. 29, 2012
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]	'	'
Stock-based compensation	$22	$19
Employee Service Share-based Compensation, Aggregate Disclosures [Abstract]	'	'
Total unrecognized compensation costs, net of estimated forfeitures, related to non-vested awards expected to be recognized	166	'
Weighted average period that unrecognized compensation costs is expected to be recognized (in years)	'1 year 3 months	'
Stock Options [Member]	'	'
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]	'	'
Stock-based compensation	14	13
Restricted Stock Awards [Member]	'	'
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]	'	'
Stock-based compensation	8	6
Cost of Goods Sold [Member]	'	'
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]	'	'
Stock-based compensation	7	6
Selling, General and Administrative Expenses [Member]	'	'
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]	'	'
Stock-based compensation	11	9
Research and Development [Member]	'	'
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]	'	'
Stock-based compensation	$4	$4

Restucture_and_Asset_Impairmen2

Restucture and Asset Impairments Restructure and Asset Impairments (Details) (USD $)	3 Months Ended
In Millions, unless otherwise specified	Nov. 28, 2013	Nov. 29, 2012	Aug. 29, 2013
Restructuring Cost and Reserve [Line Items]	'	'	'
Restructure and asset impairments	($3)	($21)	'
Restructuring Reserve	1	'	12
Transform [Member]	'	'	'
Restructuring Cost and Reserve [Line Items]	'	'	'
Gain on lease termination	0	-25	'
Other Restucturing Activities [Member]	'	'	'
Restructuring Cost and Reserve [Line Items]	'	'	'
Restructure and asset impairments	($3)	$4	'

Other_Operating_Income_Expense2

Other Operating (Income) Expense, Net (Details) (USD $)	3 Months Ended
In Millions, unless otherwise specified	Nov. 28, 2013	Nov. 29, 2012
Component Of Operating Other Income And Expense Net [Line Items]	'	'
Rambus settlement	$233	$0
(Gain) loss on disposition of property, plant and equipment	8	-5
Other	-4	-3
Other operating (income) expense, net	237	-8
Rambus Settlement [Member]	'	'
Component Of Operating Other Income And Expense Net [Line Items]	'	'
Rambus settlement	$233	'

Other_NonOperating_Income_Expe2

Other Non-Operating Income (Expense), Net (Details) (USD $)	3 Months Ended
In Millions, unless otherwise specified	Nov. 28, 2013	Nov. 29, 2012	Nov. 29, 2012	Feb. 27, 2014
			Elpida Company [Member]	Debt Restructure [Member]
			Not Designated as Hedging Instrument [Member]	Scenario, Forecast [Member]
Component of Other Non-Operating Income (Expense), Net [Line Items]	'	'	'	'
Loss on restructure of debt	($75)	$0	'	($68)
Gain (loss) from changes in currency exchange rates	-6	-59	-62	'
Other	1	0	'	'
Other non-operating income (expense), net	($80)	($59)	'	'

Income_Taxes_Details_1

Income Taxes (Details 1) (USD $)	3 Months Ended
In Millions, unless otherwise specified	Nov. 28, 2013
Deferred foreign income tax provision	$73

Income_Taxes_Income_Tax_Holida

Income Taxes Income Tax Holiday (Details) (USD $)	3 Months Ended
In Millions, except Per Share data, unless otherwise specified	Nov. 28, 2013	Nov. 29, 2012
Income Tax Holiday [Line Items]	'	'
Tax benefit due to arrangements allowing computation of tax provision at rates below local statutory rates	$76	$11
Tax benefit per diluted share due to arrangements allowing computation of tax provision at rates below local statutory rates (in dollars per share)	$0.06	$0.01

Earnings_Per_Share_Details

Earnings Per Share (Details) (USD $)	3 Months Ended
In Millions, except Per Share data, unless otherwise specified	Nov. 28, 2013	Nov. 29, 2012
Earnings Per Share Reconciliation [Abstract]	'	'
Net income (loss) available to Micron shareholders - Basic and Diluted	$358	($275)
Weighted Average Number of Shares Outstanding Reconciliation [Abstract]	'	'
Weighted-average common shares outstanding - Basic (in shares)	1,046	1,014
Net effect of dilutive equity awards, escrow shares and assumed conversion of debt (in shares)	150	0
Weighted-average common shares outstanding - Diluted (in shares)	1,196	1,014
Earnings (loss) per share:	'	'
Basic (in dollars per share)	$0.34	($0.27)
Diluted (in dollars per share)	$0.30	($0.27)

Earnings_Per_Share_Potential_C

Earnings Per Share - Potential Common Shares Excluded in the Computation of Diluted Earnings Per Share Because They Would Have Been Antidilutive (Details)	3 Months Ended
In Millions, unless otherwise specified	Nov. 28, 2013	Nov. 29, 2012
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]	'	'
Antidilutive potential common shares that could dilute basic earnings per share in the future (in shares)	38	357

Consolidated_Variable_Interest2

Consolidated Variable Interest Entities (Details) (USD $)

3 Months Ended

12 Months Ended

3 Months Ended

3 Months Ended

In Millions, unless otherwise specified

Nov. 28, 2013

Nov. 29, 2012

Aug. 29, 2013

Aug. 31, 2006

Nov. 28, 2013

Aug. 29, 2013

Nov. 28, 2013

Nov. 29, 2012

Nov. 28, 2013

Nov. 29, 2012

Aug. 29, 2013

Nov. 28, 2013

Nov. 29, 2012

Nov. 28, 2013

Nonsoftware License Arrangement with Photronics [Member]

Nonsoftware License Arrangement with Photronics [Member]

Nonsoftware License Arrangement with Photronics [Member]

Intel [Member]

Intel [Member]

IM Flash Technologies, LLC [Member]

IM Flash Technologies, LLC [Member]

IM Flash Technologies, LLC [Member]

Variable Interest Entities Which We Have Determined That We Are the Primary Beneficiary [Member]

Variable Interest Entities Which We Have Determined That We Are the Primary Beneficiary [Member]

Variable Interest Entities Which We Have Determined That We Are the Primary Beneficiary [Member]

NAND Flash [Member]

NAND Flash [Member]

Intel [Member]

Intel [Member]

Intel [Member]

IM Flash Technologies, LLC [Member]

IM Flash Technologies, LLC [Member]

MP Mask Technology Center, LLC [Member]

NAND Flash [Member]

NAND Flash [Member]

NAND Flash [Member]

Variable Interest Entity [Line Items]

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Variable interest entity, ownership percentage (in hundredths)

'

'

'

'

'

'

'

'

'

'

'

51.00%

'

50.01%

Variable interest entity, ownership percentage by noncontrolling owners (in hundredths)

'

'

'

'

'

'

'

'

'

'

'

'

'

49.99%

R and D expenses reduced by reimbursements from Intel

'

'

'

'

'

'

$29

$32

'

'

'

'

'

'

Net sales

4,042

1,834

'

'

'

'

'

'

101

99

'

'

'

'

Trade Receivables

2,533

'

2,069

'

'

'

'

'

59

'

68

'

'

'

Proceeds for entering into license agreement with Photronics

'

'

'

72

'

'

'

'

'

'

'

'

'

'

Term of license agreement with Photronics (in years)

'

'

'

'10 years

'

'

'

'

'

'

'

'

'

'

Deferred income and other noncurrent liabilities related to license agreement with Photronics

'

'

'

'

18

19

'

'

'

'

'

'

'

'

Distributions to, and contributions from, shareholders [Abstract]

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Distributions to Micron from Consolidated VIE's

'

'

'

'

'

'

'

'

'

'

'

0

0

'

Distributions to noncontrolling interests from consolidated VIE's

9

0

'

'

'

'

'

'

'

'

'

0

0

'

Micron contributions to consolidated VIE's

'

'

'

'

'

'

'

'

'

'

'

51

0

'

Cash received from noncontrolling interests

$49

$0

'

'

'

'

'

'

'

'

'

$49

$0

'

Consolidated_Variable_Interest3

Consolidated Variable Interest Entities - Assets & Liabilities (Details) (USD $)	Nov. 28, 2013		Aug. 29, 2013		Nov. 29, 2012	Aug. 30, 2012
In Millions, unless otherwise specified
Assets	'		'		'	'
Cash and equivalents	$3,654		$2,880		$2,102	$2,459
Receivables	2,833		2,329		'	'
Inventories	2,459		2,649		'	'
Other current assets	207		276		'	'
Total current assets	9,369		8,911		'	'
Property, plant and equipment, net	7,733		7,626		'	'
Other noncurrent assets	494		439		'	'
Total assets	19,794		19,118		'	'
Liabilities	'		'		'	'
Accounts payable and accrued expenses	2,630		2,115		'	'
Deferred income	236		243		'	'
Equipment purchase contracts	104		182		'	'
Current portion of long-term debt	1,543		1,585		'	'
Total current liabilities	4,513		4,125		'	'
Long-term debt	4,260		4,452		'	'
Other noncurrent liabilities	875		535		'	'
Total liabilities	9,648		9,112		'	'
Variable Interest Entity, Primary Beneficiary [Member] | IM Flash Technologies, LLC [Member]	'		'		'	'
Assets	'		'		'	'
Cash and equivalents	105	[1]	62	[1]	'	'
Receivables	67	[1]	76	[1]	'	'
Inventories	48	[1]	49	[1]	'	'
Other current assets	4	[1]	4	[1]	'	'
Total current assets	224	[1]	191	[1]	'	'
Property, plant and equipment, net	1,364	[1]	1,382	[1]	'	'
Other noncurrent assets	47	[1]	46	[1]	'	'
Total assets	1,635	[1]	1,619	[1]	'	'
Liabilities	'		'		'	'
Accounts payable and accrued expenses	87	[1]	88	[1]	'	'
Deferred income	9	[1]	9	[1]	'	'
Equipment purchase contracts	4	[1]	78	[1]	'	'
Current portion of long-term debt	6	[1]	6	[1]	'	'
Total current liabilities	106	[1]	181	[1]	'	'
Long-term debt	11	[1]	13	[1]	'	'
Other noncurrent liabilities	114	[1]	118	[1]	'	'
Total liabilities	231	[1]	312	[1]	'	'
Variable Interest Entity, Primary Beneficiary [Member] | MP Mask Technology Center, LLC [Member]	'		'		'	'
Assets	'		'		'	'
Total current assets	32	[1]	26	[1]	'	'
Noncurrent assets (primarily property, plant and equipment)	176	[1]	182	[1]	'	'
Liabilities	'		'		'	'
Total current liabilities	$24	[1]	$25	[1]	'	'
[1]	Amounts exclude intercompany balances that were eliminated in our consolidated balance sheets.

Segment_Information_Details

Segment Information (Details) (USD $)	3 Months Ended
In Millions, unless otherwise specified	Nov. 28, 2013	Nov. 29, 2012
Segment Reporting Information [Line Items]	'	'
Net sales	$4,042	$1,834
Operating income (loss)	551	-97
DSG [Member]	'	'
Segment Reporting Information [Line Items]	'	'
Net sales	1,785	600
Operating income (loss)	432	-112
WSG [Member]	'	'
Segment Reporting Information [Line Items]	'	'
Net sales	1,054	263
Operating income (loss)	176	-64
NSG [Member]	'	'
Segment Reporting Information [Line Items]	'	'
Net sales	806	617
Operating income (loss)	95	13
ESG [Member]	'	'
Segment Reporting Information [Line Items]	'	'
Net sales	366	278
Operating income (loss)	66	78
All Other [Member]	'	'
Segment Reporting Information [Line Items]	'	'
Net sales	31	76
Operating income (loss)	15	-12
Unallocated [Member]	'	'
Segment Reporting Information [Line Items]	'	'
Operating income (loss)	($233)	$0

Certain_Concentrations_Details

Certain Concentrations (Details) (Sales Revenue, Goods, Net [Member])	3 Months Ended
	Nov. 28, 2013	Nov. 29, 2012
Product Concentration Risk [Member] | Computing (including desktop PCs, servers, notebooks and workstations) [Member]	'	'
Concentration Risk [Line Items]	'	'
Concentration risk, percentage of net sales (in hundreths)	35.00%	20.00%
Product Concentration Risk [Member] | Mobile [Member]	'	'
Concentration Risk [Line Items]	'	'
Concentration risk, percentage of net sales (in hundreths)	25.00%	15.00%
Product Concentration Risk [Member] | Consumer electronics [Member]	'	'
Concentration Risk [Line Items]	'	'
Concentration risk, percentage of net sales (in hundreths)	10.00%	20.00%
Product Concentration Risk [Member] | Solid state drives [Member]	'	'
Concentration Risk [Line Items]	'	'
Concentration risk, percentage of net sales (in hundreths)	10.00%	10.00%
Product Concentration Risk [Member] | Networking and storage [Member]	'	'
Concentration Risk [Line Items]	'	'
Concentration risk, percentage of net sales (in hundreths)	10.00%	10.00%
Customer Concentration Risk [Member] | Apple Inc. [Member]	'	'
Concentration Risk [Line Items]	'	'
Concentration risk, percentage of net sales (in hundreths)	13.00%	'